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BIOSYNTHESIS AND RELEASE OF PEPTIDES 
RELATED TO PRO-OPIOMELANOCORTIN 
BY THE PARS INTERMEDIA 
OF THE AMPHIBIAN XENOPUS LAEVIS 

GENERAL INTRODUCTION 
The purpose of this introduction is three-fold. First, a summarizing account 
of background adaptation in amphibians is given as this phenomenon constitutes 
the frame-work for the studies reported in this thesis. Secondly, in recent 
years - and in part concurrently with our own investigations - intriguing de-
velopments took place in research on hormone synthesis in the pituitary gland, 
in particular concerning structural relationships between melanophore stimula-
ting hormone (MSH), adrenocorticotropic hormone (ACTH) and lipotropic hormone 
(LPH). These developments are of immediate relevance to the topic of our stu-
dies and, therefore, they are briefly reviewed here. Finally, the aims of our 
investigations are formulated as an introduction to the problems dealt with in 
the Chapters l-IX. 
Background adaptation in amphibians: a neuroendocrine reflex 
The basis of the color pattern in amphibians - as indeed in most animals -
is the presence of numerous pigment cells, chromatophores, in the skin. Changes 
in pigmentation may be brought about by a wide variety of stimuli, from the 
environment as well as from within the animals. In general, two modes of color 
change are distinguished: morphological changes, which are relatively slow and 
involve an increase or a decrease in amounts of pigment or in numbers of chro-
matophores, and physiological changes, rapid displacement of pigment-containing 
organelles within the chromatophores. The latter changes are a response to some 
immediate environmental stimulus, e.g. a change in light conditions or altera-
tion of background pattern. They are mediated by nervous or hormonal mechanisms. 
In amphibians, mostly hormones are the direct cause of chromatophore behavior. 
Of the four types of pigment cells ( iridophores, xanthophores, erythrophores 
and melanophores) the melanophores are probably the most active in color changes. 
They come in two forms which occur in different anatomical divisions of the in-
tegument: epidermal melanophores and dermal melanophores. The latter type is 
directly involved in rapid changes in pigment distribution and is most sensi-
tive to hormones. 
The most common manifestation of physiological color change takes place during 
the process of background adaptation. Placing amphibians, that can adapt, on a 
dark-colored background leads to dispersal of the pigment-filled granules (me-
li 
lanosomes) ¡η the cells, thus imparting a dark color to the skin. Conversely, 
when such animals are transferred to a light background, the melanosomes will 
aggregate around the nuclei and, consequently, their skin turns pale. 
For more than 60 years it has been known that the pituitary gland is involved 
in background adaptation. As early as 1916 it was demonstrated that removal of 
the pituitary in tadpoles resulted in a silvering of the skin (Smith, 1916; 
Allen, I916) and it was soon postulated that the pituitary gland contains a 
'chromatophore stimulating agent' (Smith, 1920). The source of this hormone 
appeared to be the pars intermedia (Atwell, 1919; Swingle, 1921; Zondek ε 
Krohn, 19З2) and hence the hormone was called intermedin, a name later to be 
replaced by 'melanophore stimulating hormone', MSH. The full significance of 
these early observations became clear through a series of classical experiments 
by L. Hogben, F.R. Winton and D. Slome in the twenties and thirties. Using the 
South African clawed toad, Xanovus laevin, these investigators showed that 
visual perception is directly involved in background adaptation. Briefly, the 
starting observation was that in the toads, in a normal position, only the 
lower parts of the retinae of the eyes are stimulated by direct light from 
above, while the upper parts may receive light reflected by the background. 
When, on a black background in the absence of reflected light, only the lower 
parts of the retinae are excited, the pigment granules in the dermal melano-
phores are dispersed and the animal becomes dark. Illumination of the upper 
parts of the retinae, on a white background by reflected light, leads to me-
lanosome aggregation and, consequently, pallor of the skin. Thus, in amphibians 
- and possibly also in other lower vertebrates - the fraction of reflected 
light, referred to as the 'background albedo', is a determining factor in 
background adaptation of the skin. For detailed reviews of the numerous inves­
tigations on which the above brief account is based, see Waring (1963), Bagnara 
and Hadley (1973), Bagnara (1976) and Novales (1977). 
Altogether, it may be said that background adaptation in amphibians is an exam­
ple of a response to an environmental cue with the physiological characteristics 
of a neuroendocrine reflex. The environmental cue is a change in background; the 
receptors involved are the eyes, whereby a differential sensitivity of dorsal 
and ventral parts of the retinae probably leads to selective central processing 
in the brain. Precisely how the retina discriminates the light sensations and 
what pathways are involved in the central processing is largely unknown. There 
is, however, little doubt that in coupling the neuronal to the hormonal link 
in the chain of events, the hypothalamus plays a significant role. That the 
hypothalamus exerts an inhibitory influence on the MSH secretion by the pars 
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intermedia was f i r s t shown by E t k i n (ІЭ'*!) and t h i s r o l e has since been c o n ­
f i r m e d by a number of exper iments. Yet, concerning the exact mechanism(s) of 
the c o n t r o l of MSH release from the pars i n t e r m e d i a , much remains t o be e l u ­
c i d a t e d . The f i n a l step in the chain of e v e n t s , the a c t i o n of MSH on the me-
lanophores, has been the s u b j e c t of a number of recent i n v e s t i g a t i o n s . Ev ident­
l y , the mechanism of a c t i o n of MSH involves b i n d i n g of the hormone to s p e c i f i c 
eel 1-membrane-bound r e c e p t o r s and s ignal t r a n s d u c t i o n r e s u l t i n g in a c t i v a t i n g 
the adenylate c y c l a s e . Thus, a r o l e f o r adenosine S ' . S ' - c y c l i c monophosphate 
( c y c l i c AMP) as a second messenger is w e l l e s t a b l i s h e d , as is the n e c e s s i t y 
2+ 
o f Ca - i o n s , but the exact s i g n i f i c a n c e of these agents f o r the i n t r a c e l l u l a r 
process t h a t u l t i m a t e l y leads t o m i g r a t i o n of pigment g r a n u l e s , is s t i l l l a r g e ­
ly unknown. O t h e r w i s e , t h i s aspect is beyond the scope of t h i s i n t r o d u c t o r y 
note and r e f e r e n c e may be made t o p e r t i n e n t reviews (Turner et al., 1977; 
Hadley ei al., 1981; De Graan, 1981). 
Strsalvral relationship betoeea a-MSH, ACTH and ß-lFh 
Current research on hormone synthes is in the pars intermedia has been p ro -
foundly in f luenced by the idea proposed by Lowry & Scott (1975) t ha t a-MSH, 
the most potent MSH, is der ived from ACTH. This no t ion was based on the f a c t 
t ha t the amino ac i d sequence of a-MSH is i d e n t i c a l to the N-terminal p o r t i o n 
(13 amino ac ids) of ACTH, and the presence in the pars intermedia of equimolar 
amounts of a-MSH and a pept ide corresponding to the C-terminal p o r t i o n of ACTH 
(ACTH( l8-39) ) , the s o - c a l l e d c o r t i c o t r o p i n - l i k e in termedia te lobe pept ide (CLIP). 
At about the same t ime , evidence accumulated tha t ACTH i t s e l f (ACTH(l-39)) is 
a l so der ived f rom a prohormone. Radioimmunoassays of p i t u i t a r y e x t r a c t s , which 
had been f r a c t i o n a t e d w i t h gel f i l t r a t i o n chromatography, showed tha t ACTH can 
occur as par t of a h igh-molecu lar weight molecu le , which was termed ' b i g ACTH' 
(Yalow Ь Berson, 1973)· A more p r e c i s e d e t e r m i n a t i o n of the s i z e - h e t e r o g e n e i t y 
of ACTH was e s t a b l i s h e d w i t h SDS gel e l e c t r o p h o r e s i s . This l a s t s e p a r a t i o n t e c h ­
nique resolved 31K- and 23K-forms (K = 1000 d a l t o n s ) of immunoreacti ve ACTH 
(Eipper & Mains, 1976) which were thought t o correspond t o ' b i g ACTH'. S t r u c ­
t u r a l analyses of p r o t e i n s , however, give only c i r c u m s t a n t i a l evidence f o r a 
p o s s i b l e p r e c u r s o r - p r o d u c t r e l a t i o n s h i p . B i o s y n t h e t i c s t u d i e s were necessary 
t o show the p r o t e o l y t i c convers ion of the precursor t o i t s p r o d u c t s . The b i o ­
s y n t h e s i s of ACTH was f i r s t examined by Mains 6 Eipper (1976) in a mouse tumor 
eel 1-1 ine (AtT-20/D-l6v) d e r i v e d from c o r t i c o t r o p h s of the pars d i s t a l is of 
the p i t u i t a r y g l a n d . Using pulse-chase t e c h n i q u e s , they demonstrated t h a t in 
these tumor c e l l s r a d i o a c t i v e 31K-ACTH, designated pro-ACTH, f u n c t i o n s as the 
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biosynthetic precursor to ACTH. At about the same time Roberts ε Herbert 
(1977a), Jones et al. (1977) and Nakanishi ev al. (1976) obtained an ACTH-re-
lated protein of approximately the same size when pituitary mRNA was transla­
ted in a cell-free protein synthesis system. Thus, clear evidence was available 
that ACTH is synthesized through processing of a high-molecular weight precur­
sor. A crucial observation was that pro-ACTH is also the prohormone for g-lipo-
tropic hormone (g-LPH) , a peptide with weak lipotropic activity discovered by 
Li et al. (1965). The observation that peptides related to ACTH and g-LPH were 
released from pituitary glands in approximately equimolar amounts (Abe et al., 
1969; Gilkes et al., 1975), together with the finding that ACTH and 3-LPH were 
immunohistochemically localized in the same secretory granules of pituitary 
cells (Moriarty, 1973), already had suggested that there might exist some re­
lationship between ACTH and B"LPH. By sequential immunoprecipi tat¡on experi-
ments, Mains e с al. (1977) and Roberts ε Herbert (1977b) established that in 
mouse pituitary tumor cells a single ЗОК-protein contained antigenic determi­
nants for both ACTH and g-LPH. Pulse-chase experiments demonstrated that ACTH 
and g-LPH were biosynthetic products in the processing of the 30K-product 
(Mains ε Eipper, 1978), the common prohormone which was termed pro-ACTH/'g-LPH. 
A similar precursor has since been demonstrated in normal corticotropiс cells 
of the pars distal is and in the pars intermedia (see Eipper ε Mains, I98O, and 
Chrétien ε Seidah, I98I) as well as in hypothalamic neurons (Liotta et al., 
1979) and in the placenta (Odagiri et al., 1979). 
The protein that accounted for the non-ACTH, non-g-LPH mass of the precursor 
molecule appeared to be a glycoprotein with a molecular weight of ^16.000 da 1-
tons, which was called ІбК-fragment (Eipper ε Mains, 1978). This protein was 
found to constitute the N-terminal part of the prohormone, while ACTH occupied 
a central position in the prohormone structure and g-LPH represented its C-
terminal (see Eipper ε Mains, 198O). This model, derived from biosynthetic data, 
fits well with the protein structures which have recently been deduced from nu­
cleotide sequence analyses. Application of nucleotide sequencing technology has 
led to the structures of pro-ACTH/ß-LPH in bovine, human and rat (Nakanishi et 
al., 1979; Chang et al., I98O; Drouin ε Goodman, 198θ). A schematic representa­
tion of the structures of these prohormones is given in Fig. 1. The processing 
of rat pro-ACTH/g-LPH, as revealed by biosynthetic studies, is also shown. The 
proteolytic conversion of the prohormone appeared to be tissue-specific. In the 
corticotrophs of the pars distal is, processing yielded primarily ІбК-fragment, 
glycosylated (ІЗК)АСТН and non-glycosylated (^.5K)ACTH, and ß-LPH. In the pars 
intermedia, ACTH is further processed to a-MSH and CLIP, and ß-LPH is cleaved 
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Figure 1. Schematic r e p r e s e n t a t i o n of the s t r u c t u r e s of bovine, human and r a t pro-opiomelanocortίπ 
(рго-АСТН/0-LPH) and of processing o f the r a t prohormone. The s t r u c t u r e s of the pro-opiomelanocor-
t i n s were deduced from n u c l e o t i d e sequence analyses and the scheme o u t l i n i n g the processing is 
based on b i o s y n t h e t i c s t u d i e s (see t e x t ) . In the box ( b o t t o m ) : cleavages and m o d i f i c a t i o n s t h a t 
occur in the pars intermedia but not in the cor.t i c o t r o p i c c e l l s of the pars d i s t a l i s . 
ι ι corresponding p o r t i o n s of the t h r e e prohormones w i t h very s i m i l a r amino a c i d sequences. 
• ^ ^ н corresponding p o r t i o n s o f the t h r e e prohormones w i t h d i f f e r e n t amino a c i d sequences. 
—--ц—. p o r t i o n s of the prohormones in human and r a t w i t h p a r t i a l l y known amino a c i d sequences 
t h a t suggests s i m i l a r i t y . 
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 responsible for melanotropic a c t i v i t y . 
t o form ß-endorphin and mod i f ied forms of t h i s endogenous op ia te (see Eipper 6 
Mains, 198O, and Chrét ien & Seidah, I 981 ) . Thus, pro-ACTH/g-LPH generates a 
number of pep t i des , i n c l ud i ng o p i a t e s , melanotropins and c o r t i c o t r o p i n s which 
led Chrét ien βτ al·. (1979) t o propose the name p r o - o p i o m e l a n o c o r t i n in order 
t o r e f l e c t the f u l l m u l t i p l i c i t y of i t s p o t e n t i a l f u n c t i o n s . 
The e l u c i d a t i o n of the complete pr imary s t r u c t u r e of p r o - o p i o m e l a n o c o r t i n 
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allows us to give some characteristics of the precursor molecule. The high con­
tent of hydrophobic amino acids in the N-terminal sequence of the bovine pro­
hormone indicates that this portion functions as a signal peptide. In the part 
corresponding to the ІбК-fragment, an amino acid sequence is present which is 
strikingly similar to that of a- and f5-MSH and it was, therefore, named γ-MSH 
(Nakanishi et al., 1979). These three MSHs contain the tetrapeptide His-Phe-
Arg-Trp, a sequence responsible for melanotropic activity (Schwyzer ε Eberle, 
1977). The ІбК-portions in the three species contain the sequence Asn-X-Ser, 
a sequence required for an asparagine-linked N-glycosylat¡on (Pless 6 Lennarz, 
1977)· In the rat, the region corresponding to ACTH contains a second potential 
glycosylat ion site and, indeed, glycosylated ACTH and CLIP were found in this 
species (Roberts et al., 1978; Elpper & Mains, 1978). In the structure of the 
pro-opiomelanocortins, the regions corresponding to the ІбК-fragment, γ-MSH, 
ACTH, α-MSH, CLIP, ß-LPH and S-endorphin are flanked on both sides by pairs of 
basic amino acids. Such pairs of basic amino acids generally represent clea-
vage sites in prohormones (Steiner et al., I98O). Their presence, however, does 
not necessarily imply that at these sites cleavage occurs, as illustrated by 
the tissue-specific cleavage pattern of prohormones in the pars distal is and 
the pars intermedia. Finally, it may be mentioned that there is a remarkable 
homology between the structures of bovine, human and rat pro-opiomelanocortin 
concerning three regions. Two of these regions correspond to bioactive pep-
tides, namely α-MSH, ACTH and g-endorphin. The third one is found within the 
portion corresponding to the ІбК-fragment. The presence of this third, appa­
rently 'stable1, amino acid sequence may suggest that pro-opiomelanocortin 
could be the source of additional biologically important peptides. 
Scope of the investigations reported in this thesis 
Although the production of a melanophore stimulating hormone by the amphi­
bian pars intermedia had been firmly established, the identity of this hormone 
remained unknown for a long time. It was not until 1972 that immunological evi­
dence indicated the presence of α-MSH (Shapiro et al., 1972). It was also postu­
lated, however, that the pars intermedia of amphibians contains more than one 
melanophore stimulating substance (Burgers et al., 1963; Preslock ε Br¡nkley,1970; 
Hopkins, 1972). Moreover, the complexity of the biosynthetic events became 
apparent when indications were obtained that MSH is derived from a stored pre-
cursor (Thornton, I97I; Jenks et al., 1977). Indeed, biochemical studies by Loh 
ε Gainer (1977) demonstrated that in Xeno-pus a precursor is synthesized, which 
is processed to a number of smaller peptides including some with melanotropic 
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activity. In our laboratory the existence of such a precursor-product relation-
ship was confirmed (Jenks 6 Van Overbeeke, I98O) . During these studies gel 
electrophoresis was used and it was noted that some of the pars intermedia pep-
tides co-migrated on the gel, which illustrated the need for better separation 
methods. Therefore, high-performance liquid chromatography (HPLC) was intro-
duced to analyse peptide biosynthesis in neurointermediate lobes of Xenopus 
laevis (Chapter l). Subsequently, the various peptides derived from the pre-
cursor were characterized. Three groups of newly synthesized peptides could be 
distinguished: melanotropins, peptides related to corticotropin, and endorphin-
like peptides (Chapter II). In view of the nature of these products, the pro-
hormone was designated pro-opiomelanocort¡n. One of the melanotropic products 
was identified as des-Na-acetyl-a-MSH and another one as a-MSH. A third mela-
notropin appeared to be a γ,-MSH-like peptide (Chapter III). The results con­
cerning the characterization of products suggested that the pars intermedia 
peptides might be derived from two different prohormones. A subsequent inves­
tigation demonstrated that indeed in the pars intermedia of ХепориЗ two struc­
turally different pro-opiomelanocortins occur (Chapter IV). The studies des­
cribed in Chapters l-IV concern analyses of peptide biosynthesis in incubated 
neurointermediate lobes. The question had to be asked whether the results of 
these in vitro investigations reflect the pattern of biosynthesis in the living 
animal. In Chapter V the in vivo production of MSH and related peptides is des-
cr ibed. 
For a tissue like the pars intermedia which produces a variety of secretory 
peptides, all derived from the same prohormone but which could have different 
physiological functions, the fundamental question is whether all products are 
released simultaneously or whether the gland is capable of selective release. 
A directly related question is which factors are involved in the regulation of 
product release. To investigate some aspects of pars intermedia regulation, a 
microsuperfus ion technique was developed (Chapter VI). Using this technique in 
combination with HPLC as a separation method, effects of a number of potential 
regulatory factors on release of the newly synthesized products derived from 
pro-opiomelanocortin were analyzed (Chapter VII). This study was followed by 
an investigation concerning control of a-MSH release, whereby levels of this 
hormone were measured with a radioimmunoassay (Chapter V I M ) . The last chapter 
reports that the final step in the biosynthesis of a-MSH is an No-acetylat ion 
of des-Na-acetyl-a-MSH, which takes place immediately prior to or during re­
lease of the hormone (Chapter IX). 
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PART I 
BIOSYNTHESIS OF PEPTIDES RELATED TO PRO-OPIOMELANOCORTI N 
BY THE PARS INTERMEDIA OF XENOPUS LAEVIS 
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(1980) 67B, 1*31-1*97 
ANALYSIS OF PEPTIDE BIOSYNTHESIS IN THE NEUROINTERMEDIATE LOBE 
OF XENOPUS LAEVIS USING HIGH-PERFORMAHCE LIQUID CHROMATOGRAPHY: 
OCCURRENCE OF SMALL BIOACTIVE PRODUCTS 
Gerard J.M. Martens, B.G. Jenks and A.P. van Overbeeke 
Department of Zoology, Faculty of Saienoe, Catholic University, 
Toernooiveld, 6525 EO Nijmegen, The Netherlands 
ABSTRACT 
1. Peptide biosynthesis in neurointermediate lobes of Ыаск-adapted Xenopus 
laevis was studied using pulse-chase incubations and reversed-phase, high-
performance liquid chromatographic analysis. 
2. During the pulse period one major product was synthesized, which was sub­
sequently converted to 12 chase peptides, suggesting a precursor-product 
mode of biosynthesis for this tissue. 
3. Chase peptides I, II and IV possessed high melanotropic activity. Alpha-MSH 
did not appear to be among the chase peptides. Peptide II had also high 
corticotropic activity. 
't. Peptides I and II are probably small, since they were TCA-soluble and ran 
faster on acid-urea gels than a-MSH. They may, however, well be structurally 
related to this latter hormone. 
INTRODUCTION 
Many amphibians, when placed on a black background, darken as a result of the 
dispersion of the black pigment melanin in the dermal melanophores. This disper­
sion is controlled by a melanophore stimulating hormone (MSH) from the pars 
intermedia of the pituitary gland. Electrophoretic analysis of amphibian pitui­
tary glands has revealed the presence of a number of melanotropic peptides 
(Burgers, 1961; Preslock ε Brinkley, 1970a,b; Hopkins, 1972; Loh Б Gainer, 1977). 
Pulse-chase analysis of biosynthetic events in neurointermediate lobes of the 
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African clawed toad, Xenopus laevin (Loh, 1979; Jenks Б van Overbeeke, I98O) , 
suggests that most, if not all, of the melanotropic peptides are derived from 
a precursor that is a prohormone to corticotropin (ACTH) and endorphins. While 
it has been generally accepted that a-MSH represents the melanotropic peptide 
in amphibians, Jenks & van Overbeeke (1980) obtained results pointing towards 
the possibility that this product is not synthesized in fully black-adapted 
Xenopus laevis. They suggest that one of the other chase peptides might act 
as the melanotropic factor responsible for maintaining the animal in the dark­
ened state. 
Although in our laboratory important information on the complex pathways of 
peptide biosynthesis has been obtained by employing gel electrophoresis, we 
have indications that some of the neurointermediate lobe peptides were co-
migrating on the gel, thus indicating the need for improved separation methods, 
preferably with higher resolution. Nice & O'Hare (1979), attempting to separate 
synthetic corticotropin- and endorphin-1ike peptides, successfully employed 
reversed-phase high-performance liquid chromatography (HPLC) . 
We wish to report on the application of HPLC to analyse peptide biosynthesis 
in neuro i η termed iate lobes of Ыаск-adapted Xenopus laevis. In vitro pulse and 
pulse-chase experiments were performed. The melanotropic and corticotropic 
activity of the various peptides separated with HPLC were analysed with appro­
priate bioassays. 
MATERIALS AND METHODS 
Anima Is 
Adult male Xenopus laevis were bred and reared in the Department of Zoology, 
University of Nijmegen. In all experiments neurointermediate lobes from fully 
Ыаск-adapted animals were used. The conditions for adaptation to a black back­
ground were the same as previously described (Jenks & van Overbeeke, Ι9Θ0). 
American lizards, Anolis carolinensiss to be used for the MSH bioassay, 
were purchased from Carolina Biological Supply Company (Burlington, North 
Carol ina, U.S.A. ). 
Adult male Wistar rats, to be used for the preparation of adrenal cell sus­
pensions in the ACTH bioassay, were obtained from the Central Animal Laboratory, 
University of Nijmegen. 
Ih 
Pulse and pulse-ohase -incubations 
NeurointeriTiediate lobes of Ыаск-adapted Xenopus were p r e i n c u b a t e d f o r 1 h 
¡η 500 μΐ i n c u b a t i o n medium (112 mM NaCl , 2 mM KCl, 2 mM CaCl-, 15 mM Hepes, 
bovine serum albumin (BSA) 0.3 mg/ml, glucose 2 mg/ml, pH 7 . 3 8 ) . The 30-min 
pulse i n c u b a t i o n was done in the presence of kO yCi [ H ] l y s i n e (New England 
N u c l e a r , sp. a c t . 60 Ci/mmol) on a Dubnoff m e t a b o l i c shaker (220C) . The lobes 
were then homogenized in 500 \i\ 0.1 M a c e t i c a c i d (HAc) in an a l l - g l a s s homo-
g e n i z e r , the homogenate was c e n t r i f u g e d (5 m i n , 10.000 g , Beekman microfuge) 
and the supernatant was analysed w i t h HPLC. In pulse-chase i n c u b a t i o n s , a f t e r 
the 30-min pulse in [ H ] l y s i n e , the lobes were chase- incubated f o r 6 h in 
medium c o n t a i n i n g 5 mM L - l y s i n e (Calbiochem, San Diego, C a l i f o r n i a , U.S.A.) . 
F o l l o w i n g the chase i n c u b a t i o n , the lobes were homogenized, the homogenate was 
c e n t r i f u g e d and the supernatant was i n j e c t e d onto the HPLC column. 
To determine which of the newly synthesized products c o n t a i n e d the amino 
a c i d l e u c i n e , n e u r o i n t e r m e d i a t e lobes were pul se- incubated f o r 6 h in medium 
c o n t a i n i n g 40 pCi [ H ] l e u c i n e (New England Nuclear, sp. a c t . 120 Ci/mmol) and 
lobe e x t r a c t s , prepared as d e s c r i b e d above, were submit ted t o HPLC a n a l y s i s . 
Hign-perfovmanoe liquid ckpomatography 
A Spectra Physics high-performance l i q u i d Chromatograph (model SP 8000) 
equipped w i t h manual i n j e c t o r and t e r n a r y g r a d i e n t system was used (Spectra 
Physics B.V., Eindhoven, The N e t h e r l a n d s ) . The s t a i n l e s s - s t e e l column (250 χ 
4.6 mm i . d . ) was packed w i t h Spherisorb 10 0DS (Chrompack B.V., M i d d e l b u r g , 
The N e t h e r l a n d s ) . The l i n e a r g r a d i e n t was e s t a b l i s h e d w i t h two s o l v e n t s . 
Solvent A c o n s i s t e d of 0.5 M f o r m i c a c i d , 0.14 M p y r i d i n e (pH 3-0) and s o l v e n t 
В was 1-propanol . A l l s o l v e n t s were p u r i f i e d on a 0.45 pm f i l t e r ( type HA, 
M i l l ¡ p o r e B.V. , B russe l s , Be lg ium) . 
P re l im ina ry experiments were conducted concern ing the g rad ien t p r o f i l e t o 
op t im ize r e s o l u t i o n o f neuro in te rmed ia te lobe pep t i des . The f i n a l g rad ien t 
e l u t i o n adopted, is inc luded on the chromatograms. During the g rad ien t e l u t i o n 
the pressure increased from 700 t o 2000 p . s . i . The po lypept ides were concen-
t r a t e d on the head of the column dur ing a 2-min load ing phase. E q u i l i b r a t i o n 
of the column to the i n i t i a l c o n d i t i o n s las ted about 10 m in . In a l l exper iments , 
the sample volume brought on the column was 500 μΐ o f lobe e x t r a c t . The column 
was e l u t e d w i t h a f l o w r a t e of 2 ml/min and 0.5-min f r a c t i o n s were c o l l e c t e d 
w i t h a f r a c t i o n c o l l e c t o r (LKB Redirac, model 2112). To each f r a c t i o n 4 ml Aqua 
luma (Baker Chemicals B.V., Deventer, The Nether lands) was added and the samples 
were counted on a l i q u i d s c i n t i l l a t i o n ana lyser ( P h i l i p s , model PW 4 5 1 0 ) . 
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To determine the e l u t i o n t ime of a-MSH on the HPLC-system, s y n t h e t i c a-MSH 
( P e n i n s u l a , San C a r l o s , C a l i f o r n i a , USA) was d i s s o l v e d in 250 y l s o l v e n t A and 
detected in the e l u a t e f r a c t i o n s a t 280 nm (Zeiss spectrophotometer, model PM 6 ) . 
MSH bioassay 
Neurointermedlate lobes were homogenized in 500 μΐ 0.1 M HAc, the homogenate 
was centrifuged, and the supernatant was submitted to HPLC. To the 1-min HPLC 
fractions, 50 ug BSA was added and the samples were freeze-dr¡ed. The Anolis 
aarolinensis skin bioassay, as described by Tilders et al. (1975). was used 
with minor modifications. Each freeze-dried fraction was dissolved in 50 μΐ 
A. aarolinensis Ringer's solution and, as a preliminary survey for melanotropic 
activity, 20 pi of this solution was added to 100 yl Ringer's solution contai­
ning a small piece of A. aarolinensis skin. Those fractions which showed mela­
notropic activity (darkening of the skin) were further diluted to determine 
their relative potency, i.e. the dilution factor whereby the sample was capable 
of visibly changing the bright green colour of the skin sample into a greenish-
brown within 15 min. 
ACTÜ bioassay 
HPLC-fTactions, 0.5 min, were prepared as described above under 'MSH bioassay' . 
ACTH bioactivity of individual fractions was determined using adrenal cell sus-
pensions following the Sayers assay (Sayers et al.y 1971) in a modification as 
reported by Coverde et al. (I98O). The sensitivity of this modified bioassay was 
1 -"JQ 
approx 1 pg per ml cell suspension, using human ACTH (CIBA-Geigy Ltd, Basel, 
Switzerland) as a standard. 
Eleatrophoretia analysis 
To compare the results of the HPLC analysis with previous data of electropho-
retic analysis, some of the labelled peptides separated by HPLC were submitted 
to electrophoresis. To the appropriate HPLC fractions, 50 yg BSA was added, the 
fractions were freeze-dried and then analysed by the acid-urea electrophoretic 
procedure described earlier (Jenks et al., 1979). 
It was evident that some of the peptides that were resolved by HPLC had not 
been found in the previous electrophoretic study (Jenks Б van Overbeeke, I98O). 
As in this last investigation trichloroacetic acid (TCA) was used to prepare 
lobe homogenates, the possibility was considered that these new 'HPLC peptides' 
constitute a TCA-soluble pool. A lobe extract from a pulse-chase incubation 
using [ H]lysine was divided into two equal aliquots. One aliquot was precipi-
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tated with 20% TCA and the precipitate analysed with electrophoresis. The other 
aliquot was freeze-dried and the lyophilized extract was submitted to electro-
phoretic analysis. 
RESULTS 
HPLC analysis of pulse and pulse-ekase inoubations 
HPLC analysis of the incorporation of [ H]lysine into neurointermediate lobes 
of Xenopus laevis during the pulse period, showed one major labelled product 
(peak XI), eluting at 50 min (Fig. 1, filled circles). The peaks eluting in the 
Ргдиге 7. High-performance l i q u i d rad ι ochroma togram of n e u r o i n t e r m e d i a t e lobe p e p t i d e s of b l a c k -
adapted X. Іаг гэ. The t i s s u e was pul s e - m c u b a t e d f o r 30 mm ( f i l l e d c i r c l e s ) or pulse-chase 
Incubated (30 mm p u l s e , 6-h chase, open c i r c l e s ) w i t h [ H ] l y s i n e . S e p a r a t i o n a t ambient tempe­
r a t u r e was on Spherisorb 10 ODS (250 χ 4 . 6 mm i . d . ) w i t h a f l o w r a t e of 2 m l / m m , f r a c t i o n s were 
c o l l e c t e d every 30 sec. Primary solvent (A) 0 . 5 M formic a c i d - O . H M p y r i d i n e (pH 3 . 0 ) . 
Secondary sol ven t ( B ) . 1-propanol. 
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first 10 min were [ H]lysine and contaminations in the [ H]lysine preparation. 
After a 6-h chase incubation, peak XI was greatly reduced and at least 12 other 
products (peaks 1-Х, XII and XI II) could be resolved on the reversed-phase 
column with the gradient system used (Fig. 1, open circles). 
It could be established that, following the chase period, only a very small 
amount of product XI was present in the incubation medium (data not shown). 
Release of newly synthesized products is currently under investigation. 
Melanotropic and cortiaotropie activity 
Using the Ano lis earolinensis skin bioassay it was shown that there were 
three major peaks of melanotropic activity (Fig. 2a). The elution times for 
these products corresponded exactly with those of chase peptides I, II and IV. 
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Figure 2 (ai.Melanotropic activity of a high-performance liquid chromatogram prepared from neuro-
intermediate lobe extract of black-adapted X. laevis. Activity of l-min fractions was determined 
(see also Materials and Methods), (bi Adrenocorticotropic activity of a high-performance liquid 
chromatogram prepared from neurointermediate lobe extract of black-adapted X. laevis. Activity of 
Q.5-min fractions was determined (see also Materials and Methods). The chromatographic conditions 
were the same as given in Fig. 1. 
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S y n t h e t i c a-MSH e l u t e d from the HPLC column a t 17 m i n , which is between peaks 
I I and IV (data not shown). 
The bioassay f o r a d r e n o c o r t i c o t r o p i c a c t i v i t y demonstrated the presence of 
a number of minor peaks and one major peak ( F i g . 2 b ) . The e l u t i o n t ime of the 
major peak corresponded e x a c t l y w i t h t h a t of chase p e p t i d e I I . 
Acid-urea gel electrophoresis 
The e l e c t r o p h o r e t i c p a t t e r n f o r the f r e e z e - d r i e d e x t r a c t of 30-min p u l s e , 
6-h chase- incubated n e u r o i n t e r m e d i a t e lobes i s i l l u s t r a t e d in F i g . 3 (open 
c i r c l e s ) . This p a t t e r n is e s s e n t i a l l y the same as t h a t r e p o r t e d by Jenks ε van 
Overbeeke (198O) w i t h the e x c e p t i o n t h a t t h e r e are three new p r o d u c t s , namely 
W, Y and Z, which m i g r a t e t o gel s l i c e s hi, hS-hb and 48 r e s p e c t i v e l y . A n a l y s i s 
of the T C A - p r e c i p i t a t e d lobe e x t r a c t showed these peaks W, Y and Ζ t o be absent 
from the e l e c t r o p h o r e t o g r a m ( F i g . 3, f i l l e d c i r c l e s ) , which i n d i c a t e s t h a t p r o ­
ducts W, Y and Ζ are TCA-soluble. E l e c t r o p h o r e s i s of HPLC-peaks I , I I and IV, 
which corresponded t o peaks of major b i o a c t i v i t y ( F i g . 2 ) , revealed t h a t these 
cpm Ю - 2 
30 tO 50 
gel slice no 
Fbi,ujt*e 3. Acid-urea gel e l e c t r o p h o r e s i s of products synthesized in n e u r o m t e r m e d i a t e lobes of b l a c k -
adapted X. iaeJzs d u r i n g a 30-min p u l s e , 6-h chase incubation using [ H j l y s m e . Part of the lobe 
e x t r a c t was f r e e z e - d r i e d (open c i r c l e s ) . The remainder was T C A - p r e c ι ρ ι t a t e d , the p r e c i p i t a t e 
produced e s s e n t i a l l y the same e l e c t r o p h o r e t o g r a m , w i t h the e x c e p t i o n of the area between gel s l i c e s 
I4O and 50 ( f i l l e d c i r c l e s ) . 
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products co-migra ted w i t h Z, Y and E r e s p e c t i v e l y . Product VI appeared to co -
migrate w i t h the TCA-soluble pept ide W. The major l a b e l l e d product of the pulse 
i n c u b a t i o n , product X I , corresponded w i t h product A on the ac id -u rea g e l . 
3 Í Н]Ьеиогпе inoorporation 
Comparison of the peak p a t t e r n f o l l o w i n g [ H ] l e u c i n e i n c o r p o r a t i o n ( F i g . 4) 
w i t h t h a t a f t e r [ H ] l y s i n e i n c o r p o r a t i o n ( F i g . 1) s t r o n g l y i n d i c a t e s t h a t peaks 
I and I I do not c o n t a i n l e u c i n e . To improve the r e s o l u t i o n of the area concerned, 
the same leuc ine- labe I led sample was analysed us ing a less steep g r a d i e n t ( F i g . 
k, i n s e r t ) . I t was c o n f i r m e d t h a t products I and I I , present a f t e r [ H ] l y s i n e 
i n c o r p o r a t i o n , were absent f rom the chromatogram. 
0 10 20 30 ΊΟ 50 60 
time (min.) 
Figure 4, High-performance l i q u i d radiochromatogram of neurointermediate lobe peptides of black-
adapted X. laevis. The tissue was pulse-incubated for 6 h w i t h [ H]leucine. Value for peak XI was 
1662 cpm. The chromatographic condit ions were the same as given in F ig. 1. Insert : Same e x t r a c t , 
but chromatographed wi th a less steep gradient (see also t e x t ) . 
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DISCUSSION 
HPLC, in general, has some important advantages over eletrophoretic techni­
ques: (l) higher capacity for sample loading which no longer necessitates TCA 
precipitation or f reeze-dry ing of the extract, (2) shorter separation time, 
(3) higher resolution and (4) possibility to adjust the resolution in selected 
areas. In using HPLC with a reversed-phase column, we did, however, experience 
one problem, namely that initially product XI did not elute from the column. 
In our opinion, this may have been due to a loading effect, such as irreversible 
binding to residual silanol groups. This suggestion was earlier proposed by 
O'Hare 6 Nice (1979) to explain the lack of elution of some high-molecular weight 
proteins from a reversed-phase column. The fact that in our study after repeated 
analyses using the same column, peak XI did eventually elute, suggests that a 
conditioning of the column occurred, presumably through saturation of the sila­
nol groups. 
The results of our HPLC analysis of pulse and pulse-chase incubations reveal­
ed the synthesis in the neurointermediate lobe of 13 products. Since peak XI re­
presented the only major product during the pulse incubation and since this peak, 
furthermore, became reduced during the chase period, simultaneous with the ap­
pearance of the 12 other peaks, it may be concluded that product XI most likely 
functions as a precursor for the 12 chase peptides. This confirms the existence 
of a precursor-product mode of biosynthesis in the neurointermediate lobe, re­
ported by Jenks 6 van Overbeeke (I98O). It is therefore not surprising that pro­
duct XI appeared to have the same electrophoretic properties as product A, con­
sidered to be the precursor by Jenks ε van Overbeeke (I98O). 
Three of the chase peptides, namely I, II and IV, had high melanotropic ac­
tivity but, at least on the basis of elution time, none of these corresponded to 
a-MSH. The lack of any newly synthesized peptide corresponding to a-MSH seems to 
support the suggestion by Jenks ε van Overbeeke (198O) that a-MSH is not a major 
biosynthetic product in fully black-adapted Xenopus laevis. The melanotropic pep­
tides I and II are most likely the same products as peptides Ζ and Y, respective­
ly, and they are, therefore, TCA-soluble. Moreover, on acid-urea gels these two 
peptides ran faster than a-MSH (a-MSH migrates to gel slices 3^-35, Jenks et al., 
1979)· Both their solubility in TCA and their electrophoretic behaviour point to 
the likelihood that peptides I and II are small peptides. The occurrence in Xe­
no-pus laevis of a TCA-soluble, melanotropic peptide has been reported earlier by 
Loh ε Gainer (1977). The amino acid composition of the peptides I and II, dis­
covered in our study, remains to be elucidated. The fact, however, that they have 
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malanotropic a c t i v i t y i n d i c a t e s t h a t they c o n t a i n the 'message sequence' 
ACTH " (Schwyzer & E b e r l e , 1977)· Thus, they may w e l l be s t r u c t u r a l l y r e l a t e d 
to a-MSH. The absence of the amino a c i d l e u c i n e in pept ides I and I I , t o o , is 
r e m i n i s c e n t of a-MSH, since leuc ine is not found in any of the known a-MSH 
s t r u c t u r e s . 
I t is s u r p r i s i n g t h a t the major p a r t of the c o r t i c o t r o p i c a c t i v i t y e l u t e d 
w i t h the s m a l l , TCA-soluble, melanotropic p e p t i d e I I and not w i t h any of the 
l a r g e r p e p t i d e s . Schwyzer et al., (1971) demonstrated t h a t small p e p t i d e s , 
1-2/1 
namely fragments of ACTH , possess some c o r t i c o t r o p i c a c t i v i t y , but f a r less 
than the complete molecule (ACTH ) . I f , indeed, the c o r t i c o t r o p i c potency of 
p e p t i d e I I were low, then p e p t i d e I I must have been present in a h igh concen­
t r a t i o n . A l t e r n a t i v e l y , i t might be a new, small p e p t i d e w i t h a h igh c o r t i c o -
t r o p i c potency. The n a t u r e of the small b i o a c t i v e p e p t i d e s I and I I is c u r r e n t ­
ly under i n v e s t i g a t i o n . 
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BIOSYNTHESIS OF PAIRS OF PEPTIDES RELATED TO MELANOTROPIΝ, CORTICOTROPIN 
AND ENDORPHIN IN THE PARS INTERMEDIA OF THE AMPHIBIAN PITUITARY GLAND 
Gerard J.M. Martens, Bruce G. Jenks and A.P. van Overbeeke 
Department of '¿oology. Catholic University of Nijmejen 
UMMARY 
This study concerns the biosynthesis of a number of peptides in the neuro-
ntermediate lobe of the pituitary gland of the aquatic toad, Xenopus laevis. 
sing pulse-chase incubations in Ji-'rc and high-performance liquid chromato-
raphic analysis, it could be shown that these peptides are synthesized through 
rocessing of a prohormone, pro-opiomelanocortin ; all peptides were released 
nto the incubation medium. On the basis of electrophoret¡c analysis, selective 
mino acid incorporation and immunoprecipitat ion, as well as peptide mapping by 
¡gh-performance liquid chromatography, the peptides were classified into three 
istinct groups: two related to melanocyte-st ¡mulat ing hormone (melanotrop'm) , 
wo related to adrenocorticotropic hormone (corticotropin) and two endorphin-
ike peptides. Using tryptic and chymotryptic maps of synthetic a-melanotropin 
aN 
nd des-Ac -α-melanotropîn as references, one of the melanotropin-1 ike pep-
aN ides was identified as des-Ас -a-melanotropin; the other one represents 
either α-melanotropin nor any other known melanotropic peptide. The two pep-
ides that were immunologically related to corticotropin had characteristics 
onsistent with a structure resembling a peptide previously named 'cortico-
ropin-like intermediate lobe peptide', cort¡cotropin-(18-39). The two endor-
hin-like peptides, although highly related, do not have the sartie primary 
tructure. In view of the apparent structural differences between the two pep-
ides in each group, the possible occurrence of two prohormones is discussed. 
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INTRODUCTION 
Many amphibians, when placed on a b lack background, respond by d i s p e r s i n g 
the melanin granules in the dermal melanophores of t h e i r s k i n , thus causing 
the animal to darken. This phenomenon, known as background a d a p t a t i o n , is me­
d i a t e d by melanotropin from the pars intermedia of the p i t u i t a r y g l a n d . I t has 
been demonstrated by a number of i n v e s t i g a t o r s t h a t the amphibian pars i n t e r ­
media produces not one, but several m e l a n o t r o p i c pept ides [ 1 - 5 ] · The pars 
intermedia from Ыаск-background-adapted South A f r i c a n clawed t o a d s , Xenopus 
laevis, when incubated in Oitvo, synthesizes a p r e c u r s o r ; t h i s precursor is 
subsequently processed t o a number o f smal ler p e p t i d e s , i n c l u d i n g some melano­
t r o p i c ones [h, 5 ] . Such a p r e c u r s o r - p r o d u c t mode of p e p t i d e b i o s y n t h e s i s is 
a l s o found in mammalian p i t u i t a r y g l a n d s . A common prohormone t o c o r t i c o t r o p i n 
and g-endorphin has been e s t a b l i s h e d in a mouse p i t u i t a r y tumor eel 1-1 ine [ 6 - 8 ] , 
as w e l l as in the pars intermedia and the a n t e r i o r lobe of the r a t p i t u i t a r y 
g land [ 9 , 1 0 ] . The c i rcumstance whereby several p r o d u c t s , each w i t h i t s own 
s p e c i f i c b i o a c t i v i t y , are d e r i v e d from a common prohormone r a i s e s important 
q u e s t i o n s concern ing the r e g u l a t i o n of both the b i o s y n t h e s i s and the re lease of 
such p r o d u c t s . For X. ZeavLs, aspects of the c o n t r o l of product re lease from 
the n e u r o i n t e r m e d i a t e l o b e , p a r t i c u l a r l y the e f f e c t of dopamine and the p o s s i b l e 
involvement of cAMP, were r e p o r t e d e a r l i e r [ 1 1 ] . During a p r e l i m i n a r y study of 
the pars intermedia of X. teavia, employing high-performance l i q u i d chromato­
graphy as a p e p t i d e s e p a r a t i o n t e c h n i q u e , the b i o l o g i c a l p r o p e r t i e s of several 
p r o d u c t s , n o t a b l y the m a l a n o t r o p i c and a d r e n o c o r t i c o t r o p i c a c t i v i t i e s , c o u l d be 
e s t a b l i s h e d [ 5 ] . The study r e p o r t e d here was undertaken t o c h a r a c t e r i z e f u r t h e r 
and t o i d e n t i f y the pept ides synthesized in the pars i n t e r m e d i a . For t h i s pur­
pose, e l e c t r o p h o r e s i s , s e l e c t i v e amino a c i d i n c o r p o r a t i o n and immunoprecip i ta-
t i o n , as w e l l as p e p t i d e mapping by high-performance l i q u i d chromatography were 
employed. The r e s u l t s led t o the c o n c l u s i o n t h a t most of the products synthe­
s ized may be c a t e g o r i z e d i n t o t h r e e groups: m e l a n o t r o p i n - 1 i k e pept ides ( i n c l u ­
d ing des-Ac - α - m e l a n o t r o p i n ) , c o r t i c o t r o p i n - r e l a t e d p e p t i d e s , and e n d o r p h i n -
1 ike pept i des . 
MATERIALS AND METHODS 
Animals 
F u l l y Ы а с к - a d a p t e d Xenopus laevis, bred and reared in the a q u a t i c f a c i l i t y 
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of the Department of Zoology, University of Nijmegen, were used. For adaptation 
to black background, the animals were kept in black buckets for two weeks in an 
environmental chamber at 22 0C under constant illumination. For every experiment, 
animals of roughly the same weight (approximately 18 g) were selected. 
Materials 
L - [ i t , 5 - 3 H ] L y s i n e .HCl (90 С ¡ /mmol), L- [ 5n - 3 H]a rg in ine . HCl (20 Ci /mmol) , L-
[2 ,J4,6- 3H]pheny la lan ine (80 Ci /mmol) , L- [ 3 ,5 - 3 H] t y r o s i n e (50 C i / rm io l ) , L - [ 5 - 3 H ] -
t ryptophan (26 Ci /mmol) , L - [ i | , 5 " H] leuc ine (120 Ci/mmol) and L - [ 3 ,4 (n ) - H]pro-
1 ine (65 Ci/mmol) were purchased from Amersham. L -Lys ine , L -pheny la lan ine , i n -
s u l i n , glucagon and goat ant ibody to r a b b i t immunoglobulin G were f rom Ca lb io -
chem. Chicken a lbumin , chymotrypsinogen and cytochrome с were purchased from 
Boehr inger. T r y p s i n ( t r e a t e d w i t h d iphenyl-carbany1 c h l o r i d e ) , α-chymotrypsin 
( t r e a t e d w i t h N - t o s y 1 - L - l y s i n e chloromethy l k e t o n e ) , aminopept¡dase M, p r o -
o 
nase P, 8-bromoadenosine 3 ' ,5 ' -monophosphate (br cAMP) , 3-hydroxytyramine . HCl 
(dopamine), bovine serum albumin and o-ph tha ld ia ldehyde were obta ined from 
Sigma. a-Melanot rop in was from Pen insu la . C o r t i c o t r o p i n - { \ - 2 h ) , human c o r t i c o -
t r o p i n - (1-39) and ß-endorphin were a g i f t f rom Dr H.J.M. Coverde (Department 
αΝ 
of Medical B i o l o g y , Ni jmegen). Des-Ac - α - m e l a n o t r o p i n and the d i p e p t i d e s Ser-
Tyr and AcSer-Tyr were a g i f t f rom Dr G . I . Tesser (Department of Organic Che­
m i s t r y , Ni jmegen). T r a s y l o l was from Bayer, n i n h y d r i n f rom Merck and Hydroluma 
from Baker. 
High-Performanoe Liquid Chromatography 
A Spectra Physics l i q u i d Chromatograph (model SP 8000) and a Spher isorb 10 
ODS-col umn (Chrompack, 250x^.6 mm i n t e r n a l d iameter) were used. The g r a d i e n t 
was e s t a b l i s h e d w i t h 0,.5 M f o r m i c a c i d , 0.14 M p y r i d i n e (pH 3 · 0 , s o l v e n t A) 
and 1-propanol ( s o l v e n t B) ; the g r a d i e n t s used are presented in the f i g u r e s . 
The f l o w r a t e was 2 m l / m i n ; 0.5-min f r a c t i o n s were c o l l e c t e d us ing a LKB 
Redirac f r a c t i o n c o l l e c t o r (model 2112). Further d e t a i l s on the chromatogra­
phic procedure have been p u b l i s h e d e a r l i e r [ 5 ] . 
Pulse-Chase Analysis 
N e u r o i n t e r m e d i a t e lobes of Ыаск-adapted Xenopus were pre incubated in groups 
of two lobes each f o r 1 h a t 220C in 100 μΐ i n c u b a t i o n medium ( f o r composi t ion 
see [ 5 ] ) . F o l l o w i n g p r e i n c u b a t i o n , each group of lobes was p u l s e - i n c u b a t e d f o r 
30 min in 100 μΐ of i n c u b a t i o n medium c o n t a i n i n g 20 y C i [ H ] l y s i n e and 20 uCi 
[ H ] p h e n y l a l a n i n e . One group of lobes was then processed f o r high-performance 
l i q u i d chromatography a n a l y s i s (pulse g r o u p ) . The remaining groups were t r a n s -
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f e r r e o t o 100 μΐ of f r e s h incubat ion medium c o n t a i n i n g 5 mM of both L - l y s i n e 
and L-phenylalan ine (chase medium). A f t e r the a p p r o p r i a t e chase- incubât ion 
time ( 1 , 2 , 3 · 5 , 8 or 16 h ) , the lobes and the incubat ion medium in which they 
were chase- incubated were processed f o r chromatographic a n a l y s i s . To prepare 
lobes and media f o r a n a l y s i s , the lobes were homogenized in 500 μΐ 0.1 M HCl 
in an a l l - g l a s s homogenizer and t o the media 500 μΐ 0.1 M HCl was added. The 
lobe homogenates and the a c i d i f i e d media were c e n t r i f u g e d (5 m i n , 10 000 χ g , 
Beekman microfuge) and the supernatants were analysed immediately by h i g h -
performance l i q u i d chromatography or s t o r e d a t -20oC u n t i l a n a l y s i s . To d e t e r ­
mine the r a d i o a c t i v e chromatographic p r o f i l e , k ml of Hydroluma was added t o 
each f r a c t i o n and the f r a c t i o n s were counted on a LKB l i q u i d s c i n t i l l a t i o n 
counter (Rack B e t a , model 1216). Tota l l e v e l s of i n c o r p o r a t e d r a d i o a c t i v i t y 
f o r each group were determined by adding the values of the f r a c t i o n s from the 
lobe and medium p r o f i l e s ( f r a c t i o n s 1 - 20, c o n t a i n i n g the f r e e r a d i o a c t i v e 
amino a c i d s , were not included in t h i s summation). The r a d i o a c t i v i t y in each 
f r a c t i o n was then expressed as a percentage of these t o t a l l e v e l s . 
Selective Amino Aaid Incorporation Studies 
To survey newly synthesized lobe pept ides f o r p a r t i a l amino a c i d c o n t e n t , 
separate pulse experiments were conducted us ing d i f f e r e n t H - l a b e l l e d amino 
a c i d s , namely l y s i n e , a r g i n i n e , t y r o s i n e , p h e n y l a l a n i n e , t r y p t o p h a n , l e u c i n e 
or p r o l i n e . F o l l o w i n g a 4-h pulse in r a d i o a c t i v e label (20 p C i ) , the lobes 
were processed as descr ibed above and the lobe e x t r a c t s were submit ted t o 
high-performance l i q u i d chromatography. 
t'lectrophcretic Analysis 
Dodecyl s u l p h a t e gel e l e c t r o p h o r e s i s , as descr ibed by Swank and Munkres [ 1 2 ] , 
was performed w i t h 12.5% Polyacry lamide g e l s . The molecular weight markers used 
were: chicken a l b u m i n , chymotrypsinogen, cytochrome c , i n s u l i n , c o r t i c o t r o p i n -
( 1 - 3 9 ) , g l u c a g o n , c o r t i c o t r o p i n - ( 1 - 2 4 ) and a - m e l a n o t r o p i n . To o b t a i n newly syn­
t h e s i z e d pept ides f o r molecular weight d e t e r m i n a t i o n , n e u r o i n t e r m e d i a t e lobes 
were pul se- incubated in [ ^ H j l y s i n e (20 \iC i , ^ . S h ) . The lobes were e x t r a c t e d and 
submit ted t o high-performance l i q u i d chromatography; a 100-μ1 a l i q u o t of each 
f r a c t i o n was c o u n t e d . From the r a d i o a c t i v e p r o f i l e o b t a i n e d , those f r a c t i o n s 
c o n t a i n i n g r a d i o a c t i v e products were s e l e c t e d , 20 μg bovine serum albumin was 
added t o each of them and they were l y o p h i l ¡ z e d in p repara t ion f o r the e l e c t r o -
pho re t i c a n a l y s i s . 
To c h a r a c t e r i z e f u r t h e r the pept ides i so l a ted by high-performance l i q u i d 
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chromatography, their electrophoret¡с mobilities were also determined on acid/ 
urea gels. An 11% ac¡d/urea/polyacry1 amide gel, as described by Davis οτ al. 
[13], was used with a vertical slab cell (Bio-Rad model 220). Cytochrome с was 
the marker and the mobility of a peak is given relative to this marker (R_ 
value). For comparison, synthetic α-melanotropin, des-Ас -a-melanotropin, 
corticotropin-(1-39) and ß-endorphin were also submitted to the acid/urea gel 
electrophores i s. 
Immunopreoipitation 
To achieve a high specific activity of newly synthesized peptides for immu-
noprecipitat ion , neurointermediate lobes were first preincubated for 1 h in 
о 
medium containing 6 mM br cAMP; cAMP has been shown to stimulate the release 
of stored melanotropic peptides [14]. The lobes were then pul se-incubated for 
4.5 h in medium containing 20 pCi each of [ H]lysine, [ H]tyrosine, [ H]phenyl-
alanine and [ H]tryptophan. During the last 2 h of this pulse incubation, dopa­
mine was added to the medium to a final concentration of 10 uM. Dopamine has 
been shown to inhibit the release of the newly synthesized peptides [11]. The 
lobes were homogenized in 600 μΐ 0.1 M HCl, the homogenate was centrifuged and 
the supernatant freeze-dried in 100-yl aliquots. A double antibody immunopre-
cipitation technique was used. A freeze-dried aliquot of the extract was dis­
solved in 50 yl 0.01 M phosphate buffer pH 7.3 (containing Q.\% bovine serum 
albumin, 0 . U NaN,, 100 Kill Trasylol/ml) and 100 yl antiserum (1:50 dilution) 
was added. After incubation for 24 h at 4 0C, 100 yl goat anti-(rabbit IgG) 
serum (10 mg/ml in phosphate buffer) was added. After a further 24-h incubation 
at 4 0C, the sample was centrifuged at 10 000 χ g for 5 min and the pellet was 
washed with ice-cold phosphate buffer. To dissociate this immunoprecipita ted 
complex, 500 yl 0.1 M HCl was added and the solubilized peptides were analysed 
by high-performance liquid chromatography using the gradient given ¡n Fig. 2. 
It was previously determined by a radioimmunoassay which concentrations of 
antiserum and goat ant i -(rabbit IgG) serum gave optimum immunoprecipi tat Ion. 
Using the above procedures, immunoprecipi tat ion of newly synthesized peptides 
was performed with antisera directed against a-melanotropin, corticotropin and 
endorphin. To determine non-specific binding, excess peptide [5-10 yg a-melano-
tropin, corticotropin-(1-24) or ß-endorphin] was added to the appropriate ex-
tract aliquot before immunoprecipitat¡on (control groups). The a-melanotropin 
and corticotropin antisera were a gift from Dr De Wied (Rudolf Magnus Institute, 
Utrecht). The endorphin antiserum was kindly provided by Dr H. Vaudry (Rouen, 
France). The a-melanotropin antiserum is mainly specific for the C-terminal 
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Lys-Pro-Val-NH- sequence; c r o s s - r e a c t i v i t y , r e l a t i v e t o α - m e l a n o t r o p i n , was 
< 0.03% w i t h c o r t i c o t r o p i n - ( 1 - 1 0 ) , c o r t i c o t r o p i n - (it-IO) , c o r t i c o t r o p ¡ n - (4 -7 ) , 
c o r t i c o t r o p i n - ( 7 - 1 0 ) and γ - m e l a n o t r o p i n , and was 0.5% w i t h c o r t i c o t r o p ¡ n - ( 1 - 3 9 ) 
and 3-melanotropin [ 1 5 ] . 
The c o r t i c o t r o p i n ant iserum was made using c o r t i c o t r o p i n - ( 1 - 2 Ί ) as a n t i g e n ; 
c r o s s - r e a c t i v i t y was < 0.03% w i t h c o r t i c o t r o p i n - ( 2 5 - 3 9 ) , c o r t i c o t r o p i n - ( 1 - 1 0 ) , 
c o r t i c o t r o p i n - ( А - Ю ) and a - m e l a n o t r o p i n , 0.1% w i t h c o r t i c o t r o p i n - ( 5 - l 6 ) - N H . , 
1it% w i t h human c o r t i c o t r o p i n , 17% w i t h c o r t i c o t r o p i n - ( 18-39) and 140% w i t h 
c o r t i c o t r o p i n - ( 1 1 - 2 4 ) [ r e l a t ¡ v e to c o r t i c o t r o p i n - ( 1 - 2 4 ) ] ; t h i s ant iserum is p ro -
bably d i r e c t e d towards the 18-24 po r t i on of the c o r t i c o t r o p i n molecule [ 1 6 ] . 
The endorphin ant iserum was d i r e c t e d aga ins t the 68-77 p o r t i o n of ß-1 ipo-
t r o p i n [17] · 
Mapping of Newly Synthesized Peptides 
Neurointermediate lobes were pu lse- incubated f o r 4.5 h in medium c o n t a i n i n g 
a mix ture of 20 uCi each of [ H ] l y s i n e , [ H ] t y r o s i n e , [ H]pheny la lan ine and 
[ H ] t r y p t o p h a n . The newly synthesized products were then i s o l a t e d by h igh -pe r -
formance l i q u i d chromatography as descr ibed under 'E l ec t r opho re t ¡ c A n a l y s i s ' . 
For enzymatic d i g e s t i o n of the i so la ted r a d i o a c t i v e pep t i des , the l y o p h i l i z e d 
mate r ia l was d isso lved in 50 μΐ 15 mM Hepes b u f f e r (pH 8.0) and 10 yg t r y p s i n 
or 10 vg a-chymotrypsin was added; d i g e s t i o n t imes were 5 m i n , 20 m i n , 2 h or 
16 h a t 37 0 C. The d i g e s t i o n was t e r m i n a t e d by adding 500 μΐ 0.1 M HCl, the 
d i g e s t was then c e n t r i f u g e d , and the supernatant was immediately analysed by 
high-performance l i q u i d chromatography, us ing the g r a d i e n t g iven in F i g . 5 · 
The r a d i o a c t i v e p r o f i l e of the c o l l e c t e d f r a c t i o n s was then d e t e r m i n e d . To 
assess which r a d i o a c t i v e amino ac ids were present in each of the r a d i o a c t i v e 
(chymo) t r y p t ic f r a g m e n t s , these fragments were d i g e s t e d t o y i e l d f r e e amino 
a c i d s . For t h i s purpose, the f r a c t i o n s c o n t a i n i n g the (chymo) t ryp t ¡c fragments 
were f r e e z e - d r i e d (w i thout a l bum in ) , d i sso lved in 50 y l 15 mM Hepes b u f f e r (pH 
8.0) and 10 yg aminopeptidase M and 10 yg pronase Ρ were added. The d i g e s t i o n 
(370C) l a s t e d a t l e a s t 48 h and the d i g e s t was then chromatographed t o sepa­
r a t e and determine the r a d i o a c t i v e amino a c i d s . 
Mapping of Synthetic Peptides 
aN 
a-Melanotropin or des-Ас - a - m e l a n o t r o p m (50 yg) were d i g e s t e d w i t h 10 yg 
t r y p s i n or 10 yg a-chymotrypsin (16 h, 370C) and chromatographed under the 
same c o n d i t i o n s as descr ibed f o r the mapping of the newly synthesized p e p t i d e s . 
A post-column der i vat i zat ion procedure was developed t o d e t e c t the (chymo)-
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t r y p t i c fragments of the syn the t i c pep t i des . o-Phtha1diaIdehyde (100 mg), which 
reac ts w i t h pr imary amines to g ive a f l u o r e s c e n t p roduc t , was d i sso l ved in 1,2 
ml e thano l /2-mercaptoethano l (5 :1) and t h i s was added t o 100 ml 1.07 M bo r i c 
ac i d (pH 11 .5 ) . The high bo r i c ac i d concen t ra t i on was necessary to n e u t r a l i z e 
con t inuous ly the pH-3.0 mobi le phase ( f i n a l pH 9 · 5 ) · A mul t ichannel pump (Cenco) 
was used to pump a p o r t i o n of the column e f f l u e n t (1 ml/min) as we l l as the o-
phtha ld¡a ldehyde s o l u t i o n (1.2 m l / m i n ) . These two s o l u t i o n s were then brought 
together v ia a Τ j o i n t and passed v ia a m i x i n g m a n i f o l d t o a f l u o r o m e t e r 
( S c h o e f f e l , model 970) equipped w i t h a f l o w c e l l . A f t e r e x c i t a t i o n a t З^О nm, 
f l u o r e s c e n c e was measured a t Ίδδ nm. The remainder of the column e f f l u e n t was 
c o l l e c t e d in 0.5"niin f r a c t i o n s and the f r a c t i o n s were f r e e z e - d r i e d , d i s s o l v e d 
in 20 y l H-0 and placed on s i l i c a gel p l a t e s ( M e r c k ) ; the p l a t e s were s t a i n e d 
w i t h s p e c i f i c techniques f o r amino a c i d s . S t a i n i n g techniques used were: Pauly 
and E h r l i c h reagents which s p e c i f i c a l l y s t a i n h i s t i d i n e and t r y p t o p h a n , respec­
t i v e l y [18] and Barton reagent f o r s t a i n i n g t y r o s i n e , t r y p t o p h a n , and meth io­
n i n e , which act as reducing agents [ 1 9 ] · N i n h y d r i n was used as a general s t a i n 
f o r p e p t i d e s . 
RESULTS 
Pulse-Chase Analysis 
A p r e v i o u s study has shown t h a t a f t e r a 30-min pulse in [ H ] l y s i n e , t h e r e i s 
s y n t h e s i s of o n l y one major p r o t e i n , product XI [ 5 ] . In the pulse-chase e x p e r i ­
ments r e p o r t e d h e r e , the same o b s e r v a t i o n was made. Product XI r a p i d l y d i s ­
appeared w i t h the concomitant appearance of a number of new p e p t i d e s , the chase 
pept ides ( F i g . 1 ) . F o l l o w i n g a 1-h chase, 10% of product XI had disappeared 
w h i l e in the lobes the f u l l assemblage of chase p e p t i d e s (products 1-Х) was 
p r e s e n t . A f t e r the f i r s t hour of chase i n c u b a t i o n , t h e r e were np newly s y n t h e ­
s ized p e p t i d e s in the i n c u b a t i o n medium except f o r a small amount o f product X I . 
A p e r i o d of 1 h is probably the t ime r e q u i r e d f o r p r o c e s s i n g and packaging of 
the newly synthes ized products in p r e p a r a t i o n f o r re lease [ 1 1 ] . During subse­
quent chase i n c u b a t i o n s i n c r e a s i n g amounts of the l a b e l l e d p e p t i d e s were found 
in the medium, such t h a t a f t e r 16 h of chase a l l r a d i o a c t i v e p e p t i d e s , w i t h the 
e x c e p t i o n of a small amount of product X I , had disappeared from the l o b e s . 
Electvophoretia Analysis 
Each r a d i o a c t i v e p r o d u c t , e x t r a c t e d from the lobes and i s o l a t e d by h i g h - p e r ­
formance l i q u i d chromatography, migrated as a s i n g l e peak on the a c i d / u r e a g e l . 
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Fujure 7. High-performance l i q u i d chromatographic a n a l y s i s of newly synthesized products f r o n n e u r o ­
i n t e r m e d i a t e lobes of X. laevïs f o l l o w i n g pulse-chase incubat ions . Groups of two lobes were pre -
incubated for I h p r i o r to a 30-min pulse incubation using a mixture of [ H j l y s i n e and [ H]phenyl -
a l a n i n e . Chase incubations of 1 , 3.5» 8 and 16 h were done in media conta in ing 5 mM of both 
L - lys ine and L -pheny la lan ine . Fol lowing the pulse-chase incubations and high-performance l i q u i d 
chromatography of lobe e x t r a c t s and incubation media, t o t a l l e v e l s of r a d i o a c t i v i t y were determined 
for each group and the r a d i o a c t i v i t y of each f r a c t i o n was then expressed as a percentage of the 
t o t a l l e v e l . The chromatographic p r o f i l e of the pulse group is not shown. 
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Table 1, Electrophoretic characteristics and selective amino acid incorporation of newly synthesized 
products I, II, IV, V, VII and VIII. Following pulse incubation of lobes, radioactive products were 
isolated by high-performance liquid chromatography and the electrophoretic mobility of each product 
was determined on an acid/urea gel (Rp value is given relative to cytochrome c) and their apparent 
molecular weights were determined using dodecyl sulphate gel electrophoresis. Lobes were also pulse-
mcubated in medium containing only one of the radioactive a m m o acids given in the table. Lobe 
extracts were analysed by high-performance liquid chromatography to determine the presence (+) or 
absence (-) of each amino acid in each of the products. 
Product R F Apparent M Amino acid incorporation 
Leu Pro Phe Trp Tyr Lys Arg 
ι 
II 
IV 
ν 
VII 
VI II 
2.18 
2.07 
0.95 
0.95 
ìM 
1.36 
< 3000 
< 3000 
5500 
5500 
3500 
3500 
+ + + 
+ + + 
- + + 
Products I and II had a high electrophoret¡e mobility on this gel (Table 1); 
on the dodecyl sulphate gel these two products migrated beyond that segment of 
the standard curve which allowed reasonable estimation of molecular weight. 
They can, therefore, only be described as having a molecular weight of < 3000. 
Products IV and V co-migrated on both the acid/urea and dodecyl sulphate gels. 
From their electrophoretic mobility on the latter gel, their molecular weights 
were estimated to be 5500. Products VII and V I M co-migrated on dodecyl sul-
phate gels (apparent M = 3500) and, on acid/urea gels, displayed similar 
electrophoretic mobilities (Table 1). The apparent M of product XI, based on 
dodecyl sulphate gel electrophoresis, was 35000. The R_ values of synthetic 
α-melanotropin (M = 1500), des-Ac -α-melanotropin (M = 1500), corticotropin 
(M
r
 = 1»500) and ß-endorphin (Mr = 3500) were 1.59, 2.07, 1.36 and I.36, res-
pectively, on the acid/urea gel. 
Selective Amino Acid InaorpOvation Studies 
The results of the selective incorporation studies are shown in Table 1. 
Products I and II contained all the radioactive amino acids employed with the 
exception of leucine; products IV and V lacked tryptophan; products VII and 
VIII lacked tryptophan and arginine. 
^ 
Іттипоргеаъръ ta tion 
The results of the ¡mmunop ree¡pi tat¡on experiments are illustrated in Fig. 2. 
The antiserum specific for the C-terminal portion of a-melanotropin precipitated 
two products (Fig. 2A). The el ut ion times of these products corresponded with 
those of products I and II. With the corticotropin antiserum, a product corres-
U/4 
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Figure 2. High-performance liquid chromatography analysis of newly synthesized products immunopre-
cipitated with (A) ant i-a-melanotropin, (B) ant¡-corticotropin or (C) ant i-endorphin. Following 
pulse incubation of lobes, the lobe extract was immunoprecipitated with a double antibody precipi-
tation technique. The profiles presented have been corrected by subtracting the control values; 
these control values were determined following immunoprec¡pi tat¡on in the presence of excess of 
the appropriate peptide. Arrows indicate the elution position of the newly synthesized products 
using the gradient shown in the lower graph (O O) of solvent A (0.5 M formic acid, 0A h M py-
ridine, pH 3) to solvent В (1-propanol). 
kk 
ponding with product IV (27 min) and another one corresponding with product V 
(32.5 min) were precipitated (Fig. 2B). Moreover, a third product (22 min), 
which did not correspond to any of the indexed chase peptides, was immunopre-
cipitated. None of the elution times of the peptides that precipitated with 
ant i-corticotropin, corresponded with the elution time of human corticotropin-
(1~39)t which, with this gradient, is Ik-lS min. The antί-endorphin serum pre­
cipitated four radioactive products; two major ones, corresponding to products 
VII {^2.5 min) and V I M (43.5 min), a product eluting at 50 min corresponding 
to product IXa, and one eluting at 40 min which did not correspond to any of 
the indexed chase peptides (Fig. 2C). All three antisera immunoprec¡pitated 
product XI (data not shown). 
Peptide Mapping 
Digestion of Product I, Produci II, Synthetic a-Melanotropin and Synthetic 
Des-Ас -a-Melanotropin (Melanotropic Peptides) 
Previous studies with Xenopus neurointermediate lobe extracts [5] showed 
that the high-performance liquid chromatography elution characteristics of 
products I and II coresponded with those of melanophore stimulating substances. 
To characterize these two products further, tryptic and chymotryptic maps were 
prepared from chromatographically isolated peptides obtained after labelling 
with the radioactive amino acids lysine, tyrosine, phenylalanine and trypto­
phan. Theoretically, with these amino acids all tryptic and chymotryptic frag-
aN 
ments of α-melanotгор in and des-Ас -a-melanotropin would be labelled. The maps 
of the radioactive products I and II were compared with maps obtained by di-
aN gesting the synthetic peptides a-melanotropin and des-Ас -a-melanotropin. 
Tryptic Maps 
A 16-h tryptic digestion of product I gave four radioactive fragments (Fig. 
ЗА). The fragments, indicated according to the sequence of their elution from 
the column, are T 1 (eluting at 7 min), T_ (8 min), Τ, (11 min) and T. (14 min). 
The elution time of the undigested product I was 22.5 min. The distribution of 
the four radioactive amino acids in the various fractions is presented in 
Table 2. The 16-h tryptic digest of product II (Fig. 3B) yielded three labelled 
fragments: T 1 (9.5 min), T„ (14 min) and T, (18 min). Short-term digestion 
(5 min or 2 h) produced only the fragments T„ and T,. The undigested product II 
eluted at 27 min. Table 2 presents the radioactive amino acid distribution in 
the tryptic fragments. 
Using the fluorescence system in combination with high-performance liquid 
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Figure ¿. High-performance liquid chromatography analysis of tryptic and chymotryptic digests of 
(A) product I, (B) product II, (C) synthetic a-melanotropin ( , 2) and synthetic des-Ас -a-
melanotropin ( , 1). Following pulse incubation in a mixture of [ H]lysine, [ Hjtyrosine, [ H ] -
phenylalanme and [ H]tryptophan, lobes were extracted and newly synthesized products I and II were 
isolated by high-performance liquid chromatography. These products, as well as synthetic a-melano-
tropin ( , 2) and des-Ас -a-melanotropin (
 f 1), were digested for 16 h at 37
0C with trypsin 
or chymotrypsm. Digests were submitted to high-performance liquid chromatography and profiles were 
determined either by counting the radioactivity of the fractions (products I and II) or by fluores­
cent detection (synthetic peptides). Arrows indicate the elution position of the undigested starting 
mater lais. 
chromatography, f rom the 16-h t r y p t i c d i g e s t of s y n t h e t i c a-melanotropin two 
fragments could be d e t e c t e d , T. and T. ( F i g . 3C, d o t t e d l i n e ) . The peak e l u t i n g 
a t 2 min represents the i n j e c t i o n s i g n a l . Since only those pept ides c o n t a i n i n g 
f r e e pr imary amino groups are detected w i t h t h i s system, and as the N-terminal 
t r y p t i c fragment of a-melanotropin lacks such a f r e e amino group (due t o ace-
t y l a t i o n of the N-terminal s e r i n e ) , the e l u t i o n time of the N-terminal t r y p t i c 
fragment was determined f o l l o w i n g s p e c i f i c s t a i n i n g of the amino a c i d h i s t i d i n e . 
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Toute 2. R a d i o a c t i v e amino a c i d c o n t e n t o f the t r y p t i c (Τ) and c h y m o t r y p t i c (C) f r a g m e n t s o f p r o ­
d u c t s I and I I . R a d i o a c t i v e p r o d u c t s I and I I were i s o l a t e d f r o m t o b e s , p u l s e - m c u b a t e d in medium 
c o n t a i n i n g a m i x t u r e o f [ • ' H j l y s i n e , [ H j t y r o s m e , [ H]pheny l a l a n m e and [ H] t r y p t o p h a n . The i s o ­
l a t e d ( c h y m o ) t r y p t i c f r a g m e n t s o f t h e s e p r o d u c t s » numbered as in F i g . 3» were s u b s e q u e n t l y d i g e s t e d 
t o f r e e amino a c i d s w h i c h were then c h r o m a t o g r a p h e d t o d e t e r m i n e w h i c h r a d i o a c t i v e amino a c i d s were 
p r e s e n t in each f r a g m e n t . Using t h e g r a d i e n t g i v e n in F i g . 5» l y s i n e , t y r o s i n e , p h e n y l a l a n i n e and 
t r y p t o p h a n e l u t e d f r o m t h e column a t 2 , 4 , 7 and 11 m m , r e s p e c t i v e l y . 
R a d i o a c t i v e P r o d u c t I P r o d u c t 11 
amino a c i d — ^ ^ — 
τ, τ 2 τ 3 η, с, c 2 C3 с,, c 5 τ, τ 2 η, с, с, с 3 с% 
Lys 
Туг 
Phe 
Тгр 
This last fragment was found to elute at 22 min. Thus, the elution characteris­
tics of a-melanotropin and its tryptic fragments are: a-melanotropm (29.5 min), 
Tj (9-5 min), T 2 (14 min) and the 22-min fragment. 
Fig. k shows the structure of a-melanotropin with the predictable tryptic 
cleavage site. a-Melanotropin-(1-8) must correspond to the 22-min fragment from 
the tryptic digest of the synthetic a-melanotropin as this is the only tryptic 
fragment to lack a free primary amino group. This conclusion is further suppor­
ted by the observation that this hi st id me-conta in ing fragment lacked trypto­
phan. u-Melanotropin-(9-13) would correspond to the Τ fragment since this frag­
ment contained tryptophan but not histidine. The lysine-proline bond in a-mela­
notropin- (9-ІЗ) could constitute a second tryptic cleavage site which, with 
prolonged digestion, would enable the splitting of this peptide into the 9-11 
h h - Τ — -I 
* 
X-Ser-Tyr-Ser-Met-Glu-His-Phe-Ärg-Trp-Gly-Lys-Pro-Val-NHo 
î t t 
— £ > — C - £4 - C — £ J — C - f/ 
f BAIT I. Structure of synthetic o-melanotгор in (X = acetyl), des-Aca -a-melanotropin (X - H) and 
their tryptic (T) and chymotryptic (C) fragments. In this figure, the amino acids used for 
labelling newly synthesized products I and II prior to their (chymo)tryptic digestion, are indi­
cated by an asterisk (*). 
hi 
and 12-13 f r a g m e n t s . Consistent w i t h the i d e n t i f i c a t i o n of fragment T.. as 
a - m e l a n o t r o p i n - ( 9 - I 1 ) is the o b s e r v a t i o n t h a t t h i s fragment indeed c o n t a i n e d 
the amino a c i d t ryptophan but not h i s t i d i n e . Using the method of Meek [21] t o 
p r e d i c t the e l u t i o n order of pept ides from a reversed-phase high-performance 
l i q u i d chromatography column, a-melanotrop in-(12-13) would be expected t o 
e l u t e r a p i d l y . This fragment ( i n d i c a t e d Τ ) i s , however, not d e t e c t a b l e by the 
f l u o r e s c e n c e system, because i t s N-terminal p r o l i n e w i l l not b ind the f l u o r e s ­
cent marker. As e x p e c t e d , a l l t r y p t i c fragments of α-melanotrop ¡π, w i t h the 
e x c e p t i o n of Τ , were B a r t o n - p o s i t i v e . 
aN The l 6 - h t r y p t i c d i g e s t of des-Ас - a - m e l a n o t r o p i n gave t h r e e f r a g m e n t s : T 1 , 
T. and T- ( F i g . 3C, s o l i d l i n e ) . The undigested p e p t i d e e l u t e d a t 27 m i n . That 
aN 
the T. and J. f ragments of des-Ас - a - m e l a n o t r o p i n are the same a s , r e s p e c t i v e ­
l y , the T, and T. fragments of a-melanotropin is suggested by t h e i r i d e n t i c a l 
e l u t i o n t imes and the o b s e r v a t i o n t h a t these two fragments of des-Ас -a-mela­
n o t r o p i n a l s o c o n t a i n e d t ryptophan but no h i s t i d i n e . The i d e n t i f i c a t i o n of the 
T , fragment as des-Ас - a - m e l a n o t r o p i n - ( I - 8 ) is c o n s i s t e n t w i t h the observa­
t i o n s t h a t t h i s fragment is d e t e c t a b l e w i t h the f l u o r e s c e n t technique (owing 
t o the f r e e pr imary amino g r o u p , which is l a c k i n g in the N-terminal fragment 
of a-melanotropin) and t h a t i t c o n t a i n s h i s t i d i n e but no t r y p t o p h a n . A l l t r y p ­
t i c f r a g m e n t s , except Τ , were B a r t o n - p o s i t i v e . 
On the basis of the data o b t a i n e d w i t h t r y p t i c mapping we propose t h a t p r o -
aN duct I I is des-Ас - a - m e l a n o t r o p i n . Undigested product I I and undigested syn-
aN 
t h e t i c des-Ас - a - m e l a n o t r o p i n had i d e n t i c a l r e t e n t i o n t imes on the chromato­
graphy column and y i e l d e d t r y p t i c fragments w i t h comparable e l u t i o n t i m e s . 
The i d e n t i f i c a t i o n of the T , fragment of product I I as the N-terminal (1-8) 
aN fragment of des-Ас - α - m e l a n o t r o p i n is c o n s i s t e n t w i t h the f i n d i n g that t h i s 
t r y p t i c fragment c o n t a i n s t y r o s i n e and p h e n y l a l a n i n e but no l y s i n e or t r y p t o ­
phan (Table 2 ) . L i k e w i s e , the d e s i g n a t i o n of the T_ fragment of product I I as 
des-Ac - α - m e l a n o t r o p i n - ( 9 - І З ) is in agreement w i t h the presence of the amino 
ac ids l y s i n e and t ryptophan and the absence of t y r o s i n e and p h e n y l a l a n i n e . 
Further evidence f o r t h i s i d e n t i f i c a t i o n was o b t a i n e d in an experiment where 
a 16-h t r y p t i c d i g e s t of a p r o l ¡ n e - l a b e l led product I I was conducted: two 
r a d i o a c t i v e peaks were o b t a i n e d , one c o - e l u t i n g w i t h T . (ík min) and ano ther , 
a minor , peak e l u t i n g a t 3 min . This l a t t e r p r o l i n e - c o n t a i n ing peak probably 
represents the Τ fragment shown in F i g . k. 
Product I gave a t r y p t i c fragment (T.) w i t h the same e l u t i o n time as f r a g ­
ments T- from both s y n t h e t i c p e p t i d e s ; the o t h e r t h r e e fragments of product I 
d i d not correspond t o any of the t r y p t i c fragments o b t a i n e d from the s y n t h e t i c 
i)8 
pept ¡des . 
Chymotryptio Maps 
Chymotrypt¡с d i g e s t i o n (16 h) of product I produced f i v e r a d i o a c t i v e f r a g ­
ments ( F i g . ЗА): С. ( e l u t i n g a t 5 m i n ) , С- (7 m i n ) , С- (8.5 m i n ) , С. (11 min) 
and С,- (12 m i n ) . Complete d i g e s t i o n of these fragments gave the d i s t r i b u t i o n 
of the r a d i o a c t i v e amino ac ids (Table 2 ) . 
Chymotrypt ic d i g e s t i o n (16 h) of product I I produced f o u r r a d i o a c t i v e f r a g ­
ments ( F i g . 3B) : C. (4 m i n ) , С- (6 m i n ) , С, (11 min) and Z¡ (15 m in ) . Short 
chymot ryp t i c d i g e s t i o n (10 min) of product I I y i e l d e d on ly two f ragments : С. 
and a fragment e l u t i n g a t 14 min. Subsequent d i g e s t i o n (2 h) of the l a t t e r 
fragment produced fragments Cr and a fragment e l u t i n g a t 11.5 m i n ; a f i n a l d i ­
g e s t i o n (16 h) of t h i s l a s t fragment y i e l d e d C, and C.. The r a d i o a c t i v e amino 
a c i d c o n t e n t of each of the fragments C.-Cr is given in Table 2. 
The post-column f l u o r e s c e n c e d e t e c t i o n system showed t h r e e fragments when a 
c h y m o t r y p t i c d i g e s t (16 h) of s y n t h e t i c a-melanotropin was chromatographed 
( F i g . 3C, d o t t e d l i n e ) : C. (k m i n ) , С, (11 min) and С· (15 m i n ) . With s p e c i f i c 
s t a i n i n g t e c h n i q u e s , fragment C_ appeared t o c o n t a i n t ryptophan but no h i s t i -
dine and fragment C, c o n t a i n e d h i s t i d i n e but no t r y p t o p h a n . Thus, C, is d e s i g ­
nated as α - m e l a n o t r o p i n - ( 8 - 9 ) and C. as a - m e l a n o t r o p i n - ( 3 - 7 ) ( s e e a l s o F i g . k). 
Since the N-terminal (1-2) fragment of a-melanotropin is a c e t y l a t e d and t h e r e ­
f o r e not d e t e c t a b l e w i t h the f l u o r e s c e n c e system, fragment C1 must be a-melano­
t r o p i n - ( 1 0 - 1 3 ) . This fragment c o n t a i n s an e x t r a pr imary amino group (of l y s i n e , 
in p o s i t i o n 1 1 ) , which was probably r e s p o n s i b l e f o r i t s enhanced f l u o r e s c e n c e 
( F i g . 3C). Moreover, i t was the o n l y Barton-negat i ve fragment a n d , t h e r e f o r e , 
conta ined n e i t h e r t y r o s i n e , t r y p t o p h a n , nor m e t h i o n i n e . To determine the e l u -
t i o n t ime of the N-terminal c h y m o t r y p t i c fragment (1-2) s y n t h e t i c AcSer-Tyr was 
chromatographed. This a c e t y l a t e d d i p e p t i d e e l u t e d at 11 min and, t h u s , the N-
t e r m i n a l C- fragment of a-melanotropin ( F i g . A) appears t o c o - e l u t e w i t h the 
C, f r a g m e n t . 
Chymotrypt ic d i g e s t i o n (16 h) of s y n t h e t i c des-Ас - a - m e l a n o t r o p i n gave f o u r 
fragments ( F i g . 3C, s o l i d l i n e ) : C1 (4 m i n ) , С- (6 m i n ) , С- ( l i min) and Cr 
(15 m i n ) . Fragment С, c o n t a i n e d t ryptophan but no h i s t i d i n e , Cr c o n t a i n e d h i s ­
t i d i n e but no t ryptophan and thus these fragments correspond t o the (8-9) and 
(3"7) f r a g m e n t s , r e s p e c t i v e l y . The C1 fragment must be i d e n t i f i e d as des-Ac 
α - m e l a n o t r o p i n - ( 1 0 - 1 3 ) , a d e s i g n a t i o n c o n s i s t e n t w i t h the f a c t s t h a t i t e x h i b i ­
ted enhanced f l u o r e s c e n c e (owing t o the e x t r a pr imary amino group of l y s i n e ) 
and t h a t i t is B a r t o n - n e g a t i ve. Fragment С. c o - e l u t e d w i t h a s y n t h e t i c d i p e p -
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t i d e Ser-Туг (6 mm) and thus c o n s t i t u t e s the N-terminal c h y m o t r y p t i c fragment 
of des-Ac - a - m e l a n o t r o p i n . 
ctN The i d e n t i f i c a t i o n of product I I as des-Ас - a - m e l a n o t r o p i n , on the b a s i s of 
these data from the c h y m o t r y p t i c d i g e s t i o n , is in complete agreement w i t h the 
e a r l i e r d e s i g n a t i o n based on the t r y p t i c mapping d a t a . Furthermore, the d i s t r i ­
b u t i o n of the r a d i o a c t i v e amino ac ids in the c h y m o t r y p t i c fragments of product 
I I (Table 2) is c o n s i s t e n t w i t h the d e s i g n a t i o n of the c h y m o t r y p t i c fragments 
presented in F i g . 4 . 
While product I gave one c h y m o t r y p t i c p e p t i d e (Cr) which c o - e l u t e d w i t h 
fragment C, of the s y n t h e t i c p e p t i d e s , the o v e r a l l c h y m o t r y p t i c p r o f i l e of p r o ­
duct I i s q u i t e d i f f e r e n t f rom t h a t of the s y n t h e t i c p r o d u c t s . The c o n c l u s i o n 
from the c h y m o t r y p t i c mapping of product I c o n f i r m s t h a t from the t r y p t i c d i ­
g e s t i o n : both i n d i c a t e t h a t product I can be designated n e i t h e r as a-melano-
aN t r o p i n nor as des-Ас - a - m e l a n o t r o p i n . Thus, the i d e n t i t y of product I remains 
t o be c i a r i f led . 
cpm.10" tryptic fragments" 
15-
40 
time (mm) 
Ргуиге 6. High-performance liquid chromatographic analysis of tryptic digests of products IV, V, 
VII and VIII. Following pulse incubation in a mixture of [ H]lysine, [ H]tyrosme, [ H]phenyl-
alanine and [ H]tryptophan, lobes were extracted and newly synthesized products IV, V, VII and 
Vili were isolated by high-performance liquid chromatography Tryptic digestion lasted 20 m m 
(products IV and V) or 16 h (products Vii and Vili). Digests were analysed by high-performance 
liquid chromatography using the gradient illustrated in the graph on the lower right (O θ) , 
as described in Fig. 2. Arrows indicate the elution position of the undigested starting materials. 
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Digestion of Prociuotä I'/, /, / I I and VIII with Trypsin 
Tryptic digestion (20 min) of product IV produced two fragments: one eluting 
at 6 min, the other at 30 min (Fig. 5 ) . Following pulse incubation of lobes 
using exclusively [ H]lysine as a label, tryptic digestion of the isolated pro-
duct IV yielded only one labelled fragment, eluting at 6 min. This indicates 
that this fragment contains lysine and, furthermore, that within the time of 20 
min the tryptic digestion was complete. The undigested starting material (pro-
duct IV) eluted at 30.5 min. Tryptic digestion (20 min) of product V gave two 
fragments, eluting at 6 min and З'* min (Fig. 5)· Digestion of a lysine-label led 
product V gave only one tryptic fragment, eluting at 6 min. The starting mate­
rial (product V) eluted at 3^-5 min. When products IV and V were digested for 
16 h with trypsin, similar maps were obtained as with the 20-min digest. 
A 16-h tryptic digestion of product VII produced three fragments eluting at 
28, 32 and 3^ min, respectively (Fig. 5 ) . The starting material (product VII) 
eluted at 39 min. A 16-h tryptic digestion of product VIII produced four frag­
ments eluting at 2, 12, 21.5 and 26.5 min, respectively (Fig. 5)· The 2-min 
fragment co-elutes with free lysine. The starting material (product VIII) eluted 
at hO min. Shorter digestion revealed that products VII and VIII are more stable 
towards trypsin than products I, II, IV and V. 
DISCUSSION 
The results of the pulse-chase experiments give clear evidence for a precur­
sor-product mode of biosynthesis in the Xenopuc neurointermediate lobe. Pro­
duct XI, the only major protein present after the pulse incubation, disappears 
during chase incubations with concomitant appearance of a number of chase pep­
tides (products 1-Х). The fact, moreover, that product XI is immunoprecipitable 
with antisera to o-melanotropin, corticotropin and endorphin suggests that it 
is probably the common prohormone for these hormonal substances. Product XI 
(M 35000) can thus appropriately be referred to as 'pro-op iomelanocort in ' , a 
term first coined by Chrétien et al. [20] in recognition of the multipl¡city of 
its functions. 
All products, with the possible exception of pro-opiomelanocortin, are re-
leased into the medium. The appearance of peptides in the incubation medium pro-
bably reflects a true release process, since we have earlier demonstrated that 
dopamine inhibits and cAMP enhances the level of peptides in the medium [11]. 
The results of the peak identification experiments (electrophoresis, selec-
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t ¡ ve amino ac i d i n c o r p o r a t i o n , ¡ішіипоргес i p i t a t ion and p e p t i d e mapping) i n d i ­
c a t e t h a t most of the chase pept ides may be c l a s s i f i e d i n t o t h r e e d i s t i n c t 
groups of p e p t i d e s : (a) m e l a n o t r o p i n - r e l a t e d , (b) c o r t i c o t r o p i n - r e l a t e d , and 
(c) e n d o r p h i n - r e l a t e d . 
Melanotropir-Related Peptides 
This group consists of newly synthesized products I and II. Product II co-
aN 
migrated with synthetic des-Ас -a-melanotropin on the acid/urea gel and also 
co-eluted with this latter peptide on two different gradients of the high-per­
formance liquid chromatography system. It gave tryptic and chymotryptic clea-
aN 
vage elution profiles identical to those obtained from synthetic des-Ас -a-
melanotropin. Furthermore, the presence of the radioactive amino acids in the 
various tryptic and chymotryptic fragments of product II was entirely in agree­
ment with the distribution predicted on the basis of the structure and cleavage 
sites of des-Ас -a-melanotropin. Concerning the С terminus, it must be pointed 
out that product II was immunoprec¡pitated with an anti-(a-melanotropin) serum 
specific for the (amidated) С terminus of a-melanotropin. Moreover, amidation 
of peptides gives rise to shifts in elution time on the chromatography column 
[21]. The elution times of product II and the C-terminal fragments resulting 
from its tryptic and chymotryptic digestion are identical to the respective elu-
aN tion times of des-Ас -a-melanotropin and its C-terminal fragments. It may be 
deduced, therefore, that the С terminus of product II is amidated. Altogether, 
the above data lead to the conclusion that product II is des-Ас -a-melanotropin. 
Product I, which has previously been shown to co-elute with a Xenopus peptide 
with melanotropic activity [5], immunoprecipitated with the antiserum to a-mela­
notropin. The fact that in the selective incorporation studies product I showed 
the same behaviour as product II (Table 1) suggests a structural resemblance be­
tween these two products. The tryptic and chymotryptic maps, however, demonstrate 
aN 
that product I is neither a-melanotropin nor des-Ас -a-melanotropin. It also 
cannot be the recently described bovine melanotropic peptide [N, O-diacetyl-
serine ]a-melanotropin [22], as a (chymo)tryptic map of this latter peptide 
would, with the exception of the N-terminal fragment, correspond to that of 
a-melanotropin. Neither are its mapping characteristics consistent with a ß-me-
lanotropin-1ike structure. Another melanotropic peptide, reported by Nakanishi 
et al. [23], is γ-melanotropin from the N-terminal cryptic region of the bo­
vine cort¡cotropin/ß-lipotropin precursor. It is, however, unlikely that pro-
duct I corresponds to bovine γ-melanotropin since this last peptide, at least 
in bovine pituitary glands, does not contain lysine or prol ine, two amino acids 
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present ¡π product I. Finally, it cannot be excluded at present that product I 
represents more than one peptide. This possibility is, however, rather remote 
since product I gives a single peak both with electrophoresis and with a num­
ber of different gradients on high-performance liquid chromatography. 
The question arises whether α-me 1anotгор in is synthesized at all in the 
pars intermedia of Xenopus. From the present study it is clear that it is not 
among the chase peptides in the tissue. Interestingly, we have recently demon-
aN 
strated that the newly synthesized des-Ас -a-melanotropin present in the lobe 
is acetylated just prior to or during the release process [24]. Thus, a-mela­
notropin is exclusively found in the medium. 
Covti-ootropin-Pelatea Peptídec 
This group consists of newly synthesized products IV and V; both products 
are immunopreci ρ i table with corticotropin antiserum and hence are classified 
as being corticotropin-related. Several lines of evidence indicate, however, 
that neither of these peptides is corticotropin-(1-39)· They do not contain 
tryptophan, an amino acid present in all known structures of corticotropin-
(1-39); they migrate much slower than this peptide on the acid/urea gel; they 
have no corticotropin bioactivity [5]; their tryptic maps differ from that ex­
pected for corticotropin-(1-39)· 
The results obtained provide strong evidence for the notion that products 
IV and V are structurally similar to the C-terminal 18-39 part of corticotro­
pin, the so-called corticotropin-like intermediate lobe peptide. First, both 
products IV and V were immunoprecipitated with a corticotropin antiserum spe­
cific for the iS-Zk sequence. Secondly, both peptides contained leucine, pro­
line, phenylalanine, tyrosine, lysine and arginine but no tryptophan, and in 
this respect too, they resemble corticotropin-(18-39). With tryptic digestion, 
products IV and V yielded two fragments. One of these was a rapidly eluting, 
lysine-contain ing fragment with the same elution time in both cases; the 
second was a fragment almost co-eluting with its respective undigested star­
ting material. The production of two tryptic fragments again is consistent 
with a structure like corticotropin-(18-39)• Moreover, the tryptic elution 
profiles of products IV and V appear to correspond well with the theoretical 
tryptic profile for this peptide, based on the predictable retention times of 
its fragments on the chromatography column,using the method of Meek [21]. In 
line with this view, the acidic nature of corticotropin-(l8-39) ι its isoelec­
tric point is estimated to be k.5 by the method of van Haard et al. [25], 
would explain the low electrophoretic mobility of products IV and V on the 
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acid/urea gel. Yet, a slight inconsistency arises from the estimated molecular 
weights of products IV and V (M = 5500) which seem to be too high for a struc-
ture like corticotropin-(18-39)· It is known, however, that electrophoretic mo-
bilities of proteins on dodecyl sulphate gels are affected by their charges 
[26] and, therefore, the molecular weight value for the highly charged pro-
ducts IV and V is inconclusive. What the difference is between products IV and 
V remains to be determined. Pertinent to this question is the observation that 
the rapidly eluting, lysine-containing, tryptic fragments of products IV and V 
were co-eluting; if indeed products IV and V resemble corticotropin-(18-39), 
these latter fragments would represent their N-terminal parts. Thus, it is 
unlikely that the structural difference between products IV and V is located 
in the N-terminal part of the molecules. None of the newly synthesized pep-
tides corresponds to cort¡cotropin-(1-39), indicating that if this latter pep-
tide acts as the immediate precursor in the production of melanotropic peptides, 
as first suggested by Lowry and Scott [27], then in our tissue its conversion 
must be very rapid. 
Endorphin-Related Peptides 
This group consists of newly synthesized products VII and VIII; both pro-
ducts are immunoprecipi table with endorphin antiserum. Several facts suggest 
that product VIII is S-endorphin or at least very similar to this peptide. Pro-
duct VIII co-migrated with synthetic ß-endorphin on the acid/urea gel, had a 
molecular weight comparable to ß-endorphin and did not contain arginine and 
tryptophan (two amino acids absent from all known ß-endorphin structures). As 
expected for a ß-endorphin-1 ike structure, tryptic digestion of product V I M 
yielded free lysine. 
The close resemblance between products VII and VI I I with regard to electro-
phoresis, chromatography and immunopreci pi tat ion, as well as with respect to 
their partial amino acid composition, indicates that product VII is an endor-
phin-! ike peptide. Although products VII and VIII have much in common, the 
tryptic maps (Fig. 5) suggest that they do differ in their structures. Further 
work is necessary for their complete identification. 
In conclusion, in the neurointermediate lobe of Xenopus laevis three groups 
may be distinguished among the products derived from pro-opiomelanocortin, 
namely peptides related to melanotropin, corticotropin-(18-39) and endorphin. 
An interesting observation is that in each group there are at least two pep-
tides. Possibly, one of the two in such a group represents an intermediate in 
the proteolytic processing leading towards the other. Or, one peptide might 
5k 
represent a modified (e.g. acetylated, glycosylated) form of the other. With 
respect to the melanotropic peptides (products I and II) and endorph¡n-1ike 
peptides (products VII and V I M ) , such explanations seem unlikely as their 
(chymo) trypt ic maps are rather different. A third possibility is that these 
pairs of products represent analogous, but distinct peptides coming from two 
closely related pro-hormones which have slightly different amino acid sequen-
ces. The existence of more than one precursor to corticotropin and endorphin 
has been reported for mouse adenocarcinoma cells [7, 28, 29] and for rat pars 
intermedia cells [30]. More pertinent to our own subject is an observation by 
Loh [31] who obtained immunological evidence for the existence of two precur-
sors to corticotropin and endorphin in the neurointermediate lobe of X. laevis. 
The above findings were explained either by assuming differences in the degree 
of glycosylation of a single high-molecular-weight precursor, or by the syn-
thesis of distinct precursors with similar but not identical primary sequences. 
With respect to the latter explanation, the results of Kawauchi et al. [32-3Ό 
are of interest. These investigators have isolated and sequenced peptides re­
lated to α-melanotropin, g-melanotropin and endorphin from salmon pituitary 
extracts. In each of these three hormone groups, two highly related peptides 
withminor variations in amino acid sequences were found. This led them to con­
clude that in salmon there are two similar but non-i denticaI prohormones. The 
existence of two genes for pro-opiomelanocortin could be a general phenomenon. 
Drouin and Goodman [35] have reported the presence of two closely related pro­
opiomelanocortin genes in the rat. The possible occurrence of two sequentially 
different prohormones in Xenopus neurointermediate lobes is currently under in­
vestigation in our laboratory. 
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BIOSYNTHESIS OF Α γ -MELANOTROPIN-LIKE PEPTIDE IN THE PARS INTERMEDIA 
OF THE AMPHIBIAN PITUITARY GLAND 
Gerard J.M. Martens, Bruce G. Jenks and A.P. van Overbeeke 
Department of Zoology, Catholic univevsity of Ilijfegen 
SUMMARY 
This study reveals the biosynthesis of a γ,-melanotropm-like peptide in the 
pars intermedia of the pituitary gland of the aquatic toad Xenopvs laevis. In 
vitro pulse-chase experiments showed that this product is synthesized through 
processing of a prohormone, pro-opiomelanocortin, and that it is released into 
the Incubation medium. The peptide immunoprecipitated with antiserum to γ,-
melanotropin, appeared to be a glycopeptide and displayed melanotropic activity. 
This last observation together with the results of tryptic and chymotryptic pep­
tide mapping of the newly synthesized product indicate that Xpnopus γ,-melano-
tropin is structurally different from the proposed mammalian γ-melanotropins. 
INTRODUCTION 
It is well established that in the adrenocorticotropic cells of the pituitary 
gland corticotropin and ß-lipotropin are produced through processing of a common 
prohormone (for a review, see [1]). In the pars intermedia, the same prohormone 
functions as the precursor for α-melanotropin, corticotropin-!ike intermediate 
lobe peptide (corticotropin-(18-39)) , and ß-endorphin; it was, therefore, named 
pro-opiomelanocortin [2]. Nakanishi et al. [3] revealed the nucleotide sequence 
of the cloned cDNA which is complementary to the mRNA that codes for pro-opio-
melanocortin in bovine pituitary glands. The primary structure deduced from 
this nucleotide sequence showed three repetitive units consisting of the tetra-
peptide His-Phe-Arg-Trp, which sequence is characteristic for melanotropic pep-
tides. One of these units constituted a segment of the sequence corresponding to 
α-melanotropin, a second unit was part of the region corresponding to 6-melano-
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tropin. A segment of 12 amino acids containing the third unit and flanked on 
either side by pairs of basic amino acids was named γ-melanotropin. Subsequent­
ly, three forms of γ-melanotropin were postulated, γ., γ. and γ, ['t]. Of these 
forms, γ. corresponds to the segment of 12 amino acids; γ. represents the se­
quence 1-11 of γ. with an amidated C-terminus; γ, constitutes a segment of 27 
amino acids, namely γ, C-terminally extended with a sequence of 15 amino acids. 
The putative γ,-melanotropin contains the sequence Asn-Gly-Ser and, thus, could 
be a glycopept¡de. 
Immunological investigations [5, 6] as well as analyses of amino acid sequen-
ces [7-9] indicate the occurrence of γ-melanotropin-like peptides in the pitui­
tary gland of several species. Biosynthetic studies showing the processing of 
pro-opiomelanocortin to yield γ-melanotropin have, however, not been reported. 
Indeed, while considerable information is available concerning the enzymatic 
conversion of the C-terminal portion of pro-opiomelanocortin (which contains 
the sequences of α-melanotropin, corticotropin-(18-39), S-melanotropin and B -
endorphin) little is known about the significance of the N-terminal 'cryptic 
region' containing the sequence of γ-melanotropin. 
Using pulse-chase incubations and high-performance liquid chromatographic 
analysis, we recently demonstrated that in the neurointermediate lobe of 
Xenopus laevis pro-opiomelanocortin is processed to a number of peptides, three 
of which (indexed as products I, II and IV) have high melanotropic activity 
[10]. Of the three melanotropic peptides, one was identified as des-Ас -o-
aN 
melanotropin; the second appeared to represent the acetylated form of des-Ac 
α-melanotropin (a-melanotropin)[11]. We now report that the third product with 
melanotropic activity is a γ,-melanotropin-like peptide which is synthesized 
and released into the incubation medium by the pars intermedia of the pituitary 
gland of Xenopus laevis. 
MATERIALS AND METHODS 
Animals 
F u l l y Ыаск-adapted Xenopus laevis, bred and reared in the Department of 
Zoology, U n i v e r s i t y of Ni jmegen, of appi o x i m a t e l y the same weight (25 g) were 
used. For b lack-background a d a p t a t i o n , the animals were kept in b lack buckets 
f o r a t l e a s t two weeks a t 22°C and under c o n s t a n t i l l u m i n a t i o n . 
Anolis carclinensis, used in the bioassay f o r m e l a n o t r o p i c a c t i v i t y , were 
purchased from C a r o l i n e B i o l o g i c a l Supply Company ( B u r l i n g t o n , North C a r o l i n a , 
U.S.A.) . 
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Chronatcyrapny and elecvì'Obhoresιβ 
The high-performance l i q u i d chromatographic s e p a r a t i o n s were on Spher isorb 
10 ODS (Chrompack, 250x4.6 mm i n t e r n a l d iameter) w i t h a f l o w r a t e of 2 m l / m i n , 
and 0.5-min f r a c t i o n s were c o l l e c t e d . The g r a d i e n t c o n s i s t e d of 0.5 M f o r m i c 
a c i d , 0.14 M p y r i d i n e (pH 3 . 0 , so lvent A) and 1-propanol ( s o l v e n t B) . For 
f u r t h e r chromatographic d e t a i l s see [ 1 0 ] . Acid/urea gel e l e c t r o p h o r e s i s was 
performed on \\% Polyacry lamide g e l s a c c o r d i n g t o Davis et at. [ 1 2 ] . The m i ­
g r a t i o n of a p e p t i d e is given r e l a t i v e t o cytochrome с (Boehr inger) which was 
the marker ( R p - v a l u e ) . For comparison, s y n t h e t i c p o r c i n e c o r t i c o t r o p i n - ( 1 - 3 9 ) , 
des-Ac - α - m e l a n o t r o p i n ( g i f t s from Organon I n t e r n a t i o n a l B.V., Oss, The 
N e t h e r l a n d s ) , a-melanotropin ( P e n i n s u l a ) , ß-endorphin (Peninsula) and human γ , -
m e l a n o t r o p i n were submit ted t o e l e c t r o p h o r e s i s . 
Pulse and pulse-chase inevbations 
For the pulse-chase a n a l y s i s , Xenopus n e u r o i n t e r m e d i a t e lobes were p r e i n c u -
bated f o r 1 h in 100 μΐ i n c u b a t i o n medium ( f o r composi t ion see [ 1 0 ] ) a t 220C on 
a Dubnoff m e t a b o l i c shaker. A f t e r the pulse i n c u b a t i o n f o r 30 min in 50 μΐ me­
dium c o n t a i n i n g 50 uCi [ H ] l y s i n e (80 Ci/mmol, Amersham), the lobes were e i t h e r 
homogenized (pulse group) or chase-incubated in 100 μΐ medium c o n t a i n i n g 5 mM 
L - l y s i n e (Calbiochem) f o r 4 h (chase g r o u p ) . Lobes were homogenized in 500 μΐ 
0.1 M HCl, the homogenate was c e n t r i f u g e d (5 min, 10000 g , Beekman microfuge) 
and the supernatant was analyzed w i t h high-performance l i q u i d chromatography 
us ing the g r a d i e n t given in F i g . l a . To the chase i n c u b a t i o n medium, 500 μΐ 
0.1 M HCl was added, the a c i d i f i e d medium was c e n t r i f u g e d and the supernatant 
was chromatographed. 
To study the s e l e c t i v e amino a c i d and glucosamine i n c o r p o r a t i o n , lobes were 
incubated f o r 5 h in 50 μΐ medium c o n t a i n i n g one r a d i o a c t i v e label (40 uCi f o r 
each amino a c i d t e s t e d ; 100 yCi in the case of [ - ^ g l u c o s a m i n e ) ; the l a b e l s 
t e s t e d were [ M i s e r i n e (14 Ci/mmol), [ H ] p r o l i n e (48 Ci/mmol), [ H ] l e u c i n e 
(120 Ci/mmol), [ 3 H ] i s o l e u c i n e (87 Ci/mmol), [ 3 H ] a s p a r t i c a c i d (5 Ci/mmol), [ 3 H ] -
g l u t a m i c a c i d (34 Ci/mmol) or [ H]glucosamine (27 Ci/mmol). A l l r a d i o a c t i v e 
l a b e l s were purchased from Amersham. 
Unglycosy lated chase product I was prepared f o r submittance t o a c i d / u r e a gel 
e l e c t r o p h o r e s i s by p r e i n c u b a t i n g lobes f o r 4 h in medium c o n t a i n i n g 10 ug/ml 
tun icamycin (Sigma) p r i o r t o a 5"h pulse i n c u b a t i o n . Tunicamycin is an a n t i b i o ­
t i c t h a t i n h i b i t s the g l y c o s y l a t ion of p r o - o p i o m e l a n o c o r t i n [13] by p r e v e n t i n g 
the at tachment of a carbohydrate t o an asparagine res idue [ 1 4 ] ; p r e v e n t i o n of 
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g l y c o s y l a t ion was over 90%. A f t e r the 5"h i n c u b a t i o n in medium c o n t a i n i n g kO 
\iC\ [ H j l y s i n e and 10 yg/ml t u n i c a m y c i n , the lobes were homogenized, the homo-
genate was c e n t r i f u g e d and the supernatant was chromatographed us ing the g r a ­
d i e n t given in F i g . l a . An a l i q u o t of each f r a c t i o n was counted t o o b t a i n the 
r a d i o a c t i v e chromatographic p r o f i l e and from t h i s p r o f i l e f r a c t i o n s c o n t a i n i n g 
u n g l y c o s y l a t e d product I were s e l e c t e d ; i t was found t h a t the e l u t i o n t ime of 
u n g l y c o s y l a t e d product I was almost the same as t h a t of ( g l y c o s y l a t e d ) product I . 
Irmunopreeipi tation 
The p r e p a r a t i o n of newly synthesized pept ides w i t h h igh s p e c i f i c a c t i v i t y and 
the double a n t i b o d y immunoprecipi t a t ion technique have been descr ibed e a r l i e r 
[ 1 5 ] . The a n t i s e r u m t o γ - m e l a n o t r o p i n was k i n d l y prov ided by Dr. H. Vaudry, Rouen, 
France. This a n t i s e r u m was made w i t h human y . - m e l a n o t r o p i n as a n t i g e n and the 
c r o s s - r e a c t i v i t y w i t h a - m e l a n o t r o p i n , ß-melanot rop in , c o r t ¡ c o t r o p i n - ( 1 - 3 9 ) , a -en-
d o r p h i n , ß-endorp in , γ-endorphin and met-enkephal in was <0.001%. Using 17 d i f f e ­
r e n t γ , - m e l a n o t r o p i n - r e l a t e d , s h o r t - c h a i n analogues i t could be e s t a b l i s h e d t h a t 
the a n t i g e n i c determinant recognized by the a n t i s e r u m was γ , - m e l a n o t r o p i n - ( 5 - ΐ Ό 
(Dr. H. Vaudry, personal communicat ion). 
Bioassay fov melanoLropia aativity 
Neuroi ηtermed i a te lobes were homogenized in 500 ul 0.1 M HCl, the homogenate 
was c e n t r i f u g e d and the supernatant was chromatographed us ing the g r a d i e n t given 
in F i g . l a . To the 0.5-min f r a c t i o n s , 20 ug bovine serum albumin (Sigma) was 
added and the f r a c t i o n s were f r e e z e - d r i e d . The Anolis s k i n b i o a s s a y , as des­
c r i b e d by T i l d e r s et al. [ 1 6 ] , was used w i t h minor m o d i f i c a t i o n s as r e p o r t e d 
e a r l i e r [ 1 0 ] . A lpha-melanotropin was used as a s t a n d a r d . 
Ensymztia digestions and peptide mapping 
Neurointermediate lobes were incubated f o r 5 h in 40 y l med i urn c o n t a i n i n g a 
m i x t u r e of kO pCi each of [ H ] l y s i n e , [ H ] t y r o s i n e , [ H ] p h e n y l a l a n i n e and [ H ] -
tryptophan (80, 5**, 77 and 26 Ci/mmol, r e s p e c t i v e l y ; Amersham) . Product I was 
i s o l a t e d w i t h h igh-performance l i q u i d chromatography using the g r a d i e n t given 
in F i g . l a . The i s o l a t e d p e p t i d e was then d i g e s t e d w i t h e i t h e r t r y p s i n ( t r e a t e d 
w i t h dipheny Icarbany I c h l o r ide , Sigma) or α-chymotryps in ( t r e a t e d w i t h Nct-tosy l-
L - l y s i n e ch loromethy l k e t o n e , Sigma) and the d i g e s t was submitted t o h i g h - p e r ­
formance l i q u i d chromatography. The s p e c i f i c d i s t r i b u t i o n of each of the f o u r 
l a b e l l e d amino a c i d s in each of the ( c h y m o ) t r y p t i c fragments was determined by 
d i g e s t i n g each i s o l a t e d fragment to y i e l d f r e e amino a c i d s . The d i g e s t was ana-
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lyzed with a chromatographic elution program which gave a clear separation of 
the four labelled amino acids used. 
A separate tryptic and chymotryptic mapping experiment was conducted with 
product I which was biosynthet¡cally labelled with only [ H]arginine (20 Ci/ 
mmol; Amersham). To localize the oligosaccharide in product I, this product was 
labelled with [ H]glucosamine, digested with trypsin and the digest was analyzed 
with chromatography. Details of the mapping techniques, including the high-per-
formance liquid chromatographic elution gradients, have been published [15]. 
To assess whether product I was Na-acetylated, this newly synthesized pro-
duct was isolated and incubated with leucine aminopeptidase (Sigma) for 10 min, 
2 h or 20 h at 370C in phosphate buffer, pH = 8.0. The digestion was terminated 
by the addition of 500 μΐ 0.1 M HCl, the digest was centrifuged and the super­
natant was immediately analyzed with high-performance liquid chromatography. 
RESULTS AND DISCUSSION 
A 30-min pulse incubation of neurointermed¡ate lobes in the presence of [ H ] -
lysine resulted in the synthesis of only one protein, product XI (Fig. la). 
After a 4-h chase incubation, the amount of product XI was greatly reduced 
with the concomitant appearance of products 1-Х (Fig. lb). These observations 
confirmed those of an earlier study in which the chase peptides 11,1V, V, VI I and 
VI I I were characterized [15]. In the same investigation it could be shown that 
the precursor (product XI) was ¡mmunoprec¡p¡table with antisera to a-melanotro-
pin, adrenocort¡cotropin or endorphin, and was therefore designated pro-opio-
melanocort¡n. All chase peptides were released into the incubation medium (Fig. 
1c). 
High-performance liquid chromatographic analysis of lobes which were incuba-
ted for 5 h in medium containing [ H]glucosamine revealed the presence of four 
labelled products. The elution times of these products corresponded with those 
of products I, IX, X and XI (Fig. Id). 
The antiserum to γ,-melanotropin precipitated six products; their elution 
times corresponded with those of products I, VI, VIII, IX, X and XI (Fig. le). 
Product VI is a minor newly synthesized product; its nature and the signifi­
cance of its immunological resemblance to γ-melanotropm are unknown. Similarly, 
the identity of the immunoprecipitable product co-eluting with peptide VIII re­
mains obscure. It is unlikely that the product reacting with the antiserum ¡s 
peptide VIII itself as this last peptide was identified as an endorphin-1ike 
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peptide [15]. Since products IX and X, which are immunoprecipi table with anti-
Y.-melanotropin, are glycoproteins and have molecular weights of l8000and 
I7OOO daltons, respectively (unpublished observation) they most likely corres-
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Figure 7. High-performance l i q u i d chromatographic a n a l y s i s of ( a - e ) newly synthesized products and 
( f ) melanotropic pept ides in neuro intermediate lobes of X. laevis (a) lobes pul se- incubated for 
30 min in the presence of [ H ] l y s i n e , (b) lobes chase- incubated fo r U h in the presence of 5 mM 
L- lys ine f o l l o w i n g a 30-min pulse incubation in the presence of [ H j l y s i n e . (c) incubation medium 
of lobes chase- incubated fo r k h in the presence of 5 mH L - l ys ine f o l l o w i n g a 30-min pulse incu-
bat ion in the presence of [ H j l y s i n e . (d) lobes incubated fo r 5 h in the presence of [ H jg luco-
samine. (e) ant i - γ - m e l a n o t r o p i n immunoprecipitate of e x t r a c t of p u l s e - i n c u b a t e d l o b e s , ( f ) melano­
t r o p i c a c t i v i t y of f r a c t i o n s of lobe e x t r a c t . Arrows i n d i c a t e the e l u t i o n p o s i t i o n s of the newly 
synthesized p r o d u c t s ; f o r the r a t i o of solvent A ( 0 . 5 M formic a c i d , Ο . Ι Ί M p y r i d i n e , pH 3 · 0 ) to 
solvent θ ( 1 - p r o p a n o l ) the same g r a d i e n t was used as shown in a . 
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pond to the N-terminal 16К-fragments of pro-opiomelanocortin, first described 
by Eipper and Mains [17] in mouse pituitary tumor cells. Whether the 17K and 
18K glycoproteins represent two 'forms of ІбК-fragments' , each derived from 
one of the two forms of Xeriopus pro-opiomelanocort in [131t remains to be esta­
blished. The immunoprecipitat ion of product XI suggests that Xenopus pro-opio-
melanocortin is not only the prohormone for a-melanotropin, corticotropin-(l8-
39) and endorphin, as reported earlier [151, but also for γ-melanotropin. The 
facts that product I is derived from pro-opiomelanocortin (Fig. la, b), that 
it represents a glycopeptide (Fig. Id) and, furthermore, that it ¡mmunopreci-
pitates with ant i-γ,-melanotropin (Fig. le) demonstrate that product I is a 
γ,-melanotropin-1ike peptide. 
The production of a γ,-melanotropin in Xenopus implies that in the pars in­
termedia of this species processing of at least part of the 17K and/or 18K 
fragments must occur. Crine et al. [18] proposed that in the rat pars interme­
dia the N-terminal portion of pro-opiomelanocortin, rather than γ-melanotropin, 
is an end product of the maturation process. This last notion, however, was 
based on pulse-chase experiments with a maximum chase-period of two hours, which 
may be too short to achieve complete processing. In Xenopus laewis, after a 2-h 
chase period only a small amount of product I (the γ,-meianotropin-1ike peptide) 
was present; it took at least Зг hours of chase to reach a maximum level of this 
peptide [15] · 
The Anolis skin bioassay revealed three major melanophore stimulating sub­
stances, corresponding to products I, II and IV (Fig. If). The melanotropic 
cuN 
products II and IV are des-Ас -a-melanotropin and a-melanotropin, respectively 
[11]. The observation that product I, the Xenopus γ,-melanotropin, displays 
melanotropic activity seems to be at variance with the notion that synthetic 
(bovine) γ,-melanotropin is barely bioactive [k]. It must be realized, however, 
that the Xenopus peptide is a glycopeptide. Moreover, its primary structure 
might also be different from that of the synthetic analogue. That such a dif­
ference indeed exists, is indicated by the electrophoretic behaviour of the 
peptides: not only product I but also the unglycosylated product I migrates 
faster on acid/urea gels than synthetic γ,-melanotropin (Table 1). This rela­
tively fast migration of product I together with its rapid elution from the 
chromatography column (Fig. 1) suggest that it is a small peptide. 
Insight concerning the structure of the newly synthesized γ,-melanotropin-
like-peptide in Xenopus was obtained through tryptic and chymotryptic peptide 
mapping by high-performance liquid chromatography. When a 10-min tryptic di­
gest of product I, labelled with [ H]lysine, [ H]tyrosine, [ H]phenylalanine 
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ТаЬЪв 1. Electrophoret¡с characteristics of synthetic and newly synthesized peptides. Following in­
cubation of neurointermediate lobes in the presence of [ Hjlysine» the newly synthesized peptides 
were isolated with high-performance liquid chromatography. Following preincubation with tunicamycin, 
lobes were incubated in the presence of [ Hjlysine and newly synthesized unglycosylated product I 
was isolated with chromatography. The electrophoret¡c mobility of each peptide was determined on 
acid/urea gels; Rp-values are given relative to cytochrome с 
Peptide 
(a) synthetic peptides 
porcine corticotropin 1.36 
human 0-endorphm 1.36 
a-melanotropin 1.59 
human γ,-melanotropin 1.6*1 
des-Ас -a-melanotropin 2.07 
(b) Xenopus newly synthesized peptides 
a-melanotropin 1.59 
aN 
des-Ac -a-melanotropin 2.07 
product I 2.18 
unglycosylated product I 2.22 
and [ H ] t r y p t o p h a n , was a n a l y z e d , t h r e e fragments were o b t a i n e d ( F i g . 2 a ) . 
These f r a g m e n t s , indexed a c c o r d i n g t o the sequence of t h e i r e l u t i o n from the 
column, were: T . ( e l u t i n g a t 8 min ) , Τ , (11.5 min) and Τ. (1Ί m i n ) . Prolonged 
d i g e s t i o n of product I (20 h) y i e l d e d the same t h r e e fragments but the amount 
of T , had decreased; in a d d i t i o n , a f o u r t h fragment had appeared: T. a t 7 min 
( F i g . 2 b ) . A 10-min c h y m o t r y p t i c d i g e s t of product I gave t h r e e fragments 
( F i g . 2 c ) : C- (8.5 m i n ) , С- (12 min) and С, (\k m i n ) . Longer d i g e s t i o n (20 h) 
w i t h chymotrypsin produced f i v e fragments ( F i g . 2 d ) : C. (5 m i n ) , C7 (7 .5 m i n ) , 
С,, С. (11 min) and С-. Thus, a f t e r long d i g e s t i o n fragment C¿ disappeared and 
the amount of C- decreased wh i le three new fragments appeared. A t r y p t i c d iges t 
(20 h) of product I , which was b i o s y n t h e t ¡ c a l l y l a b e l l e d w i t h [ H ] a r g i n i n e , 
y i e l d e d on ly the fragments T . , Τ» and Τ , . When [ H ] a r g i n ¡ n e - l a b e l led product I 
was d igested w i t h chymotrypsin f o r 10 min, the fragments Cr and C/· were o b t a i n -
ed ; a 20-h d iges t of t h i s product gave C, and Cr. T r y p t i c d i g e s t i o n (20 h) of 
a [ H ]g lucosamine- labe l led product I produced one f ragment , e l u t i n g a t 10 min , 
which d id not correspond to T j , T . , Τ , or T . . In a l l cases the undigested 
s t a r t i n g m a t e r i a l e l u t e d a t 22.5 min. The p a r t i a l amino a c i d composi t ion of 
the v a r i o u s ( c h y m o ) t r y p t i c f r a g m e n t s , based on the r e s u l t s of complete d i g e s ­
t i o n of the fragments and on the a r g i n i n e i n c o r p o r a t i o n , is presented in Table 
2. The s e p a r a t e , s e l e c t i v e amino a c i d i n c o r p o r a t i o n experiments showed t h a t 
product I c o n t a i n s , in a d d i t i o n t o the amino a c i d s given in Table 2, p r o l i n e , 
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2 
chymotryptic fragments • 
time Imin] 
Figure 2. High-performance liquid chromatographic analysis of tryptic and chymotryptic digests of 
product I. Following incubation in the presence of a mixture of [ Hjlysine, [ H]tyrosine, [ H]-
phenylalanine and [ H]tryptophan, neurointermediate lobes were extracted and newly synthesized 
product I was isolated by high-performance liquid chromatography. This product was digested at 
37°C with trypsin for (a) 10 min or (b) 20 h or with chymotrypsin for (c) 10 min or (d) 20 h . 
Arrows indicate the elution position of the undigested starting material. 
Table 2, Partial amino acid content of the tryptic and chymotryptic fragments of product I. To 
determine the distribution of lysine, tyrosine, phenylalanine and tryptophan in the various (chymo)-
tryptic fragments of product I, the isolated fragments, radiolabelled with the four amino acids and 
numbered as in Fig. 2, were digested to free amino acids which were then chromatographed to assess 
which of the radioactive amino acids were present in each fagment. The distribution of arginine was 
determined by chromatographing the (chymo)tryptic digests of [ H]argin¡ne-labelled product I. 
Tryptic fragments 
Tj: Phe, Arg 
T2: Туг, Arg 
T 3: Phe, Arg 
TV Тгр, Lys 
Chymotryptic fragments 
С,: Lys 
C 2: Phe 
C 3: Tyr 
C^: Trp, Arg 
С.: Phe, Arg 
Ζ,: Trp, Lys, Arg 
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serine and aspart ic acid but lacks leucine, isoleucine and glutamic a c i d . 
The r e s u l t s of the t r y p t i c and chymotryptic mapping together w i t h the par­
t i a l amino acid composition of the various fragments were assembled and com­
pared t o e s t a b l i s h the arrangement of the fragments w i t h i n product I ( F i g . 3a, 
b ) . The proposed p a r t i a l amino acid sequence of γ,-meianotropin in Xnrovus 
along w i t h the sequences of the putat ive bovine, human and rat γ,-melanotropins 
are presented in F ig. 3c. In each of these l a s t three peptides the primary 
s t r u c t u r e provides for the p o s s i b i l i t y of a carbohydrate side c h a i n , whether 
O-glycosidic ( to a ser ine-residue) or N-glycosidic ( t o the asparagine-residue). 
In Х^пориз, such a side chain indeed occurs; i t must be located in the C-ter-
minal p o r t i o n of the molecule because the [ H]glucosamine-labelled t r y p t i c 
fragment did not contain lys ine or a r g i n i n e . As the a n t i b i o t i c tunicamycin pre­
vents g lycosy lat ion of pro-opiomelanocortin in t h i s species [13] the o l igosac­
charide of the prohormone must be l inked to asparagine [ l A ] . Since t h i s pro-
10 mm •· - T 2 -,- T3 ' . - К -7 ' — ι — " — . ^ 
—Tyr Arg'-T-Phe ArgT Trp -Lys' Asn-
20 h '- T l -
10 mm ^ С З ^ і - C5 'г C6-
-uj—-1- из - ι -
Туг A r g — . — Ρήθ* Arg Trp. Lys A s n — 
* Τ 20 h ' - C 2 ~ - Ci, -1- Cl 
с human 10 η η 
bovine Tyr-Val-Met-Oly-His-Phe-irg-Trp-Asp-Arg-Phe-Gly-Arj-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Cly-Val-tly-Cly-Ma-Ala-Gln 
\ ID го 2i 
rat Tyr-Val-Mel-Gly-His-Phf-Arg-Trp-Asp-Arg-Phe-tly-Pro-Arj-Asri-Ser-Ser-Ser-Ala-Gly-Gly-Spr-Ala-Gln 
XenopuS «Туг Arg Phe-Arg-Trp Lys Asn 
Figure 3. I n t e r p r e t a t i o n of the data from (a) t r y p t i c and (b) chymotryptic mapping of product I ; 
(c) proposed p a r t i a l amino a c i d sequence of Xenopus γ , - m e l a n o t r o p i n , compared w i t h the sequence 
of human, bovine and r a t γ , - n i e l a n o t r o p i n . The t r y p t i c (T) and chymotryptic (C) fragments a r e 
numbered as in F i g . 2 . The p a r t i a l amino a c i d composition of each fragment is o b t a i n e d from 
T a b l e 2 . The o r d e r of these amino a c i d s w i t h i n each fragment and the arrangement of the fragments 
w i t h i n product I , were deduced by comparing the napping r e s u l t s given in F i g . 2 and Table 2 . 
S o l i d , heavy arrows i n d i c a t e those s i t e s where enzymatic cleavage of the product was complete; 
d o t t e d arrows i n d i c a t e p a r t i a l c l e a v a g e . The dot on the Asn-residue denotes a carbohydrate side 
c h a i n . The mammalian s t r u c t u r e s a r e d e r i v e d from the primary s t r u c t u r e s of the corresponding p r o -
op iomelanocort ins [ 3 , 2 0 , 2 l ] . 
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hormone contains only one glycosylated site and this site is located in the 
region corresponding to product I [13] we conclude that the carbohydrate side 
chain of Xrncpus y.-melanotropin is Asn-1inked. 
Comparison of the structure and biological activity of the various γ,-mela-
notropins prompts the question as to which part of the γ,-melanotropin in 
Xenopus is responsible for its bioactivity. That the sequence His-Phe-Arg-Trp, 
the tetrapeptide which occurs in all known melanotropic substances, is also 
present in the Xenopus peptide is likely but our mapping data do not allow us 
to draw definite conclusions. The near-absence of melanophore-stimulating ac­
tivity of the synthetic (bovine) y.-melanotropin [k] indicates that the pre­
sence of His-Phe-Arg-Trp in itself is insufficient for melanotropic activity. 
According to Eberle [19]> the C-terminal message Gly-Lys-Pro-Val.NH. of a-me-
lanotropin, with the key elements Lys-Pro, is far more melanotropic than the 
'classical' tetrapeptide message. The synthetic Y.,-melanotropin lacks the se­
quence Gly-Lys-Pro-Val.NH« which might account for its very low melanotropic 
activity. Two observations point to the possibility that the C-terminal message, 
or at least a part of it, is present in Xenopus γ,-melanotropin and thus may 
account for the observed bioactivity of this peptide. First, there is a lysine-
residue in the C-terminal portion, a situation not found in the mammalian 
structures (Fig. 3 ) . Secondly, product I appeared to immunoprecipi tate with 
an antiserum specific for the C-terminal Lys-Pro-Val.NH» sequence of a-melano-
tropin [15]. 
Bovine and human γ,-melanotropin contain a recognition site for enzymatic 
cleavage of the peptide (i.e. double basic amino acids); such a cleavage would 
lead to a γ.- or γ,-πτείanotropin. In Xenopus, there are three basic amino acids 
but the peptide does not contain a pair of basic amino acids as no free lysine 
or arginine was found in the tryptic maps. Thus, the production of a γ.- or 
γ_-ηεΐ3ηοΐΓορin-1ike peptide is not to be expected. 
Concerning the N-terminus of the γ,-melanotropin-l ike peptide in Xenopi/n, 
it must be concluded that it is not tyrosine as the tyrosine-contain ing chymo-
tryptic fragment (C,, Fig. 2) did not co-elute with free tyrosine. Furthermore, 
the N-terminus is not acetylated since it was possible to digest product I with 
leucine aminopept¡dase. In this connection, it may be recalled that a-melano-
ciN 
tropin is an acetylated peptide whereby des-Ас -o-melanotropin functions as 
its immediate precursor, the acetylation taking place during or just prior to 
release [11]. No such modification occurs in the case of γ,-melanotropin as, 
judged by the elution times from the chromatography column, the structure of 
this peptide in the lobe was identical to that of the peptide in the incubation 
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medium. These l a s t o b s e r v a t i o n s , moreover, i n d i c a t e t h a t in the pars i n t e r ­
media of Xenopus Laevis there is a s p e c i f i c N a - a c e t y l t r a n s f e r a s e which c a t a -
aN 
lyzes the a c e t y l a t i o n of des-Ас -a-melanotropin but leaves the γ , - m e l a n o t r o -
p i n - l i k e p e p t i d e in i t s n o n - a c e t y l a t e d f o r m . 
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BIOSYNTHESIS OF TWO STRUCTURALLY DIFFERENT PRO-OPIOMELANOCORTINS 
IN THE PARS INTERMEDIA OF THE AMPHIBIAN PITUITARY GLAND 
Gerard J.M. Martens, Peter-Paul J . Biermans, Bruce G. Jenks 
and A.P. van Overbeeke 
Department of Zoology, Catholic University of Nijmegen 
SUMMARY 
This study reports the biosynthesis of two forms of pro-opiomelanocortin in 
the pars intermedia of the pituitary gland of the African clawed toad Xenopus 
laevis. The two forms could be resolved by dodecyl sulphate gel electrophoresis 
on a 9"l6% aery lami de-gradient and their molecular weights were 38.200 and 
37-300 daltons. Incubation of neurointermediate lobes with [ H]glucosamine 
followed by tryptic digestion of the newly synthesized glycoproteins, revealed 
that both prohormones have only one glycosylated site, namely within the region 
corresponding to γ,-melanotropin. Biosynthesis of proteins in lobes treated 
with tunicamycin to prevent glycosylat¡on again resulted in the production of 
two pro-opiomelanocortins (Mr 35.000 and ЗЬ.200), indicating that the two forms 
differ in their primary structure. This notion was corroborated by the results 
of tryptic mapping of the newly synthesized prohormones. The maps showed that 
the primary structures of the two forms of pro-opiomelanocortin differ in at 
least two parts of the molecules, one part concerning the endorphin-region. 
INTRODUCTION 
Extensive biosynthetic investigations with a mouse adrenocorticotropic tumor 
cell-line have provided evidence for the existence of a common precursor to 
corticotropin and ß-lipotropin [1]. Studies concerning the pars intermedia of 
the pituitary gland revealed the occurrence in this tissue of a similar prohor-
mone, which was named pro-opiomelanocortin [2]. In the pars intermedia this 
prohormone is processed to peptides related to a-melanotropin, corticotropin 
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and endorphin [3-6]. Several investigators have shown that more than one form 
of pro-opiomelanocortin may occur in the same species, and even in the same 
tissue [З, 5, 7-9]· From studies with mouse pituitary tumor cells [10] and rat 
pars intermedia [3], it was concluded that these multiple forms differ mainly 
in the extent of glycosylat¡on. More recently, two observations were published 
which suggest that pro-opiomelanocortins with different primary structures may 
be synthesized. Drouin and Goodman [11] reported the presence of two genes 
coding for pro-opiomelanocortin in the rat. Kawauchi et al. [12-14] isolated 
two sequentially different forms of α-melanotropin, of ß-melanotropm and of 
endorphin from salmon pituitary glands, from which they concluded that in the 
salmon two sequentially different prohormones for these peptides occur. 
We now report the biosynthesis of two forms of pro-opiomelanocortin in the 
pars intermedia of Xenovus laevis . These forms, both glycosylated, were sepa-
rated using dodecyl sulphate electrophoresis with aerylamide-gradient gels. 
On the basis of tryptic mapping of the radioactively labelled prohormones it 
was established that the two forms do not differ in degree or site of glycosy-
lation, but have different primary structures. 
MATERIALS AND METHODS 
Anirnxls 
African clawed toads, Xenopus laevis, were obtained from the aquatic facili-
ty of the Department of Zoology, University of Nijmegen. The animals were fully 
black-adapted by keeping them in black buckets for at least two weeks at 220C 
and under constant illumination; adapted animals of approximately the same 
weight (25 g) were used. 
Incubation of nevœointermediate lobes 
For biosynthesis of radioactive proteins, neurointermediate lobes were incu-
bated at 220C on a Dubnoff metabolic shaker in 50 μΐ incubation medium (for 
composition see [15]) conta in ing radioactive amino acids or [ H]glucosamine (27 
Ci/mmol; Amersham). For biosynthesis of unglycosylated radioactive proteins, 
lobes were preincubated for k h in 100 μΐ medium containing 10 yg/ml tunicamy-
cin (Sigma) prior to the incubation with radioactive amino acids. Tunicamycin 
is an antibiotic that inhibits glycosylation of proteins by preventing the 
attachment of carbohydrate side chains to asparagine-residues of the protein 
via N-acetyIgucosamine [16]. Prevention of glycosylation was over 90%. After 
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the i n c u b a t i o n s , the lobes were homogenized in 500 μΐ 0.1 M HCl, the homogenate 
was c e n t r i f u g e d (5 min, 10.000 g . Beekman microfuge) and the supernatant was 
f r e e z e - d r i e d in p r e p a r a t i o n f o r dodecyl su lphate gel e l e c t r o p h o r e s i s . 
Sodium dodecyl sulrkate gel alecLrophoresis 
The b i o s y n t h e t i c a l l y l a b e l l e d p r o t e i n s were separated by dodecyl su lphate 
s lab gel e l e c t r o p h o r e s i s , a c c o r d i n g to Laemmli [ 1 7 ] , us ing a 9~16% a c r y l a m i d e -
g r a d i e n t gel w i t h a l e n g t h of 30 cm. Before a p p l i c a t i o n t o the g e l , the samples 
were b o i l e d f o r 2 min in 25 μΐ 0.0625 M T r i s HCl, pH 6.8 ( c o n t a i n i n g 2% sodium 
dodecyl s u l p h a t e , 6 M urea and 5% 2 - m e r c a p t o e t h a n o l ) . The slab gel was f i x e d , 
t r e a t e d w i t h 2,5 d i p h e n y l o x a z o l e (Merck) a c c o r d i n g t o Bonner and Laskey [ l 8 ] 
and the gel was d r i e d on a Bio-Rad gel d r y e r (model 22k). The [ H ] - l a b e l l e d 
p r o t e i n s were d e t e c t e d w i t h s c i n t i l l a t i o n autography ( f l u o r o g r a p h y ) by exposing 
a Kodak X R - 1 - f i l m a t -70 o C. A [ C]-methylated p r o t e i n m i x t u r e (Amersham) , c o n ­
t a i n i n g lysozyme (M Й . 3 0 0 , s p e c i f i c a c t i v i t y 12 uCi/mg), carbonic anhydrase 
(M r 30.000, ]Ц t iCi/mg), ovalbumin (M r 4 6 . 0 0 0 , 13 uCi/mg), bovine serum albumin 
(M r 69-000, 2k yCi/mg), Phosphorylase b (M r 92.500, 13 pCi/mg) and myosin (M r 
200.000, 23 yCi/mg), was used t o prov ide the gel markers. 
To immunological ly c h a r a c t e r i z e the newly synthes ized p r o t e i n s separated on 
the dodecyl su lphate g e l s , immunoprecipi t a t ion experiments were conducted. For 
t h i s purpose, a h igh s p e c i f i c a c t i v i t y of b i o s y n t h e t i c a l l y l a b e l l e d p r o t e i n s in 
n e u r o i n t e r m e d i a t e lobes was achieved as descr ibed e a r l i e r [ 6 ] . Incubat ion of 
lobes was f o r 2 h in 30 μΐ medium c o n t a i n i n g 20 yCi each of [ H ] l y s i n e , [ H ] -
t y r o s i n e , [ 3 H ] p h e n y l a l a n i n e , [ 3 H ] t r y p t o p h a n and [ ^ H l s e r i n e (90, 50, 8 0 , 26 and 
14 Ci/mmol, r e s p e c t i v e l y ; Amersham). The e x t r a c t e d p r o t e i n s were incubated w i t h 
c o r t i c o t r o p i n or endorphin a n t i s e r u m in 250 μΐ phosphate b u f f e r pH 8.0 ( c o n t a i ­
n i n g 1% T r i t o n X-100, 0.5% sodium desoxy-cholate and 0 . 1 % sodium dodecyl s u l ­
p h a t e ) . To the c o n t r o l groups excess (10 yg) of the a p p r o p r i a t e p e p t i d e was 
added. The s p e c i f i c i t i e s of the c o r t i c o t r o p i n and endorphin a n t i s e r a have been 
r e p o r t e d e a r l i e r [ 6 ] . A f t e r i n c u b a t i o n f o r 2k h a t 4°C, 20 yl p r o t e i n A Sepha-
rose (Pharmacia)-sol u t ¡on (10% in phosphate b u f f e r ) was added and the sample 
was incubated on a Marius shaker f o r a f u r t h e r 2k h a t k°C. The sample was then 
c e n t r i f u g e d (1 min, 10.000 g) and the p e l l e t was washed three t imes w i t h i c e -
co ld phospha te -bu f fe r . The immunoprecipi tated complex was d i ssoc i a ted by b o i l i n g 
the p e l l e t f o r 2 min in 25 yl of the e l e c t r o p h o r e s i s sample b u f f e r and the so-
l u b i l i z e d p ro te i ns were analyzed on the dodecyl sulphate g e l . 
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Tryptic: peptide mapping 
Neurointermediate lobes were incubated f o r 2 h in the presence of e i t h e r 
[ H]glucosamine or [ 3 H ] t y r o s i n e or a mix ture of [ J H ] l y s i n e , [ ^ H ] t y r o s i n e , [ H ] -
pheny la lan ine , [ H ] t r y p t o p h a n , [ H ] s e r i n e , [ ¿ H]arg¡n¡ne (20 Ci/mmol, Amersham) 
and [ H] leuc ine (120 Ci/mmol, Amersham). The lobe e x t r a c t s were submit ted to 
dodecyl su lphate e l e c t r o p h o r e s i s on the ae ry lamide -g rad ien t g e l . The r a d i o -
a c t i v e p r o t e i n bands, detected by f l uo rog raphy , were cut out of the s lab-gel · 
and the p ro te i ns in the ge l -p ieces were d iges ted w i t h 20 μς t r y p s i n ( t r e a t e d 
w i t h d i p h e n y l c a r b a n y l c h l o r i d e , Sigma) in 200 μΐ 15 mM Hepes-buffer (pH 8.0) 
f o r 18 h a t 37°C. Recovery of r a d i o a c t i v i t y f rom the g e l s was over 90?. The 
d i g e s t i o n was t e r m i n a t e d by adding 500 μΐ 0.1 M HCl, the t r y p t i c d i g e s t s were 
then c e n t r i f u g e d and the supernatants were analyzed w i t h high-performance l i ­
qu id chromatography. 
Chromatographic s e p a r a t i o n s were performed on a Spherisorb 10 ODS-column 
(Chrompack, I'yQy.k . mm i n t e r n a l diameter) w i t h a step-wise g r a d i e n t (given in 
F i g . 2) of 0.5 M f o r m i c a c i d , 0.14 M p y r i d i n e (pH 3.0) as the pr imary s o l v e n t A 
and 1-propanol as the secondary s o l v e n t B. The f l o w r a t e was 2 ml/min and 0 . 5 " 
min f r a c t i o n s were c o l l e c t e d . For f u r t h e r chromatographic d e t a i l s see [ 1 5 ] . 
To compare the t r y p t i c maps of the prohormones l a b e l l e d w i t h [ H]glucosamine 
w i t h t h a t of the newly s y n t h e s i z e d , γ , - m e l a n o t r o p i n - l i k e p e p t i d e ( indexed p r o -
duct 1, [19]) lobes were b i o s y n t h e t i c a l l y l a b e l l e d w i t h [ H]glucosamine and the 
lobe e x t r a c t was chromatographed. To the f r a c t i o n s c o n t a i n i n g product I 20 yg 
bovine serum albumin (Sigma) was added and these f r a c t i o n s were then l y o p h i l ¡ z e d . 
To compare the maps of [ H ] t y r o s i n e - l a b e l l e d prohormones w i t h those of the newly 
syn thes i zed , endo rph in - re l a ted pept ides ( indexed products V I I and V I I I , [ 6 ] ) , 
the [ H ] t y r o s i n e - l a b e l l e d lobe e x t r a c t was chromatographed and t o the f r a c t i o n s 
c o n t a i n i n g e i t h e r product V I I or V I I I 20 μg albumin was added and the f r a c t i o n s 
were f r e e z e - d r ¡ e d . The l y o p h i l i z e d mater ia l was d i sso l ved in 50 μΐ 15 mM Hepes-
b u f f e r (pH 8 . 0 ) , d i g e s t e d w i t h 10 μg t r y p s i n ( l 8 h, 370C) and chromatographed 
under the same c o n d i t i o n s as descr ibed f o r the mapping of the p r o t e i n s i s o l a t e d 
w i t h dodecyl su lphate gel e l e c t r o p h o r e s i s . 
RESULTS AND DISCUSSION 
In an e a r l i e r s t u d y , employing pulse-chase i n c u b a t i o n s and high-performance 
l i q u i d chromatographic a n a l y s i s , we showed a p r e c u r s o r - p r o d u c t mode of p e p t i d e 
b i o s y n t h e s i s in the pars intermedia of Xenopus laevis [ 1 5 ] · During a 30-min 
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puise incubation, only the precursor (indexed as product XI on the chromato-
gram) was synthesized and following chase incubations this product was pro­
cessed to a number of peptides (indexed I to X). Among these chase peptides 
are a γ,-melanotropin-1ike peptide [19], des-Ас -a-melanotropin, two forms 
of corticotropin-1ike intermediate lobe peptide (corticotropin-(l8-39)) and 
two endorphin-1ike peptides [6]. As product XI was shown to immunoprecipitate 
with antisera specific to a-melanotropin, corticotropin or endorphin it was 
designated pro-opiomelanocortin. Using dodecyl sulphate gel electrophoresis, 
according to the method of Swank and Munkres [20], product XI appeared as a 
single band (corresponding to a molecular weight of approximately 35·000 dal-
tons) [6] . 
In the present study dodecyl sulphate gel electrophoresis was performed on 
a long slab-gel with a 9-16% aerylamide-gradient. Application to this gel of 
an extract of neurointermediate lobes, following a 30-min pulse-labelling with 
radioactive amino acid, revealed the presence of two proteins: P, and P„ (Fig. 
1, lane a). The molecular weights of P 1 and P„ were estimated as 38-200 ± 200 
daltons and 37-300 ± 200 daltons, respectively (n = 6 ) . The presence of the 
PG| 
PG2 
Figure 1. Dodecyl sulphate gel electrophoresis of radioactive proteins synthesized by Xenopua 
neurointermediate lobes during incubations in the presence of (a) [ H]lysine for 30 min, (b) tuni-
camycin for k h (preincubation) followed by [ H]lysine for 30 min or (c) [ H]glucosamine for 30 
min. The proteins were resolved by electrophoresis on a 9"16^ aery 1 amide-gradient slab gel and 
they were detected by f 1uorography. 
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newly synthes ized p r o t e i n s is not the consequence of genet ic v a r i a b i l i t y of 
the an ima ls , as s i ng le pu lse- incubated lobes a l so synthesized the same two p ro -
t e i n s . A p p l i c a t i o n to the ae ry lamide-g rad ien t gel of product X I , i so l a ted w i t h 
h igh-performance l i q u i d chromatography, showed tha t product XI in f a c t rep re -
sents two p ro te i ns w i t h e l e c t r o p h o r e t ¡ c m ig ra t ions i d e n t i c a l t o t h o s e o f P. 
and P. . Pulse-chase experiments demonstrated tha t both P^  and P- are processed. 
Moreover, immunoprec¡ρ i t a t ion experiments showed t h a t both P. and P. have c o r ­
t i c o t r o p i n as w e l l as endorphin a n t i g e n i c determinants (data not shown). The 
above o b s e r v a t i o n s c l e a r l y i n d i c a t e t h a t P. and P. c o n s t i t u t e two forms of 
pro-op i o m e l a n o c o r t i n . 
Dodecyl su lphate g r a d i e n t - g e l e l e c t r o p h o r e s i s of e x t r a c t s prepared from 
n e u r o i n t e r m e d i a t e lobes which were p u l s e - i n c u b a t e d f o r 30 min in the presence 
of [ H]glucosamine revealed two p r o d u c t s : PG. and PG- ( F i g . 1 , lane c ) . The 
e l e c t r o p h o r e t ¡ c behaviour of PG. and PG. was i d e n t i c a l to tha t of P. and Ρ-, 
r e s p e c t i v e l y . Thus, both p r o - o p i o m e l a n o c o r t i n s are g l y c o p r o t e i n s . 
To i n v e s t i g a t e whether or not the d i f f e r e n c e between P. and P. concerns the 
e x t e n t of g l y c o s y l a t i o n , i t was decided t o produce the u n g l y c o s y l a t e d p r e c u r ­
s o r s . In n e u r o i n t e r m e d i a t e lobes p r e i n c u b a t e d w i t h tunicamycin ( t o prevent as-
p a r a g i n e - 1 i n k e d glycosy1 at ion) t h e r e appeared t o be almost no b i o s y n t h e s i s of 
P. and P. but two new products were found ( F i g . 1 , lane b ) . These two p r o t e i n s , 
PT. and PT-, migrated f a s t e r on the gel than P1 and P., and t h e i r molecular 
weights were 35.000 ± 200 d a l t o n s and 3k.200 ± 200 d a l t o n s , r e s p e c t i v e l y (n = 
6 ) . That PT1 and PT- are forms of p r o - o p i o m e l a n o c o r t i n was demonstrated by the 
r e s u l t s of pulse-chase exper iments.showing t h a t both products were processed, 
and by the f a c t t h a t they were s p e c i f i c a l l y immunoprecip i tated w i t h a n t i s e r a 
t o c o r t i c o t r o p i n or endorphin (data not shown). 
To examine whether P1 and P- d i f f e r in t h e i r degree or s i t e of g l y c o s y l a t i o n , 
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t r y p t i c d i g e s t s of [ H ] g l u c o s a m i n e - l a b e l l e d P1 and P. (PG. and PG., r e s p e c t i ­
v e l y ) were prepared and analyzed w i t h high-performance l i q u i d chromatography. 
From F i g . 2 i t is e v i d e n t t h a t both PG. and PG. g i v e o n l y one r a d i o a c t i v e t r y p ­
t i c f r a g m e n t , e l u t i n g a t 10 min. One of the end products in the processing of 
Xenopus p r o - o p i o m e l a n o c o r t i n is a g l ycopep t ¡de ; t h i s p e p t i d e , indexed product I , 
has been cha rac te r i zed as a γ , - m e l a n o t r o p m - l i k e p e p t i d e [ 1 9 ] . T r y p t i c d i g e s t i o n 
of a [ H ] g l u c o s a m i n e - l a b e l l e d product I revealed one r a d i o a c t i v e f r a g m e n t , c o -
e l u t i n g w i t h the 10-min t r y p t i c fragment d e r i v e d from PG.. and PG. ( F i g . 2 ) . 
These o b s e r v a t i o n s demonstrate t h a t P. and P. have the same degree of g l y c o s y -
l a t i o n and t h a t in both p r e c u r s o r s the glucosamine-based carbohydrate s ide 
chain is a t t a c h e d t o the same s i t e , namely t o the asparag ine-res i due w i t h i n the 
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F-Ljure 2. High-perfornance l i q u i d chromatographic analysis of t r y p t i c d igests. Following incubation 
in the presence of [ H]glucosamine, neurointermediate lobes were extracted and the lobe extract was 
submittedei ther to dodecyl sulphate gel electrophoresis to iso late newly synthesized proteins PGj 
and PGj or to high-performance l i q u i d chromatography to isolate newly sythesized product I . 
Digestions w i t h t r y p s i n were at 370C for 18 h . Open arrows indicate the e l u t i o n posi t ions of the 
undigested s t a r t i n g mater ia ls . The gradient shown in the lower graph ( · #) consisted of s o l ­
vent A (0.5 M formic a c i d , O.l') M p y r i d i n e , pH 3.0) to solvent В ( l-propanol ) . 
region c o r r e s p o n d i n g t o γ , - m e l a n o t r o p i n . In c o n t r a s t , in the p i t u i t a r y gland of 
the mouse and the r a t the m u l t i p l e forms of p r o - o p i o m e l a n o c o r t i n d i f f e r in the 
degree o f g l y c o s y l a t i o n ; one of these d i f f e r e n c e s is a t t r i b u t e d t o the presence 
or absence of an o l i g o s a c c h a r i d e in the sequence corresponding t o c o r t i c o t r o p i n 
[ 8 , 1 0 ] . Processing of the mouse and r a t prohormones y i e l d s a g l y c o s y l a t e d form 
of c o r t i c o t r o p i n , the s o - c a l l e d 13K c o r t i c o t r o p i n , or a g l y c o s y l a t e d c o r t i c o ­
t r o p i n - ( 1 8 - 3 9 ) [ 8 , 1 0 ] . In Xenopus, a product resembl ing the 13K c o r t i c o t r o p i n 
is not present [ 6 ] , w h i l e the c o r t i c o t r o p i n - ( l 8 - 3 9 ) - l i k e products are not g l y c o -
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sylated [19]- These earlier observations may now be explained by the present 
finding that in this species the only glycosylated site in pro-opiomelanocortin 
is located in the γ,-melanotropin-region. 
The fact that in the experiment with tunicamycin two forms of pro-op i omelano-
cortin could still be distinguished (Fig. 1, lane b ) , strongly suggests that the 
prohormones differ in their amino acid sequence. Tryptic digestion of P.. and P., 
labelled with seven different radioactive amino acids, produced chromatographic 
profiles that were quite similar (Fig. 3, P, and P . ) . Exactly the same maps as 
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Figure ¿. High-performance liquid chromatographic analysis of tryptic digests. Following incubation 
" 1 Ì ч 4 
in the presence of a mixture of [ H]lysine
r
 [ H]tyrosine, [ H]phenylalanine, [H]tryptophan, 
[Miserine, [ Hjarginine and [ H]leucine, neurointermediate lobes were extracted and the lobe ex­
tract was submitted to dodecyl sulphate gel electrophoresis to isolate newly synthesized proteins 
P. and P.. Following preincubation in the presence of tunicamycin, lobes were incubated in the mix­
ture of [^H]amino acids and the lobe extract was submitted to electrophoresis to isolate newly syn­
thesized proteins PT. and PT-. Digestions with trypsin were at 37eC for 18 h. The open arrows indi­
cate the elution positions of the undigested starting materials. Fragments present (closed arrows) 
or absent (dotted arrows) in the various maps are indicated by a, b, c, d or an asterisk. Chromato­
graphic conditions as in Fig. 2. 
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presented ¡η Fig. 3 for P. and P., were obtained from prohormones immunoprecipi-
tated with the antiserum to corticotropin, which indicates that both P1 and P„ 
are single proteins and do not represent a mixture of co-migrating products. 
Despite the similarity in the maps of P. and P-, there were clear differences 
concerning the presence or absence of four fragments, indicated in Fig. 3 as 
a, b, с and d. P1 yielded fragments Ь and c, which were absent from the tryptic 
map of P.. P_ gave fragments a and d, which were lacking in the tryptic digest 
of P.. The tryptic maps of the non-glycosylated forms PT. and PT. were nearly 
identical to those of P. and P., respectively (Fig. 3)· This indicates that PT. 
is the поп-glycosylated form of P., and PT. is the non-glycosylated form of P.. 
The only difference between the maps of PT1 and P. and between the maps of PT-
and P. concerns the presence of a 9.5-mm tryptic fragment in the maps of the 
non-glycosylated forms (Fig. 3, asterisk). This 9-5-min fragment presumably re­
presents the non-glycosylated form of the glucosamine-contain ing tryptic frag­
ment of P. and P., which eluted at 10 min (see Fig. 2). The drastic reduction 
of the 10-min peaks in the tryptic maps of PT1 and PT-, as compared to those 
in the maps of P, and P., might be explained by assuming that the 10-min peaks 
yielded by digestion of P1 or P, represent co-eluting fragments of which one 
is glycosylated. Supposedly, this fragment is changed due to the prevention 
of glycosylat ion by tunicamycin and, as a consequence, elutes at 9.5 min in 
the maps of PT. and PT-, 
The above data indicate that in the pars intermedia of Xenovus laeOis, there 
is synthesis of two forms of pro-opiomelanocortin with slightly different pri­
mary structures. The question arises in which parts of the molecules these 
differences are located. In this connection it must be recalled that in Xeno-
pus processing of pro-opiomelanocortin yields two forms of endorphin-1ike pep­
tides. Tryptic mapping of these endorphins (indexed products VII and VIM) 
showed that the difference between them concerns their primary structure [6]. 
To determine whether the structural difference between the two endorphin-1 ike 
peptides reflects a difference between the two precursors, tryptic maps of 
these four products were made following labelling with [ H]tyrosine. Tyrosine 
was chosen as it is present in the endorphin-1 ike peptides and because, in 
view of the known amino acid sequences of mammalian pro-opiomelanocortins [11, 
21, 22], labelling with [ H]tyrosine could be expected to provide maps of the 
precursors with a limited number of tryptic fragments. Synthetic corticotro-
pin-(1-8) and ß-endorphin-(1-9) were chromatographed as these peptides repre-
sent tyrosine-contain ing tryptic fragments of the mammalian prohormones. Follo-
wing labelling with pH]tyrosine, the maps of both P. and P. showed a 17.5-min 
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Figure 4. High-performance liquid chromatographic analysis of tryptic digests. Following incubation 
in the presence of [ H]tyros ine, neurointermediate lobes were extracted and the lobe extract was 
submitted either to dodecyl sulphate gel electrophoresis to isolate newly synthesized proteins P1 
and P- or to high-performance liquid chromatography to isolate newly synthesized products VII and 
Vili. Digestions with trypsin were at 37eC for 18 h. The open arrows indicate the elution positions 
of the undigested products VII and VIII. The elution positions of synthetic corticotropin-(1-8) 
(ACTH(1-8)) and B-endorphln-(1-9) (ß-end(1-9)) are also indicated; a and с correspond to fragment a 
and fragment c, respectively, from Fig. 3· Chromatographic conditions as in Fig. 2. 
fragment c o - e l u t m g w i t h c o r t i c o t r o p i n - ( 1 - 8 ) ( F i g . h). In t h i s respect i t is 
i n t e r e s t i n g t h a t in Xenopi/s the prohormone is c leaved t o , among o t h e r p e p t i d e s , 
des-Ас - a - m e l a n o t r o p i n ; the t y r o s i n e - c o n t a i n ing t r y p t i c fragment of t h i s l a s t 
p e p t i d e c o - e l u t e s w i t h s y n t h e t i c c o r t i c o t r o p i n - ( 1 - 8 ) [ 6 ] . Thus, i t is l i k e l y 
t h a t both forms of p ro-op¡omelanocor t in are processed to des-Ас - a - m e l a n o t r o -
¡ n , which in t h i s species is the immediate precursor to a-melanotrop i η [ 2 3 ] . 
The map o f [ H] t y r o s i n e - l a b e l led P.. shows a ЗО-тіп t r y p t i c fragment c o - e l u t i n g 
w i t h fragment c ; t h i s fragment is absent from the map of P.. A 24-min t y r o s i n e -
c o n t a i n i n g fragment which is present in the map of P. but l a c k i n g in the map 
of Ρ c o - e l u t e d w i t h fragment a ( F i g . 4 ) . T r y p t i c d i g e s t i o n of the [ H ] t y r o -
s i n e - l a b e l l e d e n d o r p h i n - ! i k e products V I I and V I I I produced one fragment in 
each case. The f a c t t h a t these t r y p t i c fragments d i d not c o - e l u t e w i t h human 
ß - e n d o r p h i n - ( 1 - 9 ) ( F i g . Ό i n d i c a t e s t h a t the p r i тагу s t r u c t u r e s o f Xenopus en-
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dorphins differ from that of human ß-endorphin. Product VII yielded a fragment 
eluting at 30 min, which appeared to co-elute with the tyrosine-contain ing frag-
ment с derived from P.. Product Vili gave a fragment eluting at 2k min, co-elu-
ting with the tyrosine-contain ing fragment a from P- (Fig. k). This means that 
P. has in its amino acid sequence a region that corresponds to a part of the 
sequence of product VII while P. contains a region corresponding to part of 
the structure of product VIII. Thus, apparently, the 38K-form of pro-opiomela-
nocortin (P.) is processed to the endorphin-related product VII and the 37K-
form (P.) is the prohormone for the endorphin-related product VIII. 
Altogether, the results presented in this report show that in the pars in­
termedia of the pituitary qland of Xetiopus laevis there is synthesis of two 
forms of pro-opiomelanocortin which do not differ in the degree or site of gly-
cosylation but do differ in their primary structures, one region of difference 
being located in the portion corresponding to the endorphins. 
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IN VIVO BIOSYNTHESIS OF MELANOTROPINS AND RELATED PEPTIDES 
IN THE PARS INTERMEDIA OF XENOPUS LAEVIS 
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Department of Zoology, Faculty of Science, Catholic liniverr>ity, 
Toernooivcld, 6525 ED Nijmegen, The Iletherlands 
ABSTRACT 
To study in vivo b i o s y n t h e s i s of pars intermedia pept ides in Xenopus laevis, 
[ H ] l y s i n e was a d m i n i s t e r e d by an osmotic minipump v i a a cannula i n s e r t e d near 
the p i t u i t a r y g l a n d . F o l l o w i n g e x t r a c t i o n of the n e u r o i n t e r m e d i a t e l o b e , h i g h -
performance l i q u i d chromatography was used t o separate the newly synthesized 
p e p t i d e s . In Ыаск-background-adapted a n i m a l s , [ H ] l y s i n e was i n c o r p o r a t e d i n ­
t o a number of p e p t i d e s . The e l u t i o n c h a r a c t e r i s t i c s of these pept ides c o r r e s ­
ponded e x a c t l y w i t h those of pept ides synthesized d u r i n g in vitro i n c u b a t i o n 
of neuro i η termed i a te l o b e s , and which were i d e n t i f i e d as des-Na-acety1-a-MSH, 
а γ-MSH-like p e p t i d e , two c o r t i c o t r o p i n - I i k e i n t e r m e d i a t e lobe pept ides and 
two forms of e n d o r p h i n . In white-background-adapted Xenopus, p r a c t i c a l l y no 
s y n t h e s i s of pars intermedia pept ides o c c u r r e d . T r a n s f e r of Ыаск-adapted toads 
t o a w h i t e background a t the beginning of i n f u s i o n led t o storage of newly syn­
t h e s i z e d p e p t i d e s . When such animals were mainta ined on a whi te background f o r 
10 days, des-Na-acety1-a-MSH, but not a-MSH, was present in the pars i n t e r m e d i a ; 
t h i s supports the n o t i o n t h a t des-Na-acety1-a-MSH c o n s t i t u t e s the ' s t o r a g e f o r m ' 
of a-MSH. 
INTRODUCTION 
I t is w e l l known t h a t in many amphibians the d i s p e r s i o n of melanosomes in 
the dermal melanophores d u r i n g a d a p t a t i o n t o a b lack background is mediated by 
m e l a n o c y t e - s t i m u l a t i n g hormone (MSH) produced by the pars intermedia of the 
p i t u i t a r y g l a n d . Several i n v e s t i g a t i o n s , mainly based on e l e c t r o p h o r e t i c sepa-
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ration techniques in combination with bioassays, demonstrated that the pars 
intermedia contains three melanotropic substances (Burgers et al., 1963; Pres-
lock 6 Brinkley, 1970a,b; Hopkins, 1972) and possibly even more (Loh ε 
Gainer, 1977)· In Xenopus laevis, the complexity of the hormone production by 
the cells of the pars intermedia has recently become apparent in a series of 
biosynthetic studies involving incubation of this tissue with radioactive 
amino acids. Pulse-chase studies showed that biosynthesis commences with the 
production of a large protein which acts as a precursor for a number of small 
peptides (Loh 6 Gainer, 1977; Jenks 6 Van Overbeeke, I98O; Martens et al., 
I98O). In particular with regard to the separation of the smaller peptides, 
high-performance liquid chromatography (HPLC) proved to be a most adequate 
technique in view of its high sensitivity and high resolution (Martens et al., 
I98O). Among the peptides cleaved from the precursor, three groups may be dis­
tinguished; in addition to melanotropins, there are also adrenocorticotropin 
(ACTH)-related and endorphin-1ike products (Martens et al., I982). 
The above elucidation of the biosynthetic process in the pars intermedia 
was based on гг. vitro studies. The question arises whether the results derived 
from incubated tissue reflect the process of hormone synthesis in the living 
animal. Pertinent in vivo experiments often are hampered by insufficient in­
corporation of radioactive amino acids. We have solved this problem by admi­
nistering the labelled amino acid to the animals via an osmotic minipump. The 
results of this study led us to undertake an additional investigation on the 
effect of background adaptation on the biosynthetic activity in the pars in­
termedia of Xenopus laevis. 
MATERIALS AND METHODS 
A.nimals 
A d u l t XenopviS laevis, bred in the Department of Zoology, U n i v e r s i t y of N i j ­
megen, were used. The animals were of a p p r o x i m a t e l y the same weight (25 g) and 
f o r f u l l a d a p t a t i o n t o a b l a c k or whi te background p r i o r t o the ¡nfusKon expe-
r imen ts , the animals were kept in b lack or wh i te buckets f o r two weeks in an 
environmental chamber a t 22°C and under constant i l l u m i n a t i o n . 
Л 
Administration of [ H]lysine 
To f i n d an adequate method t o a d m i n i s t e r [ H ] l y s i n e a number of experiments 
was conducted whereby t o a d s , pre-adapted t o a b lack background, were given the 
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radioactive amino acid and subsequently placed on a white background. This 
change of background was aimed at achieving maximum incorporation of label, 
since in Ыаск-background-adapted Xenopus transferred to a white background, 
the biosynthetic activity of the pars intermedia remains high for 1-2 days 
while the release of MSH is inhibited immediately (Jenks et al., 1977). 
Several techniques for administration of [ H]lysine were tried. Repeated in­
jection into the dorsal lymph sac did not lead to sufficient incorporation in 
pars intermedia peptides. We then used Alzet osmotic minipumps (model 1702, 
Alza, Palo Alto, California, U.S.A.) which are known to release their contents 
slowly and in constant amounts (Capozza et al., 1977)· Under our experimental 
conditions the pumps release with a flow rate of approximately 0.5 μΐ/h. 
Placing of such [ i\\] lysine-f i 1 led minipumps subcutaneously or in the abdominal 
cavity proved to be unsuccessful. Infusion of the isotope from a minipump via 
a cannula, containing a concentrated solution of [ H]lysine, did not lead to 
the desired labelling when the cannula was inserted into the dorsal lymph sac. 
However, when the same technique was used with the cannula inserted in the im­
mediate vicinity of the pituitary gland, it was demonstrated that the pars in­
termedia contained detectable amounts of labelled peptides. Details of this 
infusion technique are as follows. The minipumps were filled with amphibian 
saline and placed in tapwater for 12 h at room temperature prior to use. This 
was done to avoid irregular flow during the experiments, which is often seen 
when new pumps are used. The radioactive label, 300 yCi [ H]lysine (specific 
activity 60 Ci/mmol, New England Nuclear), was freeze-dried together with 
30 цд bovine serum albumin (BSA) and re-dissolved in 10 yl amphibian saline. 
This concentrated radioactive solution was placed ina cannula (Technicon tubing) 
which was attached to the osmotic minipump. The animal to be provided with a 
minipump was anaesthetized in 0.1% MS 222 (Sandoz) and with the help of a high­
speed dental drill (Kaltenbach and Voigt, model D-7950, max. speed 20 000 rpm) 
two small holes were drilled, one between the external nares and one through 
the palate bone just anterior to the optic chiasma. The cannula was drawn 
through the hole between the external nares and inserted through the hole in 
the palate, in such a manner that the contents could be released into the sub-
meningeal space. The cannula was fixed to the bones with a fast-drying cement 
(alkyI-a-acrylate, Perfecta Chemie B.V., Goes, The Netherlands). The minipump 
itself was fastened to the back of the animal with two silk stitches. In each 
in vivo experiment one animal was used, and the duration of isotope infusion 
was 22 hours. 
After the operation, the animals were placed in 1 1 tapwater and were kept 
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under constant i l l u m i n a t i o n . To monitor e x c r e t i o n of the isotope d u r i n g the ex­
p e r i m e n t s , 200 yl samples of the tapwater were taken p e r i o d i c a l l y , k ml Aqua 
1 urna (Baker Chemicals B.V.) was added and the r a d i o a c t i v i t y was measured in a 
l i q u i d s c i n t i l l a t i o n analyzer ( P h i l i p s , model PW 1(510). 
Extraction 
At the end of each i n f u s i o n e x p e r i m e n t , the animal was k i l l e d by d e c a p i t a ­
t i o n , the n e u r o i n t e r m e d i a t e lobe was c a r e f u l l y d i s s e c t e d out and homogenized 
in 500 yl 0.1 M a c e t i c a c i d (НАС) in an a l l - g l a s s homogenizer. The homogenate 
was c e n t r i f u g e d f o r 5 min a t 10 0 0 0 g (Beekman microfuge) and the supernatant 
was immediately analyzed w i t h HPLC. A f t e r removing the n e u r o i n t e r m e d i a t e l o b e , 
the b r a i n t i s s u e was examined f o r p o s s i b l e s igns of damage due t o the cannula-
t i o n . No damage was d e t e c t e d in any of the a n i m a l s . 
To gain some i n s i g h t in the d i s t r i b u t i o n of r a d i o a c t i v e l a b e l throughout the 
a n i m a l , the r a d i o a c t i v i t y in several t i s s u e s ( b r a i n , l i v e r , stomach, i n t e s t i n e , 
k i d n e y , muscle and blood) was measured. To assess whether the animals had r e ­
ta ined the c a p a c i t y f o r background a d a p t a t i o n , the degree of melanosome d i s ­
pers ion in f o o t web melanophores (melanophore index) was determined using the 
method of Hogben and Slome (1931)· This was done both a t the b e g i n n i n g and at 
the end of each exper iment. 
In vitro incubation 
Although the b i o s y n t h e s i s of pars intermedia pept ides d u r i n g in vitro i n c u ­
b a t i o n has been the s u b j e c t of several of our e a r l i e r s t u d i e s (see I n t r o d u c t i o n ) , 
f o r reason of comparison an in vitro pulse-chase experiment was conducted s i m u l ­
taneously w i t h the in vivo a n a l y s i s . In t h i s case, the n e u r o i n t e r m e d i a t e lobes 
of b lack-adapted animals were incubated f o r 30 min in 50 yl i n c u b a t i o n medium 
c o n t a i n i n g 50 yCi [ H ] l y s i n e (pulse i n c u b a t i o n ) and subsequently chase- incuba­
ted in f r e s h medium c o n t a i n i n g 5 mM L - l y s i n e (Calbiochem) f o r 3 i h. The lobes 
were homogenized in 500 y l 0.1 M HAc, the homogenate was c e n t r i f u g e d , and the 
supernatant submit ted t o HPLC-analysi s. Further d e t a i l s concerning the in vitro 
i n c u b a t i o n have been r e p o r t e d e a r l i e r (Martens et al., 1980). 
High-performance liquid chromatography 
HPLC-analyses of lobe e x t r a c t s were performed on a Spectra Physics chromato­
graphic system (model SP 8000, Spectra P h y s i c s , Eindhoven, The N e t h e r l a n d s ) . 
Separat ion was on a Spher isorb 10-0DS column (250x^.6 mm i . d . ) w i t h a f l o w r a t e 
of 2 ml/min and 0.5-min f r a c t i o n s were c o l l e c t e d . The step-wise g r a d i e n t (see 
8it 
F i g . 1) was e s t a b l i s h e d w i t h 0.5 M formic a c i d , О.!** M p y r i d i n e (pH = 3.0) as 
the pr imary s o l v e n t and 1-propanol as the secondary s o l v e n t . Four ml Aqua 1 urna 
was added t o each f r a c t i o n and the r a d i o a c t i v i t y in each f r a c t i o n was measured 
f o r a t l e a s t h min. For f u r t h e r d e t a i l s , see Martens et al. ( I98O). 
RESULTS 
The r e s u l t s of the in vitro pulse-chase experiment ( F i g . 1 , bottom) are 
I MSH-relaled peptide 
I des-Ha-acetyl-a-MSH 
DF CUP-likt peptide 
Τ CUP-like peptide 
Ж endorphin -related peptide 
Ж endorphm-related peptide 
II pro-opiomeLanocortm 
50 60 
HPLC elution time (mini 
Figure 1. HPLC-analysis of peptides synthesized in the pars intermedia of Xenopus laevis. In vivo 
labelling with [ H]lysine was performed using an osmotic minipump; cpm-values represent the mean 
values of three independent experiments (upper graph). In vitro labelling of one neurointermediate 
lobe was performed by a 30-min pulse incubation in the presence of [ H]lysine followed by a 3i~h 
chase with L-lysine (lower graph). IB: percentage of 1-propanol in the elution gradient (see Mate­
rials and methods). Insert: peak identification as established by Martens et al. (1982). 
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essentially the same as those reported previously (Martens et al., I98O, 1982) 
and, therefore, the peaks of radioactive peptides are indexed accordingly 
( I-XI ). The identity of the products, presented in Fig. 1, upper right, is 
based on extensive characterization studies (Martens et al., 1982; see also 
Discussion). Free [ H]lysine eluted at 2-3 min; the small peak at 5 min repre­
sents a contamination of the [ H]lysine preparation. 
HPLC-analysi s of the ъп vivo incorporation of [ H]lysine into the neuroin-
termediate lobe revealed the presence of six products (Fig. 1, top). These 
products had elution characteristics corresponding exactly to those of six of 
the peptides synthesized in the ъп vitro experiment and are thus identical to 
products I, II, IV, V, VI I and VIII. Products IXa, IX, X and XI, well repre­
sented гг. vitro, were absent from the lobes of the infused animal. The amount 
of the product eluting at 10 min was, relative to the other peaks, high in the 
in vivo experiment. 
In animals subjected to three different background paradigms, release of 
radioactivity into the water showed, to a close approximation, the same course 
in each animal (Fig. 2, inserts). Analysis of radioactivity in the various 
tissues revealed that the distribution and the quantity of [ H]lysine were al­
most the same in all three situations (data not shown). The above results sug­
gest that the amount of isotope introduced into the animals was approximately 
the same. The black-adapted animal transferred to a white background immedia­
tely prior to receiving the [H]lysine (Fig. 2, top) had a melanophore index 
of 1.5 at the end of the experiment, while the animal retained on a black 
background (Fig. 2, middle) had a melanophore index of k.S· Thus, the experi­
mental treatment did not affect the animal's capacity for background adaptation. 
HPLC-analysis of the neurointermediate lobes revealed that the lobe of the 
animal transferred to a white background had much higher levels of radioactive 
peptides than the lobe of the animal that remained on a black background (Fig. 
2, top and middle). All peptides found in the animal transferred from black to 
white were also present in the Ыаск-adapted animal, with the exception of pro­
duct VIII. The white-adapted animal maintained on a white background had vir­
tually no radioactive peptides in the neurointermediate lobe except for a 
small amount of the product eluting at 10 min (Fig. 2, bottom). 
To determine which peptides synthesized ir. vivo might constitute the 'sto­
rage pool' of lobe peptides, a single long-term experiment was performed with 
an infused black-adapted animal placed on a white background and kept there 
for ten days (Fig. 3). The analysis of the neurointermediate lobe showed the 
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cpm 1 0 " 
1 - -
2-
B-B eicreted cpm 10" 
bD-
/ 
0 2C ¿.O 60 
duration of experiment [h) 
it 
w-w eicreted cpm 10*' 
1 0 -
2 0 - · 
^ 
— f 1 г 
0 20 10 60 
duration of expenmenl [h 
V V A ^ I iP-W-J!^ 
^ I I I I Г 
10 20 30 10 ВО 60 
HPLC e l u t i o n t i m e | m i n ) 
Figure 2. HPLC-analysis of peptides synthesized in vivo in the pars intermedia of black-adapted 
Xenopus placed on a white background (В -* W) ; of black-adapted animals remaining on black (B •* B) ; 
of white-adapted animals remaining on white (W ·* W). In each case, cpm-values represent the mean 
values of two Independent experiments. Inserts: accumulation of radioactivity in the water due to 
excretion. Mean values of two experiments are given. The shaded area indicates the period of in­
fusion of I Hjlysine. The chromatographic conditions were the same as in Fig. 1. 
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10 20 30 1.0 50 60 
HPLC elution time (mm) 
Ггуиге 3. HPLC-analysis of p e p t i d e s synthesized in г о m the pars intermedia of a black-adapted 
Хепорив t r a n s f e r r e d t o a w h i t e background and kept t h e r e f o r t e n days ( l o n g - t e r m e x p e r i m e n t ) . 
I n s e r t accumulation of r a d i o a c t i v i t y in the water due to e x c r e t i o n . The shaded area i n d i c a t e s 
the period of infusion of [ H j l y s m e . The chromatographic c o n d i t i o n s were the same as in F i g . 1 . 
presence of products I, I I, V, VI I and VIII and the 10-mm product. 
DISCUSSION 
In e a r l i e r in vitro b i o s y n t h e t i c s t u d i e s us ing n e u r o i n t e r m e d i a t e lobes of 
Xenopus laevis, we found t h a t a p r e c u r s o r , synthesized d u r i n g a pulse incuba­
t i o n , was processed t o a number of small pept ides d u r i n g subsequent chase i n ­
cubât ions (Martens et al., 1980, 1982). For t h i s precursor (M = 35000) we adop-
ted the name pro -op iomelanocor t in (POMC) on the bas is of i t s immunological and 
physico-chemical p r o p e r t i e s (Martens et al., 1982). This name was f i r s t p ro -
posed by Chret ien et al. (1979) f o r the p r o t e i n tha t f unc t i ons as the prohor -
mone in the pars intermedia of the r a t . Most of the chase pept ides have been 
cha rac te r i zed using gel e l e c t r o p h o r e s i s , immunoprecipi t a t i o n , s e l e c t i v e amino 
ac id i nco rpo ra t i on and pept ide mapping (Martens et al., 1982). Product 11 ¡s 
des-No-acety1-α-MSH. Products IV and V c o u l d be immunoprecip i tated w i t h a n t i ­
serum t o ACTH ( s p e c i f i c f o r the sequence ACTH „ _ , ) and in view of t h e i r t r y p -
t i c maps as w e l l as c o n s i d e r i n g t h e i r s e l e c t i v e amino a c i d i n c o r p o r a t i o n , they 
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were designated as cort¡cotropm-1¡ke intermediate lobe peptides (CLIP's). 
During in vitro release studies we found that although in the lobe extracts 
peak IV represents only the CLIP-like product, in the medium this peak con-
sists of two co-eluting peptides: one was indeed the CLIP-like product, and 
the other was identified as a-MSH. Products VII and VIII appeared to be en-
dorphin-related peptides. Product I was shown to be MSH-related; recently, we 
demonstrated that it is a glycopeptide (unpublished observation). Therefore, 
product I might well represent γ-MSH. 
Relative to the incorporations of [ H]lysine achieved in vitro, the in 
vivo incorporation of radioactive label was extremely low. Nevertheless, the 
HPLC-system clearly resolved seven products. The strong similarity of the 
chromatographic profiles in the in vivo and the in vitro analyses indicates 
that also in the living animal the pars intermedia synthesizes the melanotro-
pic, CLIP-like, and endorphin-related peptides. The amount of radioactive pro­
duct IV synthesized in vivo was insufficient to determine whether this product 
contained only CLIP (as is the situation in the lobe following in vitro incu­
bation) or whether also a-MSH was present. 
In vitro processing of POMC is completed within 8 hours (Martens et al., 
1982). It is, therefore, not surprising that in the 60-h in viyc-exper¡ment, 
i.e. hO hours after the infusion of [ H]lys!ne was terminated, POMC was no 
longer present. Peaks IXa, IX and X represent high-molecular weight products 
(M > ІЗ.ООО). In our opinion, these products are biosynthetic intermediates 
in the processing of POMC. Their absence from the neurointermediate lobes in 
the in vivo experiment supports this view. 
The question arises what product is represented by the peak eluting at 10 
min and that is, relative to the other peaks, conspicuously high in the in 
vivo experiments. It is relevant to this question to bear in mind that the ana­
lysis of the biosynthetic process concerned the neurointermediate lobe and thus 
might include newly synthesized products from the pars nervosa. Using autora­
diographic analys is, Jenks et al. (1977) showed that during incubation of the 
neurointermediate lobe almost no labelled amino acid was incorporated in the 
pars nervosa. During the in vivo conditions supply of newly synthesized pro­
ducts to the pars nervosa is likely to occur, in particular since the [ H]ly-
sine is released in the immediate vicinity of the hypothalamus. It is, however, 
unlikely that the 10-min product represents a neurohypophysial hormone, as the 
known nonapeptldes in amphibians do not contain lysine. 
It is well documented that the level of melanotropic substances in the pars 
intermedia of Xenopun is higher in white-adapted than in Ыаск-adapted animals 
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(Burgers et al., 1963; Thornton, 1971; Jenks et al., 1977). Further, ί-η vitro 
incubation studies indicate that protein synthesis in the pars intermedia is 
much higher in Ыаск-adapted aniñáis than in white-adapted ones (Whur ε 
Weatherhead, 1971; Jenks οτ al., 1977; Loh ε Gainer, 1977). In addition, it 
must be realized that following transfer of Xenopua from black to white back­
ground, inhibition of release occurs rapidly, while protein synthesis decrea­
ses only gradually and, in fact, remains relatively high for a period of 1-2 
days (Jenks et al., 1977)· This last observation is of particular importance 
for the interpretation of the present in vivo results concerning effects of 
background adaptation. In our opinion, the observed quantitative difference 
in peptide content between Ыаск-adapted animals transferred to a white back­
ground and those kept on a black background reflects an accumulation of pep­
tides in the transferred toads which results from continuing synthesis in 
combination with inhibited release. The fact that reduction of peptide-content 
in the animals on a black background involves all peptides suggests a conco­
mitant release of pars intermedia products which agrees with earlier results 
of in vitro superfusion experiments (Martens et al., 198la). Such concomitant 
release implies that not only meianotropins, but also CLIP-like and endorphin-
related peptides are released. The physiological meaning of these last two 
groups of products and the significance of their release together with the 
meianotropins is unknown. The absence of newly synthesized peptides in the 
pars intermedia of the white-adapted animals kept on a white background con­
firms the very low protein synthetic activity in white-adapted Xenopus. 
When one compares the chromatographic profile of the pars intermedia of the 
Ыаск-adapted animals exposed for 60 h to a white background with that of the 
long-term experiment (10 days on a white background), it is evident that the 
only peak absent from the latter profile is peak IV. The significance of the 
absence of one of the two CLIP-like products is, at present, obscure. From the 
absence of peak IV important information may be derived with respect to the 
'storage form' of a-MSH in the living animal. If a-MSH were present in the 
tissue it would, as already mentioned, co-elute with the CLIP-like product in 
peak IV. From the absence of peak IV the conclusion is inevitable that after 
long-term adaptation to a white background, the pars intermedia does not con­
tain newly synthesized α-MSH. In a recent study we showed that, in vitro, new­
ly synthesized des-Na-acetyl-α-MSH is converted to a-MSH with the acetylation 
taking place during or just prior to release (Martens et al., 198lb). The pre­
sence of des-Na-acetyl-a-MSH and the absence of α-MSH in the pars intermedia 
of Xencpus adapted to a white background for 10 days indicate that in the living 
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animal too des-Na-acetyl-α-MSH ¡s the 'storage form' of α-MSH in the tissue. 
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PART I I 
RELEASE OF PEPTIDES RELATED TO PRO-OPIOMELANOCORTIN 
BY THE PARS INTERMEDIA OF XENOPUS LAEVIS 
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CHAPTER VI Comp. В i ochem. Physiol. 
(ISSI) 69C, 75-82 
MICROSUPERFUSION OF NEUROINTERMEDI ATE LOBES OF XENOPUS LAEVIS: 
CONCOMITANT AND COORD INATELY CONTROLLED RELEASE OF NEWLY SYNTHESIZED PEPTIDES 
Gerard J.M. Martens, Bruce G. Jenks and A.P. van Overbeeke 
Depo-rtmenL of Zoology, Faculty of Science, Catholic University, 
Toemooiyeld, 6525 ED Nijmegen, The Uebherlands 
SUMMARY 
1. Release of [ H]lysine-labelled peptides from the neurointermediate lobe of 
black-adapted Xenopus laevis was studied using a microsuperfus ion system 
and high-performance liquid chromatographic analysis. 
2. It appeared that all newly synthesized peptides, inclusive the precursor 
for these peptides, were concomitantly released. 
3. On the basis of the total release of labelled peptides as a function of 
superfusion incubation time, 3 time-periods were selected to study the 
effects of secretagogues on the release process. 
k. Dopamine inhibited the release of all newly synthesized peptides, except the 
precursor, leading to an enhanced level of these peptides remaining in the 
lobe. Cyclic AMP stimulated the release of all peptides, except the precur­
sor, leading to reduced levels of lobe peptides. 
INTRODUCTION 
The pars intermedia of the amphibian pituitary gland is involved in black-
background adaptation by producing and releasing melanotropic peptides. These 
peptides cause dispersion of melanin granules in the dermal melanophores of 
the animal. In the South African clawed toad, X. laevis, it has been shown 
that, in vitro, neurointermediate lobes from black-background-adapted animals 
synthesize a precursor; this precursor is subsequently processed to a number 
of smaller peptides, some of which possess melanotropic activity (Loh 6 Gainer, 
1977; Jenks Ь van Overbeeke, I98O; Martens ei, al., I98O). This precursor-product 
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mode of peptide production is also found in mammalian tissue. A common prohor­
mone to adrenocorticotropic hormone (ACTH) and 3"endorphin has been established 
in a mouse pituitary tumor cell-line (Mains et al., 1977; Roberts ε Herbert, 
1977a,b; Eipper & Mains, 1978a; Mains & Eipper, 1978) and in cells of the rat 
pars intermedia and anterior lobe of the pituitary gland (Eipper Б Mains, 1978b; 
Mains Ь Eipper, 1979)· The circumstance whereby several products, each with its 
own specific bioactivity, is derived from a common prohormone raises important 
questions concerning the regulation of release of such products. Pertinent 
studies concerning newly synthesized peptides from the mouse pituitary tumor 
cell-line (Mains & Eipper, 1976) and cells from the rat intermediate lobe (Eip­
per & Mains, 1978b; Mains ε Eipper, 1979) indicate that all products are re­
leased concomitantly. For mouse and rat anterior pituitary cells the release of 
immunoreacti ve ACTH and endorphin has been reported to be under coordinant con­
trol (Allen et al., 1978; Vale et al., 1978). Such coordinant control is con­
sistent with the ¡mmunohistochemical observation in rat pars intermedia cells 
(Martin et al., 1979) and anterior pituitary cort icotrophs (Weber et al., 1978, 
I979) that cort¡cotropin-related peptides and endorphin-like peptides are 
present within the same secretory granules. 
The possibility to manipulate the biosynthesis and secretion of pars inter-
media peptides in amphibians, by placing the animal on different backgrounds, 
is an advantage in investigating regulatory mechanisms in this gland. Such in-
vestigations are, however, complicated by the fact that the pars intermedia 
produces a large number of peptides. Using pulse-chase analysis and high-per-
formance liquid chromatography (HPLC) , we have recently demonstrated that in 
the pars intermedia of black-adapted X. laevis the precursor is processed to 
12 chase peptides, 3 of which had high melanotropic activity and 1 of these 
also had corticotropic activity (Martens et al., I98O) . This prompted the 
question whether release is restricted to those peptides with a known biologi-
cal activity, or whether all chase peptides are secreted. To investigate this 
problem we developed a microsuperfusion system that enabled us to analyse the 
in vitro release from pulse-labelled neurointermediate lobes of X. laevis. 
HPLC was used to separate the various newly synthesized products. The effect 
of dopamine and adenosine 3',5'-monophosphate (cAMP) was studied as a first 
step towards unravelling the mechanism controlling the release. 
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MATERIALS AND METHODS 
Procedure of microsuper fusion incubation 
Two neurointermediate lobes of fully Ыаск-adapted X. laevis, bred in the 
Department of Zoology (Nijmegen), were used in each superfusion experiment. 
The lobes were pul se-incubated for 1.5 h in 100 μΐ incubation medium (for com­
position of incubation medium see Martens et al., 198O), containing 40 цСІ 
[ H]lysine (New England Nuclear, sp. act. 60 Ci/mmol, freeze-dried before use), 
on a Dubnoff metabolic shaker (22 0C). After the pulse incubation, the lobes 
were transferred to the 10 μΐ incubation chamber of the microsuperfus ion appa­
ratus (see Fig. 1) and chase incubation medium, containing 2 mM L-lysine (Cal-
biochem) was pumped through the chamber (Cenco peristaltic pump). The medium-
reservoir, with a continuous gassing of 35% 0.-5% CO. (No. 6—Fig. 1) over the 
incubation medium, and the chamber were maintained at 22 0C by means of a water-
bath (Nos 1-2, Fig. 1). One-hour fractions (8OO μΐ) were collected (LKB Redirac 
fraction collector model 2112, No. 5—Fig. 1) in 100 μΐ 0.1 N HCl or in 100 μΐ 
medium containing the enzyme inhibitor trasylol (1000 KIU/ml , Bayer, Leverkusen, 
FRO) to diminish the possibility of breakdown of released products. The 1-h 
superfusion fractions were analysed immediately with HPLC. 
HPLC-analysis -
100 ¡A 
- 0 1 N H C I -
lOjul chamber 
1 (with lobes) 
-рЁЗпШпЦп г 
Figure 7. Mîcrosuperfusion appara tus . Pulse- incubated lobes are placed in a 10 ¿1 chamber and 
superfused a t a f low of 0 . 8 ml /h . The three removable par ts (ha tched) , surrounding the chamber, 
are pressed together wi th a screw Cap, Ο-r îngs prevent ing leakage. Tef lon tubing was used 
throughout. (1) and (2) waterbaths ; (3) pumps; {h) 15 μιπ mesh nylon gauze supporting the l o b e s ; 
(5) f r a c t i o n c o l l e c t o r ; (6) gas supply. 
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To determine the r e l e a s e - p r o f i l e of newly synthesized products from neuro-
in termed i a te l obes , several super fus ion experiments were performed and a summa-
t i o n of the i n d i v i d u a l peaks on the chromatograms of the 1-h super fus ion f r a c -
t i ons was made and co r rec ted f o r background. This summation was p l o t t e d aga ins t 
super fus ion t i m e , t ak i ng the mid-po in t between the s t a r t and the end of the 
c o l l e c t i o n per iod as the t ime f o r each f r a c t i o n . 
To study the in f luence of dopamine (3-hydroxytyramine HCl, Sigma) on re l ease , 
t h i s secretagogue was d isso lved j u s t before use at a concen t ra t i on of 10 M in 
pa r t of the chase incubat ion medium. To prevent o x i d a t i o n of dopamine, the chase 
incubat ion medium in the dopamine-exper¡ment conta ined ascorb ic ac i d (Merck, 
1 m g / l ) . At the app rop r i a te t i m e , the rese rvo i r con ta i n i ng the chase incubat ion 
medium was s u b s t i t u t e d by the rese rvo i r con ta i n i ng chase incubat ion medium p lus 
dopamine. In a s i m i l a r way the in f luence of 6 mM 8-bromo adenosine 3 ' , 5 ' -mono -
phosphate (8-Br cAMP, Sigma) on re lease was s t u d i e d , except no ascorb ic ac i d 
was added to the medium. 
At the end of each super fus ion exper iment , a f t e r the l a s t 1-h f r a c t i o n was 
c o l l e c t e d , the lobes were removed from the super fus ion chamber, homogenized in 
500 y l 0.1 M a c e t i c ac i d (HAc) in an a l l - g l a s s homogenizer, c e n t r i f u g e d 
(10.000 g , 5 min . Beekman microfuge) and the supernatant was f rozen a t -20oC 
u n t i l HPLC-analysis. 
High-performanoe liquid ohromatograpky 
HPLC-analyses were performed on reversed-phase supports (Spher isorb 10 0DS) 
a t ambient temperature w i t h a f l ow ra te of 2 m l /m in . Samples were i n j e c t e d v ia 
a 1-ml loop and O.S-min f r a c t i o n s were c o l l e c t e d . The g rad ien t p r o f i l e used 
(es tab l i shed w i t h 0.5 M formic a c i d , O . l ^ M p y r i d i n e , pH = 3·0 as the pr imary 
and 1-propanol as the secondary so lven t ) and f u r t h e r chromatographic d e t a i l s 
have been p rev ious l y descr ibed (Martens et al., 1980). 
RESULTS 
Release profile during superfusion incubation 
Total release of newly synthesized peptides from neurointermediate lobes as 
a function of superfusion incubation time is given in Fig. 2. There was almost 
no release in the first hour, a rapid increase during the next 1è h, followed 
by a gradual decrease. Even after 8 h of incubation a substantial amount of 
labelled products was released. During this period of 8 h of incubation, how-
ever, no qualitative changes were observed in the chromatographic profiles of 
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Figure 2, Total release of radioactive products from neurointermediate lobes of X, laevis as a 
function of superfusion incubation time. Time in hours indicates chase incubation time following 
a period of 1.5 h of pulse-labelling. Fl, F2 and F3 refer to fractions collected in studies on 
effects of secretagogues (see text). 
the samples. S i n c e , t h e r e f o r e , t h e r e was no apparent change in the composi t ion 
of the r e l e a s e - p r o d u c t s d u r i n g the p e r i o d of i n c u b a t i o n , i t was decided t o se­
l e c t t h r e e 1-h p e r i o d s , t o be used t o determine the e f f e c t s of secretagogues 
on the re lease process. The f i r s t 2 per iods were s e l e c t e d such t h a t the p e r t i ­
nent f r a c t i o n s named Fl and F2 (see F i g . 2) would y i e l d a p p r o x i m a t e l y the same 
amount of t o t a l r e l e a s e - p r o d u c t s . F r a c t i o n 3 ( F 3 ) , c o l l e c t e d d u r i n g the t h i r d 
p e r i o d , y i e l d s a p p r o x i m a t e l y h a l f the a c t i v i t y of Fl or F2. F r a c t i o n Fl was 
designated as the c o n t r o l f r a c t i o n in each e x p e r i m e n t . Immediately a f t e r c o l ­
l e c t i n g f r a c t i o n F l , i n c u b a t i o n medium c o n t a i n i n g a p a r t i c u l a r secretagogue 
was pumped through the p e r f u s i o n chamber. The f i r s t 20 min of t h i s p e r f u s i o n 
served t o e q u i l i b r a t e the s u p e r f u s i o n system w i t h the secretagogue. Then, f r a c ­
t i o n F2 was c o l l e c t e d . Immediately t h e r e a f t e r , normal chase i n c u b a t i o n medium 
was again pumped through the p e r f u s i o n chamber. A 20-min p e r i o d was a l l o w e d t o 
r i n s e the secretagogue out of the system and then f r a c t i o n F3 was c o l l e c t e d . 
F r a c t i o n F3 was cons idered a second c o n t r o l f r a c t i o n , t o observe whether the 
e f f e c t s of the secretagogue on the re lease process were r e v e r s i b l e . 
Effect of dopamine 
The c o n t r o l f r a c t i o n Fl of superfused lobes was analysed w i t h HPLC ( F i g . 3 ) . 
Peaks are marked as d e s c r i b e d p r e v i o u s l y (Martens et al., 1980); peaks e l u t i n g 
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FbyiAre 3. High-performance l i q u i d radiochromatograms of t h r e e superfusion f r a c t i o n s , showing the 
e f f e c t of dopamine on the r e l e a s e of [^H] l y s m e - l a b e l l e d p e p t i d e s from n e u r o m t e r m e d i a t e lobes of 
X. Іае гв. Fl c o n t r o l f r a c t i o n , F2 f r a c t i o n c o l l e c t e d a f t e r adding 10 M dopamine to the medium, 
F3 c o n t r o l f r a c t i o n . For chromatographic c o n d i t i o n s , see M a t e r i a l s and Methods. 
in the f i r s t 10 min concern [ H]1ysine and c o n t a m i n a t i o n s in the [ H]1ysine 
p r e p a r a t i o n . F igure 3 c l e a r l y shows t h a t a l l products are c o n c o m i t a n t l y r e ­
leased. F r a c t i o n F2 was c o l l e c t e d a f t e r r e p l a c i n g the c o n t r o l i n c u b a t i o n medium 
by medium c o n t a i n i n g dopamine in a c o n c e n t r a t i o n of 10 M. I t i s e v i d e n t t h a t 
dopamine almost c o m p l e t e l y i n h i b i t e d the re lease of a l l newly synthesized pep­
t i d e s , except product X I . The a n a l y s i s of c o n t r o l f r a c t i o n F3 shows t h a t the 
i n h i b i t i o n by dopamine was r e v e r s i b l e . Tota l re lease of t h i s f r a c t i o n was c a l ­
c u l a t e d and appeared t o be somewhat less than 50% o f the t o t a l re lease f o r F l . 
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Effect of Ы р 
In the experiment where 6 mM 8-bromoadenos me 3 ' , 5 ' -monophosphate (8-Br 
cAMP, F i g . h) was used, the peak p a t t e r n of f r a c t i o n F1 was s i m i l a r t o t h a t of 
the c o n t r o l f r a c t i o n in the dopamine-experiment. In the presence of 8-Br cAMP 
the same products were r e l e a s e d , but each marked peak, w i t h the e x c e p t i o n of 
peak X I , was 60-80% higher than the comparable peaks in the F l - f r a c t i o n . In 
the c o n t r o l f r a c t i o n F3, the peak h e i g h t s were f rom 20-30% of the h e i g h t s in 
F l . 
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Fzgure 4, High-performance liquid radlochromatograms of three superfusion fractions, showing the 
effect of cAMP on the release of [ H] lys me-label led peptides from neuromtermediate lobes of 
X. laems. Fl control fraction; F2 fraction collected after adding 6 mM 8-bromoadenosme З'»? 1 -
monophosphate (8-Br cAMP) to the medium, F3 control fraction. For chromatographic conditions, see 
Materials and Methods. 
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Radioactive products remaining in zhe tobes 
In both the dopamine-exper¡ment and the experiment where the effect of cAMP 
was investigated, immediately upon collecting fraction F3, the lobes were homo-
genized and frozen until HPLC-analysi s. Similarly, in a control incubation ex-
periment, where no secretagogue was used, the lobes were analysed. The results 
are presented in Fig. 5· In all three cases the peaks in the control fraction Fl 
were also found in the lobe homogenates. Moreover, no additional products were 
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Figure 5. High-performance l i q u i d radiochromatograms of [ H ] l y s i n e - l a b e l led peptides present in the 
n e u r o i n t e r m e d i a t e lobe of X* taevis a f t e r completion of superFusion incubations in which no s e c r e ­
tagogue ( c o n t r o l ) , 10 M dopamine or 6 mM 8-bromoadenosine 3',5'-monophosphate (8-Br cAMP) was 
used. For chromatographic condì t ions , see M a t e r i a l s and Methods. 
102 
detected ¡η the homogenates, except that in the control-experiment and the do-
pamine-exper¡ment an indication of peak III was detectable. However, with regard 
to the relative heights of the peaks in any-one profile, there were differences 
between the homogenate and the control incubation media. Notably, the relative 
heights of peaks I and II in the homogenate exceeded by far the comparable 
values in the media. Contrastingly, the relative heights of peak IV were possi-
bly lower in the homogenate than in the media. 
Comparison of the homogenate in the controls with that in the dopamine-trea-
ted lobes indicates that dopamine-treatment led to an appreciable increase in 
radioactive products in the tissue. On the other hand, addition of cAMP caused 
a reduction in the amount of lobe products. Product XI constituted an exception, 
however, as the lobe contents of this product seemed neither affected by dopa-
mine nor by cAMP (Fig. 5 ) . 
A compilation of the values for total activities found in the three fractions 
of the incubation as well as in the lobes, for each of the three experiments, is 
cpm.lO"4 
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Figure 6, Effect of dopamine and cAMP on total amounts of radioactive peptides released into the 
medium and retained in the tissue by neurointermediate lobes of λ. laevis. Each column represents 
the total radioactivity» calculated by adding the individual HPLC-peak values of the three frac­
tions of the med Í um and those values of the 1obe homogenate. 
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presented ¡π Fig. 6. It ¡s obvious from this figure that the treatment with the 
two secretagogues did not greatly affect the total amounts of newly synthesized 
products. 
DISCUSSION 
Up to now, -in vitro release of newly synthesized peptides f rom Xenopus 
neuroi ηtermed i a te lobes has been studied in static incubation systems (Loh 6 
Gainer, 1977; Jenks Б van Overbeeke, I98O) . The microsuperfusion system, des­
cribed in the present report, provides an alternative approach. It differs in 
some important aspects from the static incubation method. First, with the 
superfusion method, both the control-data and data concerning the effects of 
secretagogues are obtained from the same tissue, thus eliminating animal vari­
ability. Examining the same tissue implies, moreover, a reduction in the number 
of animals used. Secondly, the perfusion method permits the immediate collec­
tion of the release-products in the presence of acid or enzyme inhibitor, which 
greatly reduces the possibility for enzymatic breakdown or conversion of such 
products. This is important in view of the fact that intermediate lobe peptides 
are derived from a common precursor where enzymatic conversion is an essential 
part of the processing. A third advantage of the superfusion system is that the 
lobes are continuously bathed in fresh incubation medium. This eliminates any 
possibility of feedback by released peptides on the release process. The exist­
ence of such feedback has been reported for amphibians (Iturriza, 1973), al­
though there are data to the contrary (Huntington ε Hadley, ^ЭТ**) · The continu­
ous perfusion with fresh medium also reduces possible inaccuracies concerning 
the dosage of secretagogues, which may develop as a consequence of breakdown of 
the secretagogues in the incubation medium. 
The use of gel electrophoretic techniques to study the release f rom Xenopus 
neu roi η termed¡ate lobes, necessitated TCA-precip¡tat ion of the incubation medium 
prior to analysis (Loh Б Gainer, 1977; Jenks Б van Overbeeke, I98O) . Some newly 
synthesized products, however, have been shown to be TCA-soluble (Loh Б Gainer, 
1977; Martens et al., I98O) and would not be detected with the electrophoretic 
technique. HPLC-analysis allows the incubation media to be directly injected 
onto the column and, thus, in the present investigation all released peptides 
were analysed. These peptides appeared to be the same as those described in a 
previous investigation, employing static pulse-chase incubation and HPLC-analy-
sis (Martens et al·., I98O). In the latter study we demonstrated the existence 
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of a precursor-product mode of biosynthesis in Xenopus neurointermediate lobes. 
The precursor (product XI), formed during the pulse period, was processed to 12 
chase peptides (products 1-Х, XII & XIII). It appeared that products I, II and 
IV had melanotropic activity and product II had, in addition, ACTH bioactivity; 
none of the chase peptides could be identified as ci-melanophore stimulating 
hormone (α-MSH). 
Concerning the study reported here, it is evident from the analysis of total 
release as a function of time (Fig. 2) that, under the conditions of the experi­
ment, in the release of newly synthesized products three phases may be recognized. 
During the first hour there was little or no release, this hour presumably being 
the time required to process and package the newly synthesized products. The fol­
lowing k h constitute a period of enhanced release of radioactive peptides. 
During this phase there is adequate opportunity to collect the three fractions 
(Fl, F2 Б F3) serving the purpose of the experiment, i.e. to study the effects 
of secretagogues. The length of the third phase, a period of low but relatively 
constant release, was surprising. This extended release-period might point to­
wards the existence of a separate pool of slowly releasable products. Further 
studies will be necessary to investigate this possibility. 
It is important to realize that the shape of the total release curve appeared 
to be highly reproducible; the ratio of total radioactivity of the three frac­
tions was always roughly the same. Even more important is the observation that 
the three fractions showed essentially the same chromatographic profile. 
It is evident that during the superfusion incubation of neurointermediate 
lobes, there was a concomitant release of all newly synthesized products. Among 
these products was the precursor (peak XI), which is surprising in view of the 
fact that results reported by others, who employed a static incubation method 
(Loh 6 Gainer, 1977; Jenks Б van Overbeeke, I98O), indicate that the precursor 
is not released. A possible explanation for this difference might be that in 
our system the use of acid or enzyme inhibitor reduced the breakdown or pro­
cessing of the precursor that may well take place in static incubations. Inte­
restingly, Eipper Б Mains (1978b), who also used static incubations but added 
enzyme inhibitor to the medium, found release of prohormone from rat anterior 
and intermediate lobe pituitary cells. They suggested that release of precursor 
could represent secretion from a distinct intracellular pool (Mains Б Eipper, 
1979). 
The spontaneous release of newly synthesized products from perfused neuro-
intermediate lobes of Xenopus is consistent with the concept that control of 
pars intermedia function in amphibians is primarily inhibitory. This control is 
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thought to be mediated by aminergic nerve fibres penetrating the pars inter-
media (Terlou & Ploemacher, 1973). Indeed, dopamine has been demonstrated to 
inhibit the release of immunoreact ¡ve α-MSH in Λ'. leavis (Jenks, 1977). The 
present results show that dopamine, at the concentration used, in fact inhi­
bits the release of all newly synthesized peptides, which suggests the like­
lihood of coordinate inhibition of release. The increased release following 
withdrawal of dopamine shows that the inhibitory effect is readily reversible. 
The enhanced levels of radioactive peptides in the lobes following treatment 
with dopamine indicate that inhibition of release by this secretagogue is 
accompanied by accumulation of peptides in the cells. Release of the precur­
sor is, however, hardly affected by dopamine, which may be an indication that 
releasable precursor constitutes a distinct intracellular poo]. Since the 
amount of precursor retained in the lobes a-t the end of the experiment was 
approximately the same in the dopamine-treated tissue as in the controls (Fig. 
5), it is probable that dopamine exerted no effect on the processing of the 
precursor. 
The involvement of adenylate cyclase or cAMP in the release of MSH has been 
indicated for mammals (Baker, ІЭ?**, 1976; Munemura et al., I98O) , reptiles 
(Thornton ε Geschwind, 1975) and amphibians (Jenks, 1977). Jenks (1977) showed 
that dibutyryl cAMP stimulates release of immunoreacti ve MSH from neurointer­
mediate lobes of white-adapted Xcnopus. In a later study, however, where the 
release of newly synthesized peptides from the lobes of Ыаск-adapted toads 
was examined, no stimulating effect of cAMP could be established (Jenks 6 van 
Overbeeke, I98O). The authors suggested that in black-adapted animals release 
was at a maximum rate. Our results clearly showed cAMP to have a stimulatory 
effect. It enhanced the release of all radiolabelled peptides (with the excep­
tion of the precursor) which, once again, suggests a coordinate control-mecha­
nism of release. It is, furthermore, evident that the enhanced release led to 
a reduced amount of labelled peptides in the tissue. Apparently, the effect of 
cAMP was limited to the release process and did not involve processing, as this 
nucleotide did not appreciably alter the amount of precursor in the tissue 
(Fig. 5). 
Although, as mentioned before, the HPLC separation method allows quantita­
tive analysis of all newly synthesized peptides, the amount of products result­
ing from complete degradation of peptides cannot be determined. Since in our 
study total levels of radioactive products were roughly the same in the controls, 
the dopamine-treated and cAMP-treated lobes (Fig. 6), it seems justified to con­
clude that if degradation of newly synthesized peptides took place, neither do-
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pamine nor cAMP had an e f f e c t on t h i s p r o c e s s , a t l e a s t w i t h i n the t ime l i m i t s 
of the e x p e r i m e n t s . 
A f i n a l comment must be made concerning the f i n d i n g t h a t the q u a n t i t a t i v e 
composi t ion of newly synthes ized p e p t i d e s , n o t a b l y w i t h regard t o p e p t i d e s 
I , I I and IV, in the medium d i f f e r e d from t h a t in the t i s s u e . This c o u l d p o i n t 
towards the p o s s i b i l i t y t h a t the chase pept ides occur in d i f f e r e n t r e l e a s e -
p o o l s . The i m p l i c a t i o n s of the p o s s i b l e e x i s t e n c e of such pools f o r the re lease 
mechanism r e q u i r e f u r t h e r a p p r a i s a l . 
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CHAPTER VI I 
CONTROL OF RELEASE OF NEWLY SYNTHESIZED PEPTIDES DERIVED FROM 
PRO-OPIOMELANOCORTIN IN THE PARS INTERMEDIA OF XENOPUS LAEVIS 
SUMMARY 
This chapter concerns a preliminary survey of the effects of a number of po-
tential secretagogues on the release of newly synthesized peptides derived from 
pro-opiomelanocortin in the pars intermedia of the pituitary gland of Xenopus 
lasvi-Cy adapted to a black background. Microsuperfusion of [ H] lysine-label led 
neurointermediate lobes and high-performance liquid chromatographic analysis of 
the peptide-contain ing medium were employed. 
The catecholamines dopamine, adrenaline, noradrenaline and isoproterenol, in 
-Ç -8 
concentrations of 10 M and 10 M, induced a clear inhibition of the release 
of all peptides. At a concentration of 10 M they had no effect, except iso-
proterenol which caused a slight stimulation of release. On the basis of the 
effects of specific antagonists, it is proposed that the inhibitory control of 
the pars intermedia is mediated by dopaminergic and o-adrenergic receptors, 
while 3-adrenergic receptors may be involved in a stimulatory control mechanism. 
No clear effect on peptide release of the neurotransmitters acetylcholine and 
serotonin, and the peptides L-proly1-L-leucy1-glycinamide (PLC), vasotocin, 
8-endorphin and met-enkephalin could be established. The neurotransmitter γ-
amino butyric acid (GABA) induced a general release-inhibition for all peptides, 
whereby the inhibition for the γ,-MSH-like peptide was appreciably higher than 
that for the other peptides. 
+ 2+ 
Also analysed were the effects of altering the К - and Ca - concentrations of 
the incubation medium. A ten-fold increase in К caused a 30% inhibition of re-
2+ 2+ 
lease. A ten-fold decrease in Ca or omitting Ca from the medium induced an 
2+ 80-90% inhibition; a ten-fold increase in Ca caused a kQ% inhibition. 
2+ 
Only when the medium was Ca - deficient, a change in the peptide composition 
of the lobes was noted. 
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INTRODUCTION 
Background adaptation in amphibians is brought about by dispersion or aggre-
gation of the melanosomes in the dermal pigment cells. Direct control of these 
pigment cells is exercized by melanophore stimulating hormone (MSH) of the 
pars intermedia of the pituitary gland. This hormone causes melanosome dis-
persion; its absence leads to aggregation of the melanosomes. 
It was established by Hogben and co-workers that the receptor organs invol-
ved in background adaptation are the eyes. Using mainly the South African 
clawed toad, Xenopus laevis, they could show that when the animal remains on 
a black background only the ventral segments of the retinae are excited by 
direct, incident light. On a white background the dorsal segments are also sti-
mulated, namely by reflected light. In this last case, the retinal information 
is processed in the brain and leads to an inhibition of MSH release from the 
pars intermedia cells (for a review, see [1]). The pathway by which the brain 
regulates MSH release is not well understood but it is generally accepted that 
the hypothalamus plays a key role. A large number of experiments, involving 
disconnecting the pituitary gland from the hypothalamus or transplantation of 
the gland, proved that MSH release is under inhibitory control by hypothalamic 
nuclei. In amphibians, the pars intermedia (unlike the pars distal is) is poor-
ly vascularized and it is, therefore, improbable that hypothalamic regulating 
factors reach the cells of the pars intermedia via the blood vessels of the 
portal system. Morphological investigations have demonstrated that the pars in-
termedia is well innervated. In particular, the presence of aminergic fibres 
between the secretory cells has been demonstrated by a number of histochemical 
and electronmicroscopical investigations (see [2]). Of immediate relevance to 
our own studies are the results of a series of investigations in Xenopus tad-
poles [3]. In these animals catecholaminergic fibres originating from two hypo-
thalamic nuclei, the paraventricular organ and the nucleus infundibular!s dor-
sal is, course via the median eminence into the pars intermedia to reach the MSH 
cells with which they make synaptic contacts. Further histochemical analysis 
strongly indicated that the aminergic substance is dopamine [k]. Results of 
physiological studies are consistent with a regulatory function for dopamine. 
For instance, dopamine inhibits the release of immunoreacti ve MSH from incuba-
ted neurointermediate lobes of Xenopus Zaevïs [5]. Moreover, dopamine appeared 
to act as a general inhibitor of the release of peptides synthesized in the 
pars intermedia of this species [6-8]. Not only dopamine but also noradrenaline 
has an inhibitory effect on the release of immunoreacti ve MSH from incubated 
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Xenov'Mì pars intermedia [ 5 ] . This l as t observa t ion conf i rms s i m i l a r r e s u l t s ob-
ta ined w i t h o ther spec ies , i n d i c a t i n g an involvement of adrenerg ic receptors in 
the c o n t r o l of the amphibian pars intermedia [ 9 - 1 1 ] · Bower et a t . [ 1 1 ] suggested 
tha t in amphibians the i n h i b i t o r y con t ro l of MSH release is mediated by dopa-
minerg ic receptors and α-adrenerg ic r e c e p t o r s present on the membranes of the 
pars intermedia c e l l s and t h a t , in a d d i t i o n , a s t i m u l a t o r y c o n t r o l of the pars 
intermedia e x i s t s which is mediated by ß-adrenergic r e c e p t o r s . 
Other neu ro t r ansm i t t e r s have been imp l i ca ted in the con t ro l of the pars i n -
termedia. Repor ted ly , in the f r o g , MSH release is s t imu la ted by a c e t y l c h o l i n e 
[12] and by sero ton in [ 1 3 ] , wh i l e gamma-aminobutyric ac i d (GABA) appeared to 
act as an i n h i b i t o r y agent [ 1 0 ] . 
Morphological i n v e s t i g a t i o n s have shown tha t the pars intermedia is not only 
innervated by ' c l a s s i c a l ' axons but a l so by neurosecre tory f i b r e s [ Й ] and i t 
i s , t h e r e f o r e , not s u r p r i s i n g t h a t the p o s s i b l e involvement of p e p t i d e r g i c sub­
stances in the c o n t r o l of the pars intermedia was c o n s i d e r e d . I t has been c l a i m ­
ed t h a t the t r i p e p t i d e side chain of the neurohypophysial hormone o x y t o c i n , L-
p r o l y l - L - l e u c y 1 - g l y c i n a m i d e (PLG), a c t s as an MSH re lease i n h i b i t i n g f a c t o r in 
mammals [ 1 5 , 1 6 ] . However, Hadley et al. [17] were unable t o demonstrate an 
e f f e c t of PLG on MSH release in f r o g s . 
I t is understandable t h a t p r a c t i c a l l y a l l s t u d i e s concern ing the c o n t r o l of 
the pars intermedia have focussed on MSH since t h i s is a p e p t i d e w i t h a known 
hormonal f u n c t i o n . I t has now become e v i d e n t , however, t h a t in a d d i t i o n t o MSH 
the pars intermedia of Xenopus Іае гз produces a number of o t h e r p e p t i d e s as 
w e l l , and t h a t a l l these peptides(MSHs, CLIPs and endorphins,among o t h e r s ) a r e 
d e r i v e d from a common prohormone, p r o - o p i o m e l a n o c o r t i n [ 1 8 ] . This prompts the 
important q u e s t i o n as t o how the re lease of these v a r i o u s p e p t i d e s i s c o n t r o l ­
l e d . As has a l r e a d y been shown [ 8 ] , dopamine i n h i b i t s the re lease of not only 
MSH but a l s o of the o t h e r p e p t i d e s . 
The r e s u l t s r e p o r t e d in t h i s chapter concern an i n v e s t i g a t i o n on the e f f e c t s 
of a number of p o t e n t i a l secretagogues on the re lease of newly synthes ized pep­
t i d e s f rom the pars intermedia of b lack-adapted Xenopus. Among the substances 
t e s t e d were dopamine, a d r e n a l i n e , n o r a d r e n a l i n e , a c e t y l c h o l i n e , s e r o t o n i n and 
GABA. As a f i r s t step t o c h a r a c t e r i z e the p o s s i b l e r e c e p t o r s i n v o l v e d , several 
adrenerg ic and dopaminergic a g o n i s t s and a n t a g o n i s t s were employed. In a d d i t i o n , 
p o s s i b l e e f f e c t s of the t r i p e p t i d e PLG, the amphibian neurohypophysial hormone 
v a s o t o c i n and the o p i o i d pept ides endorphin and met-enkephal in were i n v e s t i g a -
+ 2+ 
t e d . F i n a l l y , the i n f l u e n c e of v a r y i n g the c o n c e n t r a t i o n s of К and Ca in 
the i n c u b a t i o n medium was d e t e r m i n e d . These analyses were conducted w i t h i n c u -
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bated neuro i η termed¡a te l obes , using the microsuper fus ion system tha t was des-
c r i b e d e a r l i e r ( [ 8 ] . Chapter V I ) . 
MATERIALS AND METHODS 
Апгграіз 
South A f r i c a n clawed t o a d s , Xenopus laevis, bred and reared in the Depart­
ment of Zoology, U n i v e r s i t y of Nijmegen, of a p p r o x i m a t e l y the same weight (20 
g) were used. For f u l l a d a p t a t i o n t o a b l a c k background, animals were kept in 
b l a c k buckets f o r a t l e a s t two weeks in an environmental chamber a t 220C under 
c o n s t a n t i l l u m i n a t i o n . Animals were f u l l y whi te-adapted by keeping them in 
w h i t e buckets f o r a t l e a s t two weeks a t 220C under c o n s t a n t i l l u m i n a t i o n . 
Materials 
[ H ] L y s i n e (sp. a c t . 6О-8О Ci/mmol) and [ H ] t r y p t o p h a n (26 Ci/mmol) were ob­
t a i n e d from Amersham. Dopamine ( 3 - h y d r o x y t y r a m i n e ) , a d r e n a l i n e ( 1 - e p i n e p h r i n e ) , 
n o r a d r e n a l i n e ( 1 - n o r e p i n e p h r i n e , 1 - a r t e r e n o l ) , 1 - i s o p r o t e r e n o l , a c e t y l c h o l i n e 
c h l o r i d e , s e r o t o n i n ( 5 - h y d r o x y t r y p t a m i n e H C l ) , γ - a m i n o - n - b u t y r i c a c i d (GABA), 
о 
L - p r o l y 1 - L - l e u c y 1 - g l y c i n a m i d e (PLC), (Arg ) v a s o t o c i n and ( d , 1Jpropranolo l 
were purchased from Sigma. Phentolamine HCl ( r e g i t i n e ) was a g i f t from CIBA-
Geigy B.V. (Arnhem, The N e t h e r l a n d s ) . H a l o p e r i d o l was a g i f t from Dr. A.R. Cools 
(Department of Pharmacology, U n i v e r s i t y of Ni jmegen). Met-enkephal in was a g i f t 
from Organon B.V. (Oss, The Nether lands) and g-endorphin was o b t a i n e d from Penin­
sula . 
High-performance liquid ahronatography (UPLC) 
HPLC-separations were done on Spherisorb 10 ODS (250x4.6 mm i . d . ) w i t h a f l o w 
r a t e of 2 ml/min and 0.5~min f r a c t i o n s were c o l l e c t e d . The e l u t i o n g r a d i e n t (see 
F i g . 1) c o n s i s t e d of 0.5 M f o r m i c a c i d , 0.14 M p y r i d i n e (pH 3.0) as the pr imary 
s o l v e n t A and 1-propanol as the secondary s o l v e n t B. For f u r t h e r chromatographic 
d e t a i l s see [19] . 
Procedure of nicrosuperfusion incubation 
In a l l s u p e r f u s i o n exper iments in which the i n f l u e n c e of secretagogues was 
examined, n e u r o i n t e r m e d i a t e lobes of b lack-adapted Xenopus laevis were used. 
F o l l o w i n g pulse i n c u b a t i o n of two n e u r o i n t e r m e d i a t e lobes f o r 1.5 h in 50 μΐ i n ­
c u b a t i o n medium ( c o m p o s i t i o n : 112 mM NaCl , 2 mM KCl, 2 mM C a C l , , 15 mM Hepes, 
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bovine serum albumin 0.3 mg/ml, glucose 2 mg/ml, pH 7.38) containing kO pCi 
[ H]lysine, lobes were transferred to the microsuperfusion apparatus and chase 
incubation medium (containing 2 mM L-lysine) was pumped through the chamber. 
To study the influence of a particular secretagogue on release of the newly 
synthesized peptides, the substance was dissolved at the proper concentration 
in part of the chase incubation medium just before use. At the appropriate 
time, after collection of the control fraction Fl, the reservoir containing 
the chase medium was substituted by the reservoir containing incubation medium 
plus secretagogue and following a 20-min perfusion, fraction F2 was collected. 
Then, control medium was pumped through again and, following 20 min, the second 
control fraction, F3, was collected. Immediately after collecting them, the 
superfusion fractions were analyzed with HPLC. To characterize the receptors 
involved in the response to the catecholaminergic secretagogues, selective an­
tagonists (phentolamine, propranolol, haloperidol) were used. The medium con­
taining the antagonist was added immediately after the collection of Fl and 
pumped through for a period of 10 min. Then,the medium containing both the an­
tagonist and the catecholamine was pumped through. To prevent oxidation of do­
pamine, (nor)adrenaline, isoproterenol and serotonin during the experiments, 
the medium contained 1 mg/1 ascorbic acid throughout these experiments. Sepa­
rate experiments had shown that ascorbic acid (l mg/1) did not have an effect 
2+ + 
on release. In all experiments in which the concentration of Ca or К was 
the variable, isotonicity of the medium was maintained by adjusting the mola­
rity of NaCl. In the course of the investigation, several control experiments 
were conducted, e.g. to examine the normal chromatographic profile of the lobe 
peptides or to follow the normal curve of total release. 
A quantitative analysis of the results was made as follows. For each peak in 
the chromatographic profiles the three highest cpm-values were added and taken 
as the peak value. The difference between the peak values for corresponding 
peaks in the two profiles (Fl and F2) was expressed as a percentage of the 
value of the Fl-peak. In most cases, these percentages were approximately the 
same for all peaks in a particular profile and, thus, could be averaged to yield 
the approximate percentage inhibition or stimulation. 
After each superfusion experiment the lobes were removed and homogenized in 
500 μΐ 0.1 M HCl. The homogenate was centrifuged (5 min, 10.000 g) and the 
supernatant was frozen at -20 oC until HPLC-analys i s . 
For further details of the microsuperfusion technique, including the designation 
of the fractions Fl, F2 and F3, see [8] or Chapter VI. 
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RESULTS 
In all superfusion experiments the control fractions Fl gave chromatographic 
profiles which were essentially the same (i.e. with regard to number and elu-
tion times of the peaks as well as the peak heights relative to one-another) as 
those of the fractions Π reported earlier ([8], Chapter Vl). Therefore, the 
peaks are indexed accordingly. Most of the products have been characterized in 
previous studies [18, 20]. In the lobe, product I is a γ,-melanotropin-like pep­
tide, product II is des-Na-acety1-a-MSH, products IV and V are CLIPs and pro­
ducts VII and VIII are endorphins. Product XI functions as the precursor for 
these peptides and was designated pro-opiomelanocortin. For the medium, the in­
dices refer to the same products except with regard to number IV which in the 
medium is a mixture of CLIP (lobe product IV) and a-MSH (the acetylated lobe 
product II [21]). 
Effects of adrenerg-ia agents: adrenaline, noradvenaline and isoyvotevenol 
Adrenaline in a concentration of 10 M caused an almost complete inhibition 
of release of newly synthesized products. All products were inhibited to the 
same degree, except product XI, the prohormone (Fig. la). That the inhibitory 
effect was reversible is clear from the fact that the amount of peptides collec­
ted in the second control fraction (F3) had increased, and was ^ 50% of the amount 
found in Fl (Fig. lb). Noradrenaline, at 10 M, produced a similar inhibition, 
-8 
that was also reversible. At concentrations of 10 M both adrenaline and nor­
adrenaline exerted a reduced inhibitory effect, while at concentrations of 10 M 
no effects were observed (Fig. 3)· The selective (S-adrenerg ¡c agonist isoprotere-
-4 -8 
nol, in concentrations of 10 M and 10 M, caused an inhibition of release of 
^55% and 20%, respectively. At a concentration of 10 M, this synthetic cate-
cholamine brought about an increase in release of тЛЗ^ (Fig. 2). In view of these 
results it was decided to investigate the possible involvement of a- and ß-adre-
-8 
nergic receptors. Specific blocking agents were used in combination with 10 M 
isoproterenol as with this last concentration it would be possible to detect a 
deviation in either direction from a 20%-inhibition. Isoproterenol in combina-
tion with the g-Ыоскег propranolol (2.10 M) produced an inhibition of peptide 
-8 
release of ^ 50%. In combination with the α-Ыоскег phentolamine (3·10 M or 
10 M), isoproterenol caused an inhibition of ^ 30% (Fig. 3)· When given alone, 
neither propranolol nor phentolamine in the concentrations indicated above affec­
ted the release (data not shown). In all cases the release of the prohormone was 
hardly affected. Analyses of the various lobe extracts, prepared after termina­
le 
cpm · 10" 
• control ( F l ) 
• 1 0 " 5 M adrenaline (F 2) 
50 
time (mm) 
Figure 1. HPLC a n a l y s i s showing the e f f e c t of a d r e n a l i n e on the r e l e a s e of [ * Н ] l y s i n e - l a b e l led pep­
t i d e s from n e u r o i n t e r m e d i a t e lobes of black-background-adapted X. Іае ъз. (a) chromatographic p r o ­
f i l e s of c o n t r o l f r a c t i o n F1 and f r a c t i o n F2, c o l l e c t e d during superfusion w i t h 10 M a d r e n a l i n e ; 
(b) chromatographic p r o f i l e of (second) c o n t r o l f r a c t i o n F3. The HPLC e l u t i o n g r a d i e n t used is 
shown in the lower graph ( · · ) . For f u r t h e r chromatographic d e t a i l s , see M a t e r i a l s and methods. 
t i o n of the e x p e r i m e n t s , showed the same chromatographic p r o f i l e s as o b t a i n e d 
in the c o n t r o l e x p e r i m e n t s . 
Effect of dopamine 
Dopamine in a c o n c e n t r a t i o n of 10 M caused an i n h i b i t i o n of re lease of 
-ft - 1 π 
^95%, which appeared t o be r e v e r s i b l e . In c o n c e n t r a t i o n s of 10 M and 10 M, 
dopamine produced i n h i b i t i o n of ^30% and ^5%, r e s p e c t i v e l y . In combinat ion w i t h 
-8 i t s s p e c i f i c a n t a g o n i s t h a l o p e r i d o l (5·10 M), dopamine in a c o n c e n t r a t i o n of 
-8 10 M had no e f f e c t ( F i g . 3 ) . When given a l o n e , h a l o p e r i d o l d i d not i n f l u e n c e 
r e l e a s e . No e f f e c t s of the t reatments were noted on the chromatographic p r o ­
f i l e s of the lobe e x t r a c t s . 
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time (min) 
Figure 2. HPLC analysis showing the effect of isoproterenol in concentrations of (a) 10 M, (b) 
10 M, (c) 10 M, on the release of [ H]lys¡ne-label led peptides from neurointermediate lobes 
of Ыаск-background-adapted X. laevis. In each case, the chromatographic profiles of control frac­
tion Fl and fraction F2 (collected during superfusion with isoproterenol) are shown. The HPLC elu-
tion gradient used is the same as illustrated in Fig. 1. 
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Figure 3. Effects of adrenaline, noradrenaline, isoproterenol and dopamine on the total release of 
[ H]lysine-labelled peptides from neurointermediate lobes of Ыаск-background-adapted X. laevis. 
On the basis of the HPLC profile of the fractions F2, collected in the superfusion experiments, for 
each peptide the release was calculated as a percentage of the corresponding peak in the control 
profile Fl. The average of all percentages of a profile is presented as a column in the figure (see 
also Materials and methods). In the case of isoproterenol, the combined effects of this secretago-
gue with the ß-adrenergic antagonist propranolol in a concentration of 2.10 M (fì-Ыоск) , or with 
-8 
the α-adrenergic antagonist phentolamine in a concentration of 3.10 M (а-Ыоск) was also analysed 
In the case of dopamine, the combined effect of this substance with the dopaminergic antagonist ha-
-8 
loperidol in a concentration of 5.10 M (D-block) was also studied. 
Effects of other neurotransmitters: acetylcholine, serotonin and y-anrlnobutyric 
acid (GABA) 
Acetylcholine in concentrations of either 10 M, 10 M or 10 M had no 
effect on release. Serotonin, in a concentration of 10 M, produced an inhibi­
tion of ^18%. GABA caused a differential effect. When calculated as an average 
for all peptides, inhibition by 10 M GABA was ^5%, but the release of pro­
duct I was inhibited by ^65%. The effect appeared to be reversible: the F3-
value averaged for all peptides was ^ 60% of that of the F1-value while the F3-
value for product I was conspicuously higher, namely ^75% of the corresponding 
F1-value. The above results are summarized in Table 1. The chromatographic 
profiles of the lobe extracts did not differ from those of the controls. 
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Table 1. Effects of some potential secretagogues on the release of [ H]lysine-labelled peptides 
from neurointermediate lobes of black-background-adapted X. laevis. On the basis of the HPLC pro-
file of fraction F2, collected during superfusion with a secretagogue, for each peptide the re-
lease was calculated as a percentage of the corresponding peak ¡n the profile of the control frac-
tion Fl. The percentages for the various peaks were averaged and yielded the percentage effect 
presented below. 
Var iab le 
a c e t y l c h o l i n e 
serotonin 
γ - a m i n o b u t y r i c a c i d (GABA) 
L - p r o l y l - L - l e u c y l - g l y e i nam i de (PLG) 
vasotocin 
B-endorphin 
met-enkephal in 
increased К ( lOx) 
increased К ( lOx) + h a l o p e r i d o l 
C a 2 + - f r e e 
decreased C a 2 + ( lOx) 
increased Ca ( lOx) 
Concentrât 
io"5 M, io' 
I O " 5 M 
10" 5 M 
3 , 5 . I O " 6 M 
io"6 M 
io"5 M 
2 . 1 0 " 7 M 
20 mM 
20 mM + IO' 
-
0 .2 mM 
20 mM 
¡or 
Τ 
-6 
ι 
м, ю"
1 0
 м 
M 
E f f e c t 
no e f f e c t 
18% i n h i b i t i o n 
4 5 1 i n h i b i t i o n * 
25% i n h i b i t i o n 
20% i n h i b i t i o n 
no e f f e c t 
no e f f e c t 
90? i n h i b i t i o n 
90% i n h i b i t i o n 
90% i n h i b i t i o n 
80% i n h i b i t i o n 
k0% i n h i b i t i o n 
л
 inhibitory effect on the release of product I was "&$% 
Effects of peptide agents: L-prolyl-L-leucyl-glycinamide (PLG), vasotonin, 
B-endorphin and mei-enkephalin 
PLG in a c o n c e n t r a t i o n of 3,5.10 M gave an i n h i b i t i o n of re lease of ^25%. 
Vasotocin in a c o n c e n t r a t i o n of 10 M i n h i b i t e d re lease by ^20%. N e i t h e r g-en-
dorphin in a c o n c e n t r a t i o n of 10 M nor 2.10 M met-enkephal in a f f e c t e d r e ­
l e a s e . These r e s u l t s are given in Table 1 . The p r o f i l e s of the lobe e x t r a c t s 
were the same as the c o n t r o l p r o f i l e s . 
+ 2+ 
Effects of changes in К - and Ca -aoncentratio-ic 
The normal К -concentration of the incubation medium is 2 mM. A ten-fold in­
crease of this concentration resulted in a ^90% inhibition of release; this 
effect was reversible. To investigate whether the effect of high К was a direct 
one on the MSH cells or came about via an action on dopaminergic axon-terminals, 
the experiment was repeated in the presence of the dopamine receptor blocker 
haloperidol (10 M ) . In this case again a ^90% inhibition was recorded (Table 
1). The chromatographic profiles of the lobe extracts were the same as those of 
control lobe extracts. 
2+ 
The normal Ca -concentration in the perfusion medium is 2 mM. Omittance of 
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2+ Ca from the medium caused an i n h i b i t i o n of re lease of ^90%. A decrease of the 
2+ Ca t o o n e - t e n t h of the normal c o n c e n t r a t i o n r e s u l t e d in an ^80% i n h i b i t i o n . 
2+ A t e n - f o l d increase of the Ca - c o n c e n t r a t i o n caused a ^ О ^ i n h i b i t i o n (Table 
2+ 
l ) . The e f f e c t s o f changes in Ca - c o n c e n t r a t i o n were r e v e r s i b l e . The chroma­
t o g r a p h i c p r o f i l e o f the lobe e x t r a c t a t the end of the s u p e r f u s i o n experiment 
2+ 
w i t h h igh Ca was the same as those of the c o n t r o l t i s s u e . The p r o f i l e s of 
Figure 4, HPLC a n a l y s i s of [ H ] l y s i n e - l a b e l l e d p e p t i d e s present in the n e u r o i n t e r m e d i a t e lobes of 
X, Іае гз a f t e r completion of superfusion e x p e r i m e n t s , ( a ) Chromatographic p r o f i l e of c o n t r o l lobe 
p e p t i d e s (no secretagogue added) from black-background-adapted a n i m a l s ; (b) chromatographic p r o f i l e 
of lobe p e p t i d e s from black-background-adapted a n i m a l s , where Ca was o m i t t e d from the superfusion 
medium d u r i n g the " F 2 - p e r i o d M ; (c) chromatographic p r o f i l e of lobe p e p t i d e s from white-background-
adapted a n i m a l s ; the lobes had been submitted to superfusion w i t h o u t secretagogues. The HPtC e l u -
t i o n g r a d i e n t used is the same as i l l u s t r a t e d in F i g . 1 . 
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extracts from lobes exposed to low Ca or incubated in medium without Ca 
clearly deviated from the profiles of control lobes, both qualitatively and 
quantitatively. With the exception of peak IV, all peaks were reduced and, 
moreover, an indication of a new peak, indexed IVa, had appeared (Fig. ^a, b ) . 
This pattern was strongly reminiscent of the profile noted in earlier super-
fusion experiments with lobes from white-adapted toads; a characteristic 
chromatographic profile of such lobes from white-adapted animals is shown in 
Fig. kc (in these last animals both the biosynthetic activity in the pars In­
termedia and the release of peptides is very low, relative to these processes 
in Ыаск-adapted animals). The nature of the product represented by peak IVa 
remains to be established. Since it did not contain tryptophan (data not shown) 
product IVa ¡s not an MSH-like peptide. 
DISCUSSION 
In the control of hormone secretion by the pituitary gland two classes of 
catecholaminergic receptors have been implicated: dopaminergic and adrenergic 
receptors. Indications for the presence of dopamine receptors on the membranes 
of the pars intermedia cells in Xenopus laevis have been found earlier [5-8]. 
The results of our superfusion experiments, showing that a dopamine-induced 
inhibition of peptide release can be prevented by the dopamine antagonist ha-
loperidol, demonstrate that dopamine receptors are indeed Involved in the con-
trol mechanism. In general, two groups of dopamine receptors have been distin-
guished [22]. One group appeared to be coupled to the enzyme adenylate cyclase 
(type D.) and, thus, for this type adenosine 3',5'-monophosphate (cyclic AMP) 
acts as the intracellular mediator. The other group, not involving cyclic AMP 
but otherwise not well defined, are the D.-receptors. Our results, in combi-
nation with an earlier observation that cyclic AMP stimulates release of pars 
intermedia peptides [8], lead to the conclusion that the dopamine receptors 
on the MSH cells in Xenopus are not of the D^type. In a study with the rat 
pars intermedia, it has been concluded that only dopamine D.-receptors are 
present [23] . 
The notion for a role of adrenergic receptors in controlling the pars in-
termedia of amphibians, stems from pharmacological studies concerning MSH re-
lease in the frog [11]. The clear inhibition of release of newly synthesized 
products from neurolntermedlate lobes of Xenopus laevis by adrenaline and nor-
adrenaline also points to the involvement of adrenergic receptors. 
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With regard to a response to catecholamines, a- and ß-adrenergic receptors may 
be d i s t i n g u i s h e d [2k] . The potency order concerning t h i s response is f o r α - r e ­
c e p t o r s : a d r e n a l i n e > n o r a d r e n a l i n e > i s o p r o t e r e n o l ; f o r (3-receptors : i s o p r o ­
t e r e n o l > a d r e n a l i n e > n o r a d r e n a l i n e [ 2 5 ] . B inding of an a g o n i s t t o (3-adreno-
c e p t o r s leads t o a c t i v a t i o n of adenylate c y c l a s e [ 2 5 ] . Agonist b i n d i n g t o a-
adrenoceptors may be f o l l o w e d by an i n h i b i t i o n of adeny late c y c l a s e a c t i v i t y 
[ 2 6 ] . We presume t h a t the r e l e a s e - i n h i b i t i o n by ( n o r ) a d r e n a l i n e observed in 
the pars intermedia of Xenopus was brought about through b i n d i n g t o a-adreno-
c e p t o r s , s ince b i n d i n g t o ß-adrenoceptors - a t l eas t accord ing to the above-
mentioned theory - would have led to an i n t r a c e l l u l a r accumulat ion of c y c l i c 
AMP; t h i s increase in c y c l i c AMP would have caused a s t i m u l a t i o n of pept ide 
re lease [8 ] ra ther than an i n h i b i t i o n . I t has, however, been shown tha t a-
adrenerg ic agon is ts may b ind to dopamine receptors [27] and, t h e r e f o r e , the 
p o s s i b i l i t y cannot be excluded tha t the observed i n h i b i t o r y e f f e c t of ( n o r ) -
ad rena l ine was e f f e c t u a t e d through dopamine recep to rs . 
In view of the known s p e c i f i c a f f i n i t y of i sopro te reno l f o r ß-adrenoceptors, 
the observed i n h i b i t o r y e f f e c t , at leas t when t h i s s y n t h e t i c catecholamine was 
-4 -8 
admin is te red in concen t ra t i ons of 10 M or 10 M, was somewhat s u r p r i s i n g . 
The observa t ions tha t i sopro te reno l in a concen t ra t i on of 10 M s t imu la ted 
re lease and tha t the s p e c i f i c ß-b lock ing agent p roprano lo l p o t e n t i a t e d the ¡n -
-8 h i b i t o r y e f f e c t of 10 M i s o p r o t e r e n o l , suggest tha t ß-adrenoceptors, present 
on the c e l l membrane, mediate the s t imu la to r y e f f e c t . In cons ide r i ng the de-
gree of s t i m u l a t i o n - which was on ly ^15% - i t must be r e a l i z e d tha t f u l l y 
Ыаск-adapted animals were used; in such animals t h e r e is a very h igh r a t e of 
re lease [28] which makes i t d i f f i c u l t t o demonstrate the e f f e c t of a s t i m u l a ­
t o r y a g e n t . The q u e s t i o n remains how to e x p l a i n the i n h i b i t o r y e f f e c t of i s o ­
p r o t e r e n o l a t h igher c o n c e n t r a t i o n s . B inding of i s o p r o t e r e n o l t o α-adrenocep­
t o r s , and in t h i s way causing r e l e a s e - i n h i b i t i o n , is u n l i k e l y as b l o c k i n g of 
these r e c e p t o r s w i t h phentolamine d i d not reduce the i s o p r o t e r e n o l - i n d u c e d i n ­
h i b i t i o n . Indeed, i t is known t h a t i s o p r o t e r e n o l has o n l y an extremely low 
a f f i n i t y f o r a-adrenoceptors [ 2 9 ] . Rather, we would l i k e t o p o s t u l a t e t h a t i s o ­
p r o t e r e n o l in h i g h c o n c e n t r a t i o n s e n t e r s i n t o a n o n - s p e c i f i c i n t e r a c t i o n w i t h 
the ß-adrenoceptor , which r e s u l t s in an a n t a g o n i s t i c e f f e c t . Such behaviour is 
known fo r drugs i n t e r a c t i n g w i t h c h o l i n e r g i c r ecep to r s , e . g . p i l o c a r p i n e in 
low doses ac ts as an a g o n i s t , but in high doses may act as an an tagon is t [ 3 0 ] . 
An a n t a g o n i s t i c e f f e c t of i sopro te reno l in i t s e l f , however, does not exp la in 
the observed i n h i b i t i o n . The re fo re , we wish to hypothesize tha t the h igh leve l 
of 'spontaneous' re lease c h a r a c t e r i s t i c a l l y observed f o r the pars intermedia 
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of Ыаск-adapted animals ¡s ¡π fact partially caused by a stimulatory agent 
present in the incubated tissue and which acts via the ß-adrenoceptor. The sti-
mulatory effect of this hypothetical agent would be partially abolished by the 
antagonistic action of isoproterenol in concentrations higher than 10 M. 
The fact that, unlike isoproterenol, neither adrenaline nor noradrenaline at a 
concentration of 10 M had a stimulatory effect may be attributed to the 
lower affinities of these catecholamines, as compared to isoproterenol, for 
the ß-adrenoceptor. 
The existence of a cholinergic stimulatory control of the pars intermedia, 
possibly through an indirect mechanism, was first suggested on the basis of 
effects of injecting acetylcholine on MSH release in frogs [31]. An electron-
microscopic study, revealing the presence of apparently cholinergic axonal 
vesicles in the pars intermedia of the same species, likewise suggested possi-
ble cholinergic control [lA]. Cholinergic stimulation of in vitro release of 
bioactive MSH in Rana pipiens has been reported by Hadley at al. [12]. Our 
failure to demonstrate an effect of acetylcholine, administered in three dif-
ferent concentrations, is not in agreement with the above concept. 
Similarly, the slight inhibitory effect on peptide release observed with sero-
tonin in our superfusion experiments with Xenopue seems to be at variance with 
the stimulation of in vitro MSH release caused by this ¡ndoleamine in Rana pi-
piens [32] and in the lizard Anolis aarolinensis [33]· 
A direct role of GABA on cells of the pars intermedia has been proposed to ex-
plain the inhibitory effect of this neurotransmitter on the release of bio-
assayable MSH in Rana pipiens [32]. Our results, showing an appreciable, rever-
sible inhibition of release by GABA, also suggest that this amino acid neuro-
transmitter has a role in the regulation of the pars intermedia. This could be 
a direct effect on the MSH cells or the result of an action of GABA on axon 
terminals involved in controlling MSH release. The relatively strong inhibition 
by GABA of product I (γ,-melanotropin-1 ike peptide) is reminiscent of the dif­
ferential effect on peptide release exerted by guanosine 3 !.5'-monophosphate 
(cyclic GMP)(see appendix to this chapter). Whether there is a relationship be­
tween these phenomena remains to be established. 
Two groups of investigators [15, 16] have claimed that the inhibitory con­
trol of MSH release by the hypothalamus is mediated by peptides, referred to 
as MSH release inhibiting factors (MIFs). The synthetic equivalent of the C-
terminal tripeptide of the neurohypophysial hormone oxytocin,L-prolyl-L-leucyl-
glycinamide (PLG), was found to be the most potent MIF [ЗА]. Moreover, an en­
zyme from the hypothalamus appeared to stimulate the conversion of oxytocin to 
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PLG [35]· Studies on several species, including the frog, failed, however, to 
show an inhibitory effect of PLG on MSH release from the pars intermedia [17, 
З6, 37]· The inhibition exerted by PLG on the release of newly synthesized 
MSHs, CLIPs and endorphins observed in our experiments suggests that in Ápr.o-
pus this tripeptide may have a regulatory function. However, the degree of the 
inhibitory effect indicates that as a MIF, PLG is far less effective than the 
catecholamines. 
In the rat pars intermedia the presence of opiate receptors has been postu-
lated to explain the stimulatory effects of g-endorphin and met-enkephalin on 
release of MSH [38]. On the other hand, there are also indications that in 
this species a stimulatory effect of ß-endorphin on MSH release involves a 
central opiate receptor-mediated mechanism which possibly affects the dopamin-
ergic control of the pars intermedia [39]. Our results indicate that in Xer.opus 
there are no opiate receptors on the MSH cells; our data do not permit us to 
draw any conclusion with regard to a possible indirect role for endogenous 
opiates. 
The observed inhibition of peptide release by an increasedK -concentration 
is in agreement with the inhibition of MSH release by high levels of this ¡on 
noted in studies with the rat [kO] and the frog [32]. It should be added, how-
ever, that other investigators report the absence of an effect of high К on 
MSH release [ Ή ] . Tilders et al. [42] found that high К did cause an inhibi­
tion of MSH release from incubated neurointermediate lobes of the rat but that 
in eel 1-suspensions of the pars intermedia such inhibitory effect of К was 
absent. They suggested that the release-inhibition in the intact tissue was 
mediated by К -induced secretion of dopamine from axon terminals. Indeed, when 
the dopamine receptor antagonist haloperidol was added, an increased К -concen­
tration failed to evoke inhibition of MSH release from incubated lobes. In con­
trast to these results, in our experiments with Хепоры neurointermed iate lobes 
haloperidol did not abolish the К -induced inhibitory effect and, thus, we 
assume that К exerted a direct effect on the MSH cells. We can only speculate 
on the nature of this effect. Studies with neurons have shown that increasing 
the К -concentration initially leads to membrane depolarization, accompanied 
2+ by opening of the Ca -channels, but only for a short period. During maintained 
2+ 
depolar izat ion, however, the Ca -channels are closed [43]. If a similar mecha­
nism were operative in MSH eel Is,the re would be an initial increase in peptide 
release followed by an inhibition during the period of maintained high К . In 
this respect the results of Davis and Hadley [32] are of interest because they, 
indeed, observed that in the frog pars intermedia, high К leads for a very 
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short period to an increase of membrane depolarization (with stimulation of MSH 
release as a result) immediately followed by membrane hyperpolar izat ion (resul­
ting in inhibition of release). In our experiments an initial stimulation of 
secretion could have taken place in the 20-min period between Fl and F2 and, 
thus, would not have been detected. 
Since the introduction of the concept of stimulus-secretion coupling [kk] nu-
2+ 
merous studies have provided evidence for a direct role of Ca in the secre­
tory mechanism, not only in neurosecretory cells but also in epithelial endo­
crine tissue. An appropriate stimulus, whether neuronal or hormonal, causes the 
2+ 2+ 
opening of Ca -channels in the membrane. The Ca -influx triggers the process 
of exocytosis by promoting transport of secretory granules and fusion of the 
granules with the cell membrane. The inhibition of peptide release which was 
2+ 2+ 
observed when the Ca -concentration of the medium was reduced or when Ca 
ions were omitted from the medium was therefore not unexpected. Similar results 
have been reported in studies concerning MSH release [Ί1, '(S, '•б]. It was, how-
2+ 
ever, somewhat surprising that also high Ca caused a fairly strong inhibition 
2+ 
of peptide release. Almost certainlyan increased Ca -concentration in the in­
cubation medium leads to a drastically increased level of free intracellular 
2+ Ca . It is not known, however, by what mechanism such a rise in intracellular 2+ Ca would cause a deleterious effect on the process of secretion. 
One would expect that the release-inhibi tory effect of exposing the neurointer-
2+ 2+ 
mediate lobes to low Ca or a Ca -free medium would result in an accumulation 
of peptides in the lobes. In fact, a clear decrease in the quantity of peptides 
in the tissue was found. It is concluded that this decrease is the consequence 
of degradative processes. In this connection it is interesting to note that in 
cells of the bovine parathyroid gland a non-specific proteolysis of parathyroid 
2+ hormone (PTH) may take place; the proteolytic activity is dependent on the Ca 
concentration in the medium lk7] . It is noteworthy that peak IVa was found in 
the lobe extract but not in the medium, neither during the F2-period, nor during 
the F3-phase and, thus, it is not a release-product. Possibly IVa represents a 
product resulting from intracellular degradation. However, the fact that this 
peak was also found in the lobe of white-adapted Xenopus points to the possibi­
lity that it represents a product with some physiological significance. The si­
milarity between the profiles of lobe peptides in calcium deficient pars inter­
media from Ыаск-adapted animals and that in white-adapted animals prompts the 
interesting question whether perhaps in white-adapted animals the pars inter-
2+ 
media cells have a lower Ca -concentration than those in Ыаск-adapted ani­
mals. 
12Í» 
The investigations reported in this chapter are a preliminary survey of pos­
sible regula tory factors of the pars intermedia of Xenopiifs. Nevertheless, a few 
conclusions may be drawn. In Xenopi'S, the secretory activity of the pars inter­
media appears to be primarily under inhibitory control, which seems to be me­
diated by dopaminergic and α-adrenergic receptors. In addition, an indication 
for the existence of a stimulatory control via S-adrenoceptors was found. It 
should be emphasized that our analyses were conducted with incubated tissue 
and it is obvious that in the living animal the regulatory mechanism may be 
more complex and could well involve substances which failed to show an effect 
in our in vitro system. Any secretagogue which exerted an inhibitory effect 
on release, appeared to cause an inhibition of all peptides and, moreover, 
with the possible exception of one of the secretagogues tested (GABA), in each 
case the inhibitory effect was the same for all these peptides. We earlier re­
ported that the stimulatory effect of cyclic AMP also involved all newly syn­
thesized peptides [8]. Thus, in the pars intermedia of Xenovus laevis, there 
seems to occur concomitant release and coordinate control of all products. 
That the various secretagogues affected this release process and not the pro­
cessing of the prohormone (at least not in a qualitative sense) is evident 
from the fact that no alterations in the chromatographic profiles of the lobe 
peptides occurred. Finally, it is important to realize that this study con­
cerned the regulation of release of newly synthesized peptides. The question 
may be asked whether the conclusions from our results are applicable to the 
general regulation of the complete 'stores' of the various products (i.e. in­
cluding the preformed peptides). This question is the subject of the investi­
gation reported in the next chapter. 
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APPENDIX 
IS CYCLIC GMP INVOLVED IN SELECTIVE CONTROL OF RELEASE 
OF NEWLY SYNTHESIZED PEPTIDES FROM THE PARS INTERMEDIA? 
In the preceding chapter it was shown that the pars intermedia of Xenopus 
lacvis concomitantly releases newly synthesized peptides derived from pro-opio-
melanocortin into the incubation medium. Moreover, the in vitro release of 
these products appeared to be coordinately controlled by a variety of secreta-
gogues. In the course of the superfusion experiments the influence of guanosine 
3',5'"monophosphate (cyclic GMP) was also tested. Although the secretion of 
most peptides was not affected, cyclic GMP inhibited the release of product I 
by ^85%, and the release of product IV by ^35% (Pig. 1a,b). Product I is a γ,-
melanotropin-1ike peptide (γ,-MSH; Chapter III). Product IV, as found in the 
medium, usually is a mixture of two co-eluting products, namely a-melanophore 
stimulating hormone (ot-MSH) and one of the two cort icotrop in-1 ike intermediate 
lobe peptides (CLIP). To investigate to what extent the release of a-MSH and 
of this CLIP was affected by cyclic GMP, tryptic maps of medium product IV 
were prepared, following a labelling experiment with [ H]lysine, [ H]tyrosine, 
[ H]phenylalanine and [H]tryptophan. Tryptic digestion of medium product IV 
obtained from control neurointermediate lobes yielded a tryptic map consisting 
of four peaks. The elution times of two of these peaks corresponded exactly to 
those of the fragments obtained by tryptic digestion of the CLIP-like product, 
while the elution times of the other two peaks were identical to those of the 
tryptic fragments from α-MSH. From the heights of these four peaks it could be 
calculated that medium product IV consisted for ^SOt of CLIP and for ^50% of 
α-MSH; this proportion confirms earlier unpublished results of electrophoretic 
analysis of medium product IV. After incubation of lobes in the presence of 
cyclic GMP, medium product IV yielded a tryptic map consisting of two major 
and two minor peaks. The two major peaks corresponded to tryptic fragments of 
CLIP and the two minor peaks corresponded to fragments obtained from α-MSH 
(data not shown). From the results it could be calculated that cyclic GMP had 
caused a 70% inhibition of the release of α-MSH, while the release of the CLIP-
like product was hardly affected. A separate superfusion experiment, whereby 
[ H]tryptophan was used (an amino acid incorporated in α-MSH but not in CLIP) 
showed that cyclic GMP inhibited the release of α-MSH by "¿OZ. The release-
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Figure J. HPLC a n a l y s i s showing the e f f e c t of c y c l i c GMP on the r e l e a s e of [ H ] l y s i n e - l a b e l l e d pep­
t i d e s from n e u r o i n t e r m e d i a t e lobes of black-background-adapted X. laevis. (a) chromatographic p r o ­
f i l e of c o n t r o l f r a c t i o n F l ; (b) chromatographic p r o f i l e of f r a c t i o n F 2 ? c o l l e c t e d during super-
f u s i o n w i t h c y c l i c GMP (6 mM); (c) chromatographic p r o f i l e of (second) c o n t r o l f r a c t i o n F3. The 
HPLC e l u t i o n g r a d i e n t used is the same as t h a t shown in F i g . 1 of Chapter V I I . 
i n h i b i t i o n by c y c l i c GMP appeared t o be r e v e r s i b l e w i t h regard t o both γ,-MSH 
and a-MSH ( F i g . 1 c ) . 
The i n f l u e n c e of c y c l i c GMP on the re lease of the MSHs (products I and I V ) , 
CLIPs (products IV and V) and endorphins (products VI I and V i l i ) is summarized 
in F i g . 2. This f i g u r e i l l u s t r a t e s t h a t c y c l i c GMP s p e c i f i c a l l y i n h i b i t e d the 
re lease of the MSHs, l e a v i n g the re lease of the CLIPs and endorphins almost un­
a f f e c t e d . 
A second o b s e r v a t i o n made d u r i n g the s u p e r f u s i o n experiments was t h a t admin-
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Figure 2. Effects of c y c l i c GMP on the release of three groups of peptides from neurointermediate 
lobes of Ыаск-background-adapted X. laevie. This f i g u r e is a q u a n t i f i c a t i o n of F ig. 1, comparing 
the amounts for the three groups of peptides indicated. The ca lcu lat ions for the t o t a l amounts of 
CUP-related peptides and of MSH-related peptides were possible since i t was known that medium 
product IV in the control superfusion f r a c t i o n Fl consisted f o r yïOÏ of CLIP and for i-SOfc of a-MSH 
and that superfusion with cyc l i c GMP caused a 70% inh ib i t i on of release of a-MSH while th i s nucleo-
t ide had almost no e f fec t on the release of CLIP (see also t e x t ) . 
i s t r a t i o n of c y c l i c GMP resu l t ed in the appearance of two new products in the 
medium; they were indexed la and I l a ( F i g . 1 a , b ) . The HPLC e l u t i o n times of 
these products were lA min and 16 min, r e s p e c t i v e l y . Omi t t i ng the c y c l i c nu -
c l e o t i d e from the super fus ion medium led to a r e s t o r a t i o n of the o r i g i n a l (con-
t r o l ) pept ide p r o f i l e ( F i g . 1c ) . Ana lys is of the lobe e x t r a c t prepared at the 
end o f the experiment revealed tha t t reatment w i t h c y c l i c GMP d id not have an 
e f f e c t on the chromatographic p r o f i l e of the lobe pept ides (data not shown). 
A separate experiment showed tha t both products la and I l a conta ined t r y p t o -
phan. To i n v e s t i g a t e whether the two new products represent pept ides tha t are 
a l so found in the c o n t r o l s but have undergone s l i g h t m o d i f i c a t i o n s , t r y p t i c 
and chymot ryp t i c maps o f these products were made f o l l o w i n g l a b e l l i n g w i t h 
Э "1 Э "3 
[ H]lysine, [ H]tyrosine, [ H]phenylalanine and [ H]tryptophan. Tryptic and 
chymotryptic digestion of product la yielded only one labelled fragment, elu-
ting at 22 min and 23.5 min, respectively (Fig. 3a). Tryptic digestion of pro­
duct I la produced four major radioactive peaks, eluting at 10 min, 16.5 min, 
20.5 min and 23.5 min. Chymotryptic digestion of product Ila gave six labelled 
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Figure 3. HPLC analysis of t r y p t i c and chymotryptic digests of (a) product la and (b) product I la 
found in the Tedium during superfusion wi th c y c l i c GMP. Lobes were label led wi th a mixture of [ H]-
l y s i n e , ι H j tyros ine, [ Hjphenylalanine and [ H ] t r y p t o p h a n . Enzymatic digestions were for 16 h at 
370C. Other d e t a i l s concerning the enzymatic digestions and the HPLC e l u t i o n gradients used in the 
peptide mapping may be·found in Chapter I I . 
fragments e l u t i n g at 3.5 min, 5-5 п і п , 9.5 m i n , 12 min, 16.5 min and 20.5 min 
( F i g . 3 b ) . Comparison o f the t r y p t i c and c h y m o t r y p t i c maps o f products la and 
I l a w i t h maps produced by t r y p t i c or c h y m o t r y p t i c d i g e s t i o n of products I , I I , 
IV, V, V I I and V I I I (see Chapter l | ) , f o l l o w i n g l a b e l l i n g w i t h the same f o u r 
[ H]amino a c i d s , r e v e a l s t h a t products la and I l a produce maps t h a t are very 
d i f f e r e n t from any one of the maps of products l - V I I I . 
Al though one is i n c l i n e d t o t h i n k t h a t products la and I l a might be modi­
f i e d forms of γ -MSH and a-MSH, these l a t t e r p e p t i d e s being d r a s t i c a l l y r e ­
duced in the medium, the mapping a n a l y s i s suggests t h a t these new products are 
s t r u c t u r a l l y very d i f f e r e n t from the two m e l a n o t r o p i n s . The i d e n t i t y of p r o ­
ducts la and I la remains t o be e s t a b l i s h e d . In c o n c l u s i o n , w h i l e c y c l i c GMP 
o b v i o u s l y a f f e c t e d the re lease of only two p r o d u c t s , i t is too e a r l y t o i m p l i ­
c a t e t h i s c y c l i c n u c l e o t i d e as a s e l e c t i v e i n h i b i t o r o f the re lease of p e p t i d e s 
from the pars intermedia o f Xcnopur latvia. 
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CHAPTER VI I I 
CONTROL OF RELEASE OF IMMUNOREACTIVE α-MSH 
FROM THE PARS INTERMEDIA OF XENOPUS LAEVIS 
SUMMARY 
This chapter deals with the release of α-MSH from the pars intermedia of the 
pituitary gland in black-background-adapted Xenopus laeûiu. The study was con-
ducted employing microsuperfusion of neurointermediate lobes and the amounts of 
α-MSH released into the medium were determined with a radioimmunoassay. The only 
products reacting with the antiserum were des-Na-acetyl-α-MSH, the major immuno-
reactive peptide in the tissue, and α-MSH, the predominant immunoreacti ve pep­
tide found in the incubation medium. 
Of the various potential secretagogues tested, cyclic AMP appeared to stimulate 
the release of α-MSH by ^0%; the catecholamines dopamine, adrenaline, noradre-
-4 -8 
nal ine and isoproterenol, in concentrations of 10 M and 10 M, induced a 
clear release-inhibition. At lower concentrations (10 M) dopamine had no 
effect while the other three catecholamines exerted a slight stimulation of re­
lease. It is concluded that inhibition of α-MSH secretion involves dopaminergic 
and α-adrenergic receptors while a stimulatory control is effectuated through 
ß-adrenergic receptors. 
The results of this investigation are compared with those of the preceding 
chapter concerning the control of release of newly synthesized peptides. From 
the comparison it is apparent that the effects of the various secretagogues on 
total α-MSH release are proportional to the effects on release of newly synthe­
sized α-MSH. It is concluded that at least with respect to α-MSH the pars in­
termedia in black-background-adapted animals does not contain distinct secre­
tory pools. 
INTRODUCTION 
The physiological role of melanophore stimulating hormone (MSH) in amphibi­
ans is the dispersion of melanosomes in dermal melanophores. Immunological 
evidence has indicated that the melanophore stimulating substance is structu-
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rally related to α-MSH [1-3]. Biosynthetic studies have recently shown that in 
the South African clawed toad, Xenov^n lac νιο, des-Na-acetyl-α-MSH functions 
as the immediate precursor for α-MSH with the acetylation taking place just 
prior to or during release [k]. Thus, newly synthesized α-MSH is only found 
as a released product. Des-Na-acetyl-α-MSH itself is synthesized through pro­
cessing of a prohormone, pro-opiomelanocortin [5]. During in vitro studies, 
all newly synthesized peptides are concomitantly released from Xenopue neuro-
intermediate lobes into the incubation medium and the regulation of release 
of these peptides takes place in a coordinated fashion ([6], [7], Chapters VI 
and VII). The question arises whether the release of newly synthesized pep­
tides under the various experimental conditions of added secretagogues is pro­
portional to the total release of products, i.e. the sum of newly synthesized 
and preformed ('stored') peptides. 
In the study reported here, we dealt with the above problem with reference to 
one of the pars intermedia products, namely the hormone α-MSH. In view of the 
fact that catecholamines as well as adenosine 3' ,5'-monophosphate (cyclic AMP) 
were shown to exert a clear effect on release of newly synthesized peptides 
(Chapters VI and VII), the same secretagogues were used in the present inves­
tigation. To permit a comparison with the earlier results, here too, black-
adapted animals were used. The effects of the secretagogues were analysed using 
the same microsuperfusion system as used before (Chapter VI), while the release 
of α-MSH was monitored with a radioimmunoassay. 
MATERIALS AND METHODS 
Animals 
F u l l y b lack-adapted Хепсрчз lacvia, bred and reared in the Department of 
Zoology, U n i v e r s i t y of Nijmegen, and of approx imate ly the same weight (25 g ) , 
were used. 
Procedure of iviarosuperfuuion incubation 
Three n e u r o i n t e r m e d i a t e lobes of Ыаск-adapted Xenopun laevin were r i n s e d 
in i n c u b a t i o n medium ( f o r composi t ion see [ 8 ] ) and t r a n s f e r r e d to the m i c r o -
superfus ion apparatus which has been descr ibed e a r l i e r [ 9 ] . Medium was pumped 
through the i n c u b a t i o n chamber a t approx imate ly О.85 ml/h (Cenco p e r i s t a l t i c 
pump) and 10-min f r a c t i o n s (l^O μ ΐ ) were c o l l e c t e d (LKB, Redirac, model 2112) 
in tubes c o n t a i n i n g 50 yl radioimmunoassay (RIA) b u f f e r ( f o r c o m p o s i t i o n , see 
ІЗ2 
below) and the enzyme i n h i b i t o r t r a s y l o l (25 KlU/m], B a y e r ) . To t e s t the i n ­
f l u e n c e of a secretagogue, a t the a p p r o p r i a t e time the s u p e r f u s i o n medium was 
s u b s t i t u t e d by a medium c o n t a i n i n g the secretagogue. The f r a c t i o n s were s t o r e d 
at i»0C u n t i l the l a s t f r a c t i o n was c o l l e c t e d and then the l e v e l of a-MSH in 
each f r a c t i o n was determined us ing a RIA. In the experiments w i t h dopamine, 
a d r e n a l i n e , n o r a d r e n a l i n e , and I - i s o p r o t e r e n o l , the medium c o n t a i n e d a s c o r b i c 
a c i d (1 mg/1, Merck) throughout the exper iment. Control experiments showed 
t h a t a s c o r b i c a c i d (1 mg/1) had no e f f e c t on release of a-MSH. A l l s e c r e t a g o -
gues were from Sigma. 
Нааіоі тгпоапзау 
A RIA f o r a-MSH was used t o determine MSH-levels. l o d i n a t i o n of a-MSH ( S i g -
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ma) w i t h Na [ I ] (Amersham) was performed w i t h the chloramine-T method as des-12S 
c r i b e d by Goos and Jenks [ 1 0 ] . Al iquots of the [ ^l]a-MSH were s t o r e d a t '•"C 
in 0.05 M T r i s b u f f e r pH 8 . 0 , c o n t a i n i n g 0.1% bovine serum albumin (Sigma) and 
0.1% NaN,. On the f i r s t day of the assay, 100 μΐ d i l u t e d r a b b i t a n t i s e r u m to 
a-MSH ( f i n a l d i l u t i o n 1:5000) and 50 μΐ [ 1 2 5 l ] a - M S H (approx imate ly 5000 cpm) 
were added t o 50-μ1 samples of a s e r i e s of t w o - f o l d d i l u t i o n s of a-MSH t o p r o ­
duce a standard curve or t o 50 μΐ t e s t samples. The d i l u t i o n of the a n t i s e r u m 
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was s e l e c t e d such t h a t a p p r o x i m a t e l y 50% of the [ l]a-MSH was bound in a 
c o n t r o l tube c o n t a i n i n g no competing a-MSH. A l l d i l u t i o n s were made w i t h RIA 
b u f f e r (0.01 M phosphate b u f f e r , pH 7-3, c o n t a i n i n g 0.1% albumin and 0 . U NaN,). 
The i n c u b a t i o n was conducted a t ^"C f o r 20 h. On the f o l l o w i n g day, s e p a r a t i o n 
of f r e e and bound t r a c e r was achieved us ing the dextran-coated charcoal method 
125 in which f r e e [ l]a-MSH becomes bound t o the charcoal w h i l e the immunocomplex 
remains in s o l u t i o n . The dextran-coated charcoal suspension c o n s i s t e d of RIA 
b u f f e r c o n t a i n i n g 0.25% Dextran T70 (Pharmacia), 2% charcoal (Merck) and 30% 
( /v) horse serum ( G i b c o ) . A f t e r a 15-min i n c u b a t i o n a t 0°C in the presence of 
c h a r c o a l , the r e a c t i o n tubes were c e n t r i f u g e d and the r a d i o a c t i v i t y in the 
p e l l e t was counted in an LKB gamma counter (model 1280, Ultrogamma). 
The standard curve f o r the RIA was made by p l o t t i n g the % i n h i b i t i o n of b i n d i n g 
of l a b e l l e d a-MSH (tube c o n t a i n i n g no unlabel led a-MSH was taken as 0% i n h i b i ­
t i o n ) versus the c o n c e n t r a t i o n s of a-MSH expressed as d i l u t i o n f a c t o r s of a 
standard a-MSH s o l u t i o n (2.5 n g / m l ) . The procedure f o r q u a n t i f y i n g the amount 
of a-MSH in each t e s t sample is as f o l l o w s . The % i n h i b i t i o n of b i n d i n g of l a ­
b e l l e d a-MSH caused by each t e s t sample was determined in t r i p l i c a t e and the 
average value was used t o d e t e r m i n e , v ia the l i n e a r p o r t i o n of the standard 
c u r v e , the amount of immunoreacti ve α-MSH in the sample. The s e n s i t i v i t y of the 
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assay was ^15 pg a-MSH/tube. 
The a n t i s e r u m to oc-MSH was r a i s e d a g a i n s t s y n t h e t i c a-MSH (Peninsula) c o n j u ­
gated w i t h g l u t a r a l d e h y d e t o bovine serum a l b u m i n . The c r o s s - r e a c t i v i t y w i t h 
the anti-a-MSH was minimal (<0.01%) w i t h ACTHCt-IO), weak (<2%) w i t h ACTH(l-lO) 
or p o r c i n e ACTH(l-39)i whereas des-Na-acety1-a-MSH had a c r o s s - r e a c t i v i t y of 
^15% ( a l l r e l a t i v e t o a-MSH). The above s y n t h e t i c p e p t i d e s were g i f t s from 
Organon I n t e r n a t i o n a l B.V., Oss, The N e t h e r l a n d s . 
As a f i r s t step in the c h a r a c t e r i z a t i o n of immunoreacti ve α-MSH in e x t r a c t s 
of Xenovvs n e u r o i n t e r m e d i a t e lobes and in medium in which lobes had been i n c u ­
b a t e d , displacement b i n d i n g s t u d i e s were conducted. In these s t u d i e s , t h r e e 
n e u r o i n t e r m e d i a t e lobes of b lack-adapted Хепор г, were incubated in 250 μΐ me­
dium f o r 2 h a t 220C on a Dubnoff metabol ic shaker. A f t e r the i n c u b a t i o n , the 
lobes were homogenized in 250 pi RIA b u f f e r , the homogenate and the medium were 
c e n t r i f u g e d , and t w o - f o l d d i l u t i o n s of the supernatants were made. The d i s p l a c e ­
ment b i n d i n g curves o b t a i n e d w i t h the t w o - f o l d d i l u t i o n s of lobe e x t r a c t and of 
medium were compared w i t h those o b t a i n e d f o r t w o - f o l d d i l u t i o n s of s y n t h e t i c 
α-MSH and des-Na-acetyl-α-MSH; the t w o - f o l d d i l u t i o n s f o r the s y n t h e t i c pept ides 
were prepared from an i n i t i a l c o n c e n t r a t i o n of 2.5 ng/ml in both cases. 
To f u r t h e r c h a r a c t e r i z e the lobe and medium p e p t i d e s , h igh-performance l i q u i d 
chromatographic (HPLC) s e p a r a t i o n s t u d i e s were performed. Three n e u r o i n t e r m e -
d i a t e lobes were incubated in 250 y] medium f o r k h a t 220C a n d , f o l l o w i n g the 
i n c u b a t i o n , the lobes were homogenized in 500 y l 0.1 N HCl, the homogenate was 
c e n t r i f u g e d and the supernatant was submit ted t o HPLC. To the medium 500 y l 0.1 
N HCl was added, the a c i d i f i e d medium was c e n t r i f u g e d and the supernatant was 
analyzed w i t h HPLC. HPLC separat ions were done on Spherisorb 10 0DS (250x4.6 mm 
i . d . ) w i t h a f l o w r a t e of 2 m l / m i n , employing a stepwise g r a d i e n t (shown in F i g . 
2) of 0.5 M f o r m i c a c i d , Ο . ΐ Ί M p y r i d i n e , pH 3·0 as the pr imary s o l v e n t A and 
1-propanol as the secondary s o l v e n t В ( f o r f u r t h e r chromatographic d e t a i l s see 
[ 8 ] ) . To the 0.5-min HPLC f r a c t i o n s , 10 yg albumin was added, the f r a c t i o n s 
were f r e e z e - d r i e d and the MSH l e v e l s in the l y o p h i l i z e d f r a c t i o n s were d e t e r ­
mined using the radioimmunoassay. 
RESULTS 
The displacement binding curve for synthetic des-Na-acety1-α-MSH was not pa­
rellel to the curve for synthetic α-MSH. Also, the curve for an extract of 
XenoDus neurointermediate lobes and the curve for the medium in which the lobes 
134 
7.1 
100 
60 
60-
40-
20-
α - M S H i — 1 ^ 
des-Ac1^. 1 \ 
-α-MSH J \ Ч 
lobe! \ 
А ЧГ
 X ï \ 
medium ί ч ч \ г 
Ч\ \ і 
К \ Хг 
^ \ ч 
ч 
к 
Ί
ν 
I I I 
1 2 4 
I I I I I I I I I 
в 16 32 64 120 256 612 1024 2048 
DILUTION FACTOR 
Figure i . Standard curve concerning the radioimmunoassay f o r α-MSH compared w i t h the displacement 
b i n d i n g curves f o r s y n t h e t i c des-Na-acetyl-a-MSH (des-Ac-a-MSH), f o r an e x t r a c t of n e u r o i n t e r m e d i -
a t e lobes of black-background-adapted X. laevis ( l o b e ) , and f o r a medium c o n t a i n i n g p e p t i d e s r e ­
leased by n e u r o i n t e r m e d i a t e lobes (medium). %\. percentage i n h i b i t i o n of b i n d i n g of the l a b e l l e d 
a-MSH to a n t i - a - M S H . 
had been incubated were not parallel (Fig. 1). The displacement binding curve 
for the lobe extract, however, was nearly parallel to the curve for synthetic 
des-Na-acety1-α-MSH while the curve for the incubation medium was nearly pa­
rallel to the curve for synthetic α-MSH. 
HPLC-analysis followed by the RIA for α-MSH revealed the presence of two immu-
noreactive products in a neurointermediate lobe extract. The elution times of 
these products corresponded exactly with those of newly synthesized melano-
tropic products II and IV (Fig. 2a), which have been previously identified as 
des-Na-acetyl-α-MSH and α-MSH, respectively [Ί]. In the incubation medium only 
one major immunoreacti ve product was detected. The elution time of this product 
corresponded exactly with that of newly synthesized α-MSH (Fig. 2b). From the 
above data it may be concluded that to determine levels of α-MSH in superfusion 
fractions, isolation of the hormone by HPLC is not required since α-MSH is the 
only immunoreacti ve peptide released into the medium. 
Control superfusion experiments showed that during an incubation period of 
at least 6 hours, the rate of release of immunoreacti ve α-MSH was remarkably 
constant (data not shown). For the various experiments, however, the rate varied 
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Figure 2. Alpha-MSH-immunoreacti vity of products present (a) in neurointermediate lobes of black-
background-adapted X. laevis following a Д-h incubation or (b) in the medium after the 4-h incu­
bation. The products were separated by HPLC. For each HPLC fraction.the immunoreacti ν ity was de­
termined with the radioimmunoassay for a-MSH. The HPLC elution gradient is shown in the lower 
graph. Arrows indicate the elution position of newly synthesized products. 
from 1 t o 1.5 ng α-MSH/lobe/IO min. The constant r a t e of re lease d u r i n g the 6-h 
p e r i o d p e r m i t t e d us t o d e t e r m i n e , in one i n c u b a t i o n , both the c o n t r o l r a t e of 
re lease and the e f f e c t of a secretagogue on t h i s r a t e . 
Dopamine in a c o n c e n t r a t i o n of 10 M caused an i n h i b i t i o n of re lease of 
^90%. This l e v e l of i n h i b i t i o n was achieved a l r e a d y in the second 10-min f r a c ­
t i o n , which is remarkably f a s t in view of the f a c t t h a t t h e r e i s a 5-min lag 
between the t ime the s u p e r f u s i o n w i t h secretagogue s t a r t s and the time t h a t 
the secretagogue a c t u a l l y reaches the p e r f u s i o n chamber. The 90% i n h i b i t i o n was 
mainta ined throughout the p e r i o d t h a t dopamine was p r e s e n t . A f t e r dopamine was 
removed, the re lease of a-MSH increased g r a d u a l l y and reached the c o n t r o l l e v e l 
in ^30 min ( F i g . 3a) . 
C y c l i c AMP in a c o n c e n t r a t i o n of 6 mM s t i m u l a t e d a-MSH release in such a way 
t h a t a f t e r kO min of p e r f u s i o n w i t h t h i s n u c l e o t i d e re lease had increased by 
^100%. The i n c r e a s e , averaged over the p e r i o d of c y c l i c AMP-admin i s t r a t i o n , was 
^ 0 % . Already d u r i n g the l a s t 20 min of p e r f u s i o n w i t h c y c l i c AMP, the l e v e l of 
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Figure 3. Effects of (a) dopamine and (b) c y c l i c AMP on the release of immunoreactive o-MSH by 
neurointermediate lobes of Ыаск-background-adapted X. laevis. Ten-minute superfusion f r a c t i o n s 
were co l lected and the amount of immunoreacti ve i-MSH in each f r a c t i o n was determined wi th the 
radioimmunoassay for a-MSH. 
released a-MSH gradually decreased and finally reached a level somewhat lower 
than the control value (Fig. 3b). 
Fig. 4 illustrates the effects of isoproterenol on release of immunoreacti ve 
α-MSH in a dose-related manner. In a concentration of 10 M, isoproterenol 
-8 
reverslbly stimulated α-MSH release by ^35%, W M Isoproterenol reversibly 
inhibited release by ^20% while the release was reverslbly Inhibited by "^5% 
in the presence of 10 M Isoproterenol; these percentages are averages for the 
period concerned. 
Similar superfusion experiments were performed with adrenaline, noradrenaline 
and dopamine, and the results of these experiments are summarized in Fig. 5· 
Adrenaline in a concentration of 10 M stimulated α-MSH release by ^10%,while 
_Q _ С 
10 M and 10 M adrenaline inhibited release by ^30% and 80%, respectively. 
Noradrenaline, at 10 M, stimulated release by 0.5%, and 10 M and 10 M 
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Figure 4. Effects of isoproterenol (¡sopr.) on the release of immunoreacti ve α-MSH Ъу neurointerme­
diate lobes of black-background-adapted X. Іае гз. The effects of the three different concentrations 
were studied in the same superfusion experiment. Ten-minute fractions were collected and the amount 
of immunoreacti ve α-MSH in each fraction was determined with the radioimmunoassay for a-MSH. 
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Figure 5. E f f e c t s of a d r e n a l i n e , n o r a d r e n a l i n e , i s o p r o t e r e n o l and dopamine on the r e l e a s e of immuno-
r e a c t i v e α-MSH by n e u r o i n t e r m e d i a t e lobes of black-background-adapted X. laevis. In each c a s e , the 
e f f e c t s of t h r e e d i f f e r e n t c o n c e n t r a t i o n s were s t u d i e d in the same superfusion e x p e r i m e n t . Control 
l e v e l s of immunoreacti ve α-MSH were determined by a v e r a g i n g the values f o r the f i r s t nine 10-min 
superfusion f r a c t i o n s . S i m i l a r l y , l e v e l s of immunoreacti ve α-MSH during superfusion w i t h a s e c r e t a -
gogue were determined by a v e r a g i n g the values f o r the p e r t i n e n t f i v e 10-min f r a c t i o n s . In the f i g u r e , 
the colomns r e p r e s e n t the secretagogue-induced l e v e l s of α-MSH expressed as percentages of the con­
t r o l l e v e l s . 
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noradrenaline inhibited release by ^20% and 85%, respectively. Dopamine in a 
concentration of 10 M had no effect on a-MSH release, while at 10 M it 
inhibited release by ^35%. The finding that 10 M dopamine inhibited release 
of a-MSH by ^90% (Fig. 5) confirmed the earlier observation shown in Fig. 3a. 
DISCUSSION 
The non-parallelism between the displacement binding curve for the extract 
of the neurointermediate lobes and the curve for the incubation medium indi­
cates that the immunoreacti ve peptide(s) in the lobe differ(s) from that (those) 
released into the medium. The observation that the binding curves for the lobe 
extract and des-Na-acety1-a-MSH are nearly parallel, as are the curves for the 
medium and a-MSH, suggests that in the lobes there was a preponderance of des-
Na-acety 1 -a-MSH, while in the medium a-MSH prevailed. Quantitative comparison 
of immunoreacti ve peptides in the lobe with immunoreacti ve peptides in the 
medium (Fig. 2) gives strong support for this suggestion. Alpha-MSH immunoreac-
tivity in the lobes was associated with both product II and product IV, but the 
activity of product II (des-Na-acety1-m-MSH) was approximately 1.5 times higher 
than the activity of a-MSH. Since the reactivity of des-Na-acety1-a-MSH to anti-
a-MSH is low (MS^) as compared to that of a-MSH to anti-a-MSH, it can be cal­
culated that the lobe contains M 0 times more des-Na-acety 1-a-MSH than a-MSH. 
Similarly, it can be deduced that a-MSH is the major form of MSH in the medium. 
These conclusions confirm our earlier observation [4] that des-Na-acety1-a-MSH 
is the 'storage form' and a-MSH is the product released from the neurointerme­
dia te lobe of Хепорив laevis. 
The total level of a-MSH immunoreactivity in one neurointermediate lobe equals 
10-15 ng a-MSH, which corresponds to the immunoreacti vity of ^ 0 - 9 0 ng des-Na-
acety 1-a-MSH. Thus, from the observed rate of release (1-1.5 ng a-MSH/10 min/ 
lobe) it can be calculated that the MSH release per hour is ^10% of the total 
lobe contents. This rate is considerably higher than those found in the lizard 
Anolis carolinensisil 1 ] or the rat [12] for which a rate of M - 2 % of the MSH lobe 
contents has been reported. 
The observed degree of inhibition of a-MSH release from the pars intermedia 
of Ыаск-adapted Xenopus induced by dopamine, and the degree of stimulation of 
the release process by cyclic AMP are remarkably similar to the effects of these 
substances on the release of newly synthesized peptides in Ыаск-adapted animals 
(Chapters УI and VII). In vitro MSH release from the pars intermedia of white-
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adapted animals is also stimulated by cyclic AMP and inhibited by dopamine 
([13] and unpublished observations). However, when such white-adapted animals 
were used, cyclic AMP induced a 3 to 4-fold increase in release, while for the 
black-adapted animals of the present study the increase was only 60%. These 
data might indicate that in ъп vitro studies the spontaneous rate of a-MSH re­
lease from lobes of black-adapted animals is closer to the maximum obtainable 
rate of release than that exhibited by lobes of white-adapted animals. The 
fact that cyclic AMP reached a maximum stimulatory effect on release in '"•''tO min 
but apparently could not sustain this degree of stimulation during the remain­
der of the perfusion period was not only seen when lobes of black-adapted 
ХсУ'.ориг, were used, but also when tissue of white-adapted animals was incubated 
(unpublished observation). We are uncertain whether this phenomenon must be 
attributed to depletion of the MSH 'stores' or to decomposition of the cyclic 
nuc1eot i de. 
It is generally accepted that isoproterenol is a specific ß-adrenergic re-
ceptor agonist. Therefore, the fact that isoproterenol exerted an effect on 
MSH release by the pars intermedia of Xenopus indicates the presence of ß-
adrenoceptors on the plasma membrane of the MSH cells in this species. Since 
this effect was stimulatory, at least at a concentration of the secretagogue 
of 10 M, these fj-adrenoceptors seem to be involved in a release-promoting 
control mechanism. The clearly inhibitory effect of isoproterenol at high con-
centrations is puzzling. Possibly it reflects a non-specific interaction re-
sulting in an antagonistic effect; see also Chapter VII. 
Adrenaline and noradrenaline normally exert their effects on target tissues 
through binding to a- or ß-adrenoceptors. The observed effects of these cate-
cholamines in our study seem to point to the existence of both a- and ß-recep-
tors on the MSH cells. Since the ß-adrenoceptors have been implicated in a 
stimulatory response, the α-adrenoceptors probably mediated the inhibitory 
effect that was noted at high concentrations of adrenaline and noradrenaline. 
The above model is similar to the concept proposed for the adrenergic control 
mechanism of the MSH cells in Rani pipiiar, by Bower et, ab. [1Ί]. Yet, in this 
last investigation a much clearer stimulatory effect of both catecholamines 
was noted than in our study with Хвпорлс. The cause of this difference is not 
immediately clear. It could be that the proportion of α-receptors to ß-recep-
tors on the membranes of MSH cells in Rana pipicm; is lower than that in Xeno-
pus laevis. An alternative explanation may be sought in a difference in the 
experimental conditions. In the study by Bower et al. the state of background 
adaptation of the animals used is not mentioned. In our investigation the toads 
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were fully Ыаск-adapted and, therefore, the rate of release under control con­
ditions may well have been much closer to the maximum possible level than in 
the study with h ana ргтгет;, so that in our situation potential stimulatory 
effects of secretagogues could hardly be demonstrated. 
A number of recent investigations concerning the release of hormones have 
provided evidence for the notion that the secretory products consist of distinct 
pools [15-17]. The distinction may be made on the basis of peptide composition, 
sensitivity with respect to secretagogues, differences in rates of turnover, and 
considering newly synthesized versus matured ('stored') hormones. With respect 
to this last criterion, a study concerning the regulation of release of para­
thyroid hormone (PTH) is relevant. Pulse-chase studies of PTH biosynthesis in 
combination with an analysis of the release of this hormone from porcine para-
2+ 
thyroid cells showed that Ca -ions caused a preferential release of newly syn­
thesized hormone, while cyclic AMP preferentially stimulated the release of 
'matured' PTH [l8]. This led the authors to propose the concept that two secre-
table pools of PTH exist. Our data concerning the release of a-MSH from the 
pars intermedia of Xenopus show a remarkable similarity between the effects of 
the various secretagogues (cyclic AMP, dopamine, adrenaline, noradrenaline, and 
isoproterenol) on the release of newly synthesized a-MSH (Chapter Uli) and their 
effects on the release of immunoreactI ve a-MSH. Generally, the effects on re­
lease of total a-MSH are proportional to the effects on release of newly synthe­
sized a-MSH. This leads to the conclusion that there is no reason to distin­
guish between a 'pool' of newly synthesized product and a 'pool' of matured 
('stored') product. 
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CHAPTER IX Nature (198I) 294, 558-560 
Na-ACETYLATION IS LINKED TO a-MSH RELEASE FROM PARS INTERMEDIA 
OF THE AMPHIBIAN PITUITARY GLAND 
Gerard J.M. Martens, Bruce G. Jenks and A.P. van Overbeeke 
Department of Zoology, Faculty of Science, Catholic University, 
Toemociveld, 6525 ED Ki¿megen, The Netherlands 
Most amphibians can adapt their colour to that of their background by a 
mechanism which is controlled by melanophore stimulating hormone (MSH), a pro-
duct of the pars intermedia of the pituitary gland . Although the melanotropic 
peptides of amphibians have never been sequenced, immunological evidence indi-
2-it 
cates that at least some of them are structurally related to a-MSH . In our 
studies of the biosynthesis and structure of melanotropic peptides in the pars 
intermedia of Xenopus laevis, we have found evidence, reported here, for des-
Na-acetyl-a-MSH as the immediate precursor of α-MSH, with the acetylation 
taking place just before or during release from the pituitary. 
We have previously shown by in vitro pulse-chase techniques coupled to HPLC 
analysis that the biosynthesis of peptides in the pars intermedia of X. laevis 
begins by the production of a large protein which is subsequently processed to 
a number of peptides , three of which possess melanotropic activity. One of 
them has since been shown to co-migrate with synthetic des-Na-acety1-α-MSH on 
acid-urea gels and to have identical retention times to the synthetic peptide 
during HPLC analysis with several different elution gradients (unpublished ob­
servations). Tryptic digestion of this newly synthesized peptide yielded two 
fragments (Fig. 1) with elution times identical to those of the two fragments 
obtained from the tryptic digest of synthetic des-Na-acetyl-α-MSH. Moreover, 
the radioactive amino acid content of the tryptic fragments was in agreement 
with that expected on the basis of the amino acid content of the comparable 
fragments of the synthetic peptide. Therefore, this newly sythesized melano­
tropic product is des-Na-acety1-α-MSH. Another melanotropic peptide co-eluted 
from the HPLC column with synthetic α-MSH and co-migrated with this peptide 
during acid-urea gel electrophoresis. The elution times of the two radioactive 
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. Tryptic peptide mapping by HPLC of newly synthesized des-Na-acety I -a-MSH (·) and 
a-MSH (O) . Neuromternediate lobes of black-adapted /. lacvt-s were incubated for k.S h at 220C 
in 50 μΐ incubation medium (for composition see ref. 5) containing 20 pCi each of H-lysme, 
H-tyrosme, H-phenylalanme and Η-tryptophan (specific activities 90, 50, 80 and 26 Ci mmol , 
respectively, Amersham) Lobes were extracted with 500 μΐ 0.1 M HCl, the extract was analysed 
with HPLC, and the newly synthesized product co-elutmg with synthetic des-Na-acety1-a-MSH was 
isolated from the lobes To the incubation medium 500 ul 0.1 M HCl were added, the acidified 
medium was analysed with HPLC and the newly synthesized product co-elutmg with synthetic a-MSH 
was isolated from the incubation medium. Tryptic digestion of the isolated peptides (to which 
20 ug bovine serum albumin were added) was performed at 37<>C for 2 h with 10 μ g trypsin (DPCC-
treated, Sigma) in 50 μΐ 15 mM HEPES buffer (pH 8.0), the digest was analysed with HPLC 
Digestion of the radioactive tryptic fragments to free a m m o acids revealed that the 14-min 
fragments contained radioactive tryptophan and lysine, and both the 18- and 22.5-min fragments 
contained radioactive tyrosine and phenylalanine. Black arrows indicate the elution positions 
of the undigested radioactive peptides. For comparison, 50 ug synthetic des-Na-acetyI-a-MSH 
(a gift from Dr G.I. Tesser, Department of Organic Chemistry, Nijmegen) and 50 ug a-MSH (Penin­
sula) were digested with 10 pg trypsin in the same conditions as described for digestion of the 
radioactive peptides, except no bovine serum albumin was added. The tryptic fragments of the 
synthetic peptides (shown in upper boxes) were detected with a post-column der ι vat ι zat ion system, 
using o-phthaldialdehyde (Signa) as a fluorogenι с reagent, and they were further identified with 
specific staining techniques for the a m m o acids histidme and tryptophan according to ref. 20. 
The elution positions of the undigested synthetic peptides are also indicated (lower boxes). 
HPLC separation was on Sphensorb 10 0DS (Chrompack, 250 χ 4.6 mm i.d.) using a stepwise gradient 
with a flow rate of 2 ml m m , and 0.5-min fractions were collected. The gradient was established 
with 0 5 M formic acid, 0 1*t M pyridine (pH 3*0) as the primary solvent and 1-propanol as the 
secondary sol vent. 
iVt 
t r y p t i c fragments of t h i s newly synthesized product ( F i g . 1) corresponded 
e x a c t l y w i t h those of the two t r y p t i c fragments of s y n t h e t i c a-MSH. F u r t h e r ­
more, the r a d i o a c t i v e amino a c i d content of each t r y p t i c fragment of t h i s p r o ­
duct was in f u l l agreement w i t h i t s i d e n t i t y as a-MSH. The d e s i g n a t i o n of the 
two newly synthesized products is supported by the o b s e r v a t i o n t h a t the o n l y 
s t r u c t u r a l d i f f e r e n c e between them is l o c a t e d on the N-terminus. 
Pulse-chase a n a l y s i s of the b i o s y n t h e s i s of des-Na-acety1-a-MSH and a-MSH 
revealed a l i k e l y p r e c u r s o r - p r o d u c t r e l a t i o n s h i p f o r these p e p t i d e s . During 
the f i r s t 2 h des-Na-acety1-α-MSH accumulated r a p i d l y , then g r a d u a l l y decreased. 
a-MSH was b a r e l y demonstrable in the f i r s t 2 h and g r a d u a l l y increased t h e r e ­
a f t e r , concomitant w i t h the decrease of des-Na-acety1-α-MSH ( F i g . 2 ) . A f u r t h e r 
o b s e r v a t i o n was t h a t des-Na-acety1-α-MSH was almost c o m p l e t e l y r e s t r i c t e d t o 
chase incubation time(h) 
FZJUFP 2. L e v e l s o f newly s y n t h e s i z e d des-Na-acety l -α-MSH and α-MSH as a f u n c t i o n o f chase i n c u b a ­
t i o n t i m e . Хсус1.из п е и г о і п termed l a t e l o b e s were p r e m c u b a t e d f o r 1 h b e f o r e a 3 0 "
m i n p u l s e 
i n c u b a t i o n in H - t r y p t o p h a n , f o l l o w e d by chase i n c u b a t i o n s in normal i n c u b a t i o n medium f o r 1 , 2 , 
3 . 5 , 8 o r 16 h . A f t e r the p u l s e - c h a s e i n c u b a t i o n s , lobe e x t r a c t s and i n c u b a t i o n media were a n a ­
l y s e d w i t h HPLC W i t h t h e g r a d i e n t u s e d , newly s y n t h e s i z e d d e s - N a - a c e t y I-α-MSH and -i-MSH e l u t e d a t 
2 2 . 5 mm and 28 m m , r e s p e c t i v e l y . To q u a n t i f y the r e l a t i v e amounts o f t h e s e p e p t i d e s , the chroma­
t o g r a p h i c p r o f i l e between 20 and 30 mm e l u t i o n t i m e was u s e d . For each chase g r o u p , t h e t o t a l 
l e v e l o f r a d i o a c t i v i t y ( l o b e p l u s medium) was d e t e r m i n e d by a d d i n g the c . p . m . v a l u e s o f the HPLC 
f r a c t i o n s The r a d i o a c t i v i t y o f each HPLC f r a c t i o n was then e x p r e s s e d as a p e r c e n t a g e o f t h i s 
t o t a l l e v e l . In the f i g u r e , the p e r c e n t a g e s r e p r e s e n t t h e sum o f t h e p e r c e n t a g e f o u n d in t h e lobe 
and t h a t in the medium f o r des-Na-acety1-a-MSH ( · ) or a-MSH (O) a t each chase i n c u b a t i o n t i m e . 
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the t i s s u e w h i l e a-MSH was e x c l u s i v e l y found in the medium. A d d i t i o n a l e x p e r i ­
ments were performed t o e s t a b l i s h t h a t the absence of des-Na-acety1-a-MSH in 
the medium was not the consequence of e x t r a c e l l u l a r a c e t y l a t i o n or r a p i d degra­
d a t i o n of t h i s p e p t i d e . I s o l a t e d r a d i o a c t i v e des-Na-acety1-a-MSH, incubated 
w i t h n e u r o i n t e r m e d i a t e l o b e s , remained in the ποπ-acety lated form and was s t a b l e 
f o r a t l e a s t 8 h. Moreover, s u p e r f u s i o n of n e u r o i n t e r m e d i a t e l o b e s , whereby any 
p o s s i b l e m o d i f i c a t i o n or p r o t e o l y s i s of secreted pept ides was prevented by c o l ­
l e c t i n g the p e r f u s a t e in s o l u t i o n s c o n t a i n i n g a c i d or enzyme i n h i b i t o r s , demon­
s t r a t e d t h a t over 35% of the newly synthesized MSH released was in the a c e t y l -
ated f o r m . 
In amphibians, the p h y s i o l o g i c a l f a c t o r i n h i b i t i n g MSH re lease is thought t o 
be dopamine . In Xenopus, t h i s catecholamine i n h i b i t s the in vitro re lease of 
Я -1 π 
a l l newly synthesized p e p t i d e s . To i n v e s t i g a t e the e f f e c t s of i n h i b i t i o n of 
re lease on the a c e t y l a t i o n process we conducted pulse-chase experiments w i t h 
dopamine present d u r i n g the chase. In the c o n t r o l e x p e r i m e n t , ^0% of the newly 
synthes ized MSH was in the a-MSH form a n d , as e x p e c t e d , t h i s a c e t y l a t e d product 
was found e x c l u s i v e l y in the medium ( F i g . 3 a ) . The des-Na-acety1-a-MSH was 
found almost e x c l u s i v e l y in the t i s s u e . In the dopamine-treated g r o u p , re lease 
of newly synthesized p e p t i d e s was complete ly i n h i b i t e d and a l l MSH in the t i s ­
sue was des-Na-acetyI-a-MSH ( F i g . 3 b ) . Thus, i n h i b i t i o n of re lease was accom­
panied by i n h i b i t i o n of a c e t y l a t i o n . 
C y c l i c AMP s t i m u l a t e s re lease of newly synthes ized p e p t i d e s from the pars 
intermedia of Хс о лв . The present study shows t h a t c y c l i c AMP t reatment e n ­
hanced the amount of a-MSH ( F i g . 3 c ) . Approximately 75% of the newly synthe­
sized MSH was present in the a-MSH form a n d , a g a i n , t h i s form was found e x c l u ­
s i v e l y in the medium. Thus, s t i m u l a t i o n of re lease was accompanied by s t i m u ­
l a t i o n of the a c e t y l a t i o n process. A l t o g e t h e r , our r e s u l t s i n d i c a t e t h a t the 
a c e t y l a t i o n of des-Na-acety1-a-MSH occurs immediately b e f o r e or d u r i n g r e l e a s e . 
The above r e s u l t s , d e a l i n g w i t h newly synthes ized p e p t i d e s , suggest t h a t 
des-Na-acetyI-a-MSH c o u l d c o n s t i t u t e a ' s t o r a g e - f o r m ' of the hormone. This c o n ­
t e n t i o n is supported by o b s e r v a t i o n s we made concern ing s t o r e d p e p t i d e s (un­
p u b l i s h e d d a t a ) . Using b i o a s s a y s , we demonstrated t h a t the pars intermedia of 
whi te-adapted Xenovus, which is known t o s t o r e m e l a n o t r o p i c p e p t i d e s , c o n t a i n s 
MO times more des-Na-acety1-a-MSH than a-MSH. F u r t h e r , i n f u s i n g animals adap­
t i n g t o a w h i t e background w i t h Η- lysine r e s u l t e d in a p r e f e r e n t i a l accumula­
t i o n of r a d i o a c t i v e des-Na-acety1-a-MSH such t h a t a f t e r 10 days >90% of the 
r a d i o a c t i v e MSH in the pars intermedia was in the n o n - a c e t y l a t e d f o r m . 
Des-Na-acety1-a-MSH shows c o n s i d e r a b l y less m e l a n o t r o p i c a c t i v i t y than 
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Figure ό. E f f e c t of dopamine and c y c l i c AMP on the r e l e a s e of newly synthesized des-Na-acetyl-a-MSH 
and a-MSH. Lobes were p r e i n c u b a t e d f o r 1 h b e f o r e a 30-min pulse w i t h H-tryptophan, f o l l o w e d by 
chase incubations of 3 · 5 h in c o n t r o l incubation medium ( a ) , medium c o n t a i n i n g 10 M dopamine ( 3 " 
hydroxytyramine HCl; S i g m a ) ( b ) , or medium c o n t a i n i n g 6 mM c y c l i c AMP (8-bromo c y c l i c AMP; Sigma) 
( c ) . The HPLC f r a c t i o n s a r e expressed in percentages using the method described in F i g . 2 legend. 
a-MSH . That acetylation of peptide hormones need not always be accompanied by 
an increase in activity is, however, illustrated by the fact that S-endorphin 
12 
is not biologically active in its acetylated form . It is interesting that α­
ϊ 3 1Ί 
MSH and ß-endorphin are derived from the same prohormone . Whether acetyl-
ation constitutes a control point in regulating the biological potency of pars 
12 
intermedia peptides, as suggested earlier , remains to be established. 
In the ra t p i t u i t a r y g l a n d , Woodford and Dixon demonstrated the presence 
of N a - a c e t y l t r a n s f e r a s e , which can a c e t y l a t e the α-amino group of s y n t h e t i c 
1Ί7 
des-Na-acety1-a-MSH t o form α-MSH. The a c e t y l a t i o n r e a c t i o n r e p o r t e d in the 
present i n v e s t i g a t i o n is probably c a t a l y s e d by such an enzyme. As t h i s a c e t y ­
l a t i o n is c l o s e l y r e l a t e d t o the release p r o c e s s , the enzyme is probably asso­
c i a t e d w i t h the s e c r e t o r y granules or w i t h the c e l l membrane. Th is s i t u a t i o n 
would be un iqu e, as most a c e t y l a t i o n s of p o l y p e p t i d e s take place b e f o r e or 
d u r i n g packaging in the s e c r e t o r y granules ' ; a p e r t i n e n t example is the 
Na-acety l a t ¡on of (5-endorphin in the ra t pars intermedia 
The process of exocy tos is imp l ies the f us i on of the membrane of the secre-
1 ρ 
t i o n granule w i t h the plasma membrane . Membrane f u s i o n , in g e n e r a l , may be 
19 accompanied by p h y s i c a l and chemical changes in the membranes invo lved . An 
i n t r i g u i n g p o s s i b i l i t y f o r the a c e t y l a t i o n of des-Na-acety1-α-MSH in the 
amphibian pars intermedia is t h a t d u r i n g the s e c r e t o r y process phys¡cochemica! 
changes in the microenvironment near the c e l l membrane lead to a c t i v a t i o n of a 
s p e c i f i c Na-acety1 t r a n s f e r a s e , thus l i n k i n g a c e t y l a t i o n of the hormone to i t s 
re lease . 
This work was supported by a grant f rom the Netherlands Organ izat ion f o r the 
Advancement of Pure Research (ZWO) through the Foundation f o r B i o l o g i c a l Re-
search (BION). 
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CONCLUDING REMARKS 
From the investigations reported in this thesis, it is evident that functio-
ning of the pars intermedia of the pituitary gland in Xenopus laevis is consi-
derably more complicated than initially was thought. Originally, our aim was 
to study the biosynthesis of MSH, the control of its release and how these pro-
cesses are related to one-another. The complexity of the biosynthetic process 
¡ tself necessitatedto focus most of the attention on this aspect. The results 
of the release studies must be considered preliminary results and do not permit 
definitive conclusions. 
Two new techniques were successfully introduced in this area of hormone re-
search. First, HPLC turned out to be a powerful technique as it allowed for a 
rapid separation with high resolution of the products synthesized. It proved 
to be particularly worthwhile that a single analysis produces a peptide profile 
containing both the high-molecular weight precursor and the various peptides 
derived from it. Secondly, the microsuperfusion technique was found to be a 
superior method for release studies. An important advantage of this method, 
compared with the more commonly used static incubations, is that data on effects 
of secretagogues and control data may be obtained from the same tissue. This re-
duces experimental variability and, moreover, saves experimental animals. 
The results concerning the biosynthesis have led to a model, presented in 
Fig. 1. A first conclusion is that the MSH cells in Xenopus produce two melano-
phore stimulating substances, a-MSH and γ,-MSH. Perhaps more interesting is the 
fact that, in addition to these MSHs, a number of other peptides are secreted, 
not only during in vitro incubation but probably also in the living animal 
(Chapter V ) . Whether these other products possess biological activity remains 
to be established. Studies concerning the possible physiological significance 
of e.g. CLIP and endorphin are now necessary and the problem constitutes a 
challenging theme in research on pars intermedia function. 
The characterization of the products derived from pro-opiomelanocortin and, 
later on, a direct analysis of the prohormone led to the proposal that two 
different forms of pro-opiomelanocortin are synthesized. One of the consequen­
ces of the occurrence of two prohormones with different primary structures 
appeared to be the generation of two structurally different endorphin-1ike pep­
tides: endorphin-1 (product VII) and endorphin-2 (product V I M ) . Both precursor 
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Figure J. Model of the biosynthesis of peptides related to pro-opiomelanocortin in the pars inter­
media of Xevopus laevis (see text). 
m o l e c u l e s p r o d u c e d e s - N a - a c e t y l - a - M S H ( C h a p t e r I V ) . The d e r i v a t i o n o f t h e o t h e r 
p r o d u c t s , n a m e l y t h e CLIPs and t h e 17K- a n d l 8 K - f r a g m e n t s ( a n d , t h u s , t h e γ , -
MSH) i s , i n p a r t , a m a t t e r o f s p e c u l a t i o n . S u g g e s t i o n s p e r t a i n i n g t o t h e d e r i ­
v a t i o n a s p r e s e n t e d i n t h e model ( F i g . 1) a r e b a s e d on p u l s e - c h a s e a n a l y s e s 
( C h a p t e r I I a n d more r e c e n t , u n p u b l i s h e d , r e s u l t s ) . They showed t h a t d u r i n g 
p r o c e s s i n g some o f t h e t e r m i n a l p r o d u c t s a p p e a r e d f a s t e r t h a n o t h e r s . For i n -
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s t a n c e , CLIP-2 (product V) could be detected w e l l b e f o r e CLIP-1 (product IV) . 
The 17K-fragment is a product of r e l a t i v e l y slow process ing of pro-opiomelano-
c o r t i n and was, w i t h i n the t ime l i m i t s of the a n a l y s i s , not f u r t h e r processed. 
C o n t r a s t i n g l y , the l8K-fragment c o u l d be d e t e c t e d r e l a t i v e l y e a r l y d u r i n g chase 
i n c u b a t i o n a n d , s ince i t disappeared d u r i n g prolonged chase, t h i s fragment p r e ­
sumably f u n c t i o n s as the immediate precursor t o γ,-MSH. 
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The fact that the pars intermedia in Xenopus synthesizes two structurally dif-
ferent pro-opiomelanocortins indicates that these products are translated from 
two forms of mRNA with slightly different nucleotide sequences. This, in turn, 
would suggest the involvement of two different genes in the production of the 
prohormones. This does not necessarily mean that these two genes are both ac-
tivated in all cells of the pars intermedia. There have been suggestions that 
the pars intermedia contains two different cell types, but there is no clear 
experimental evidence for such cell differentiation. 
The situation whereby a tissue produces a number of peptides, each presuma-
bly with a specific biological activity but all derived from the same prohor-
mone, raises important questions concerning control mechanisms. For instance, 
do such cells have the capacity for selective release of their products in 
response to specific needs of the organism? Pertinent regulation could take 
place both during the biosynthesis and as part of the release process. Theore-
tically, control of transcription and translation, leading to selective bio-
synthesis of only one of the prohormones, is possible but at the present time 
no evidence for such control is available. Recently developed methods in DNA 
hybridization and DNA recombinant technology are now being applied in this 
field and may in the near future provide knowledge of possible control mecha-
nisms at the level of the genome. 
At the post-translational level, conversion of pro-opiomelanocortin, probably 
determined by the profile of intracellular processing enzymes, constitutes a 
point of control. Selective degradation and storage of products might represent 
another control point. Further, it should be realized that the bioactivity of 
the peptides can be altered through post-translational moaif¡cat ions. An exam-
ple of this is the acetylation of des-Na-acetyI-a-MSH to form a-MSH, which was 
shown to take place just prior to or during release; this conversion strongly 
increases the melanotropic potency of the peptide. 
Finally, there is the possibility that selective release of products may be 
brought about by extracellular factors. The results of our studies on the 
effects of secretagogues (Chapters VI, VII and V I M ) have yielded information 
on the release process and the possible involvement of dopamine, and a-adrener-
gic and g-adrenergic receptors. In general, these results indicate that, at 
least in in vitro incubations, there is concomitant release of all products, 
both during spontaneous secretion and under the influence of secretagogues. 
If indeed simultaneous release of peptides were to take place in the living 
animal, there likely is a physiological relationship between the effects of 
these peptides. 
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SAMENVATTING 
In de huid van amfibieën zijn talrijke pigment-bevattende cellen, chronvato-
foren, aanwezig die deze dieren in staat stellen van kleur te veranderen. Der-
gelijke kleurveranderingen worden veelal teweeggebracht door prikkels uit de 
omgeving, dan wel van binnenuit het dier. Twee typen kleurverandering worden 
onderscheiden: morfologische veranderingen, een verhoudingsgewijs langzaam 
proces gekenmerkt door toename of afname van het aantal chroma toforen of ook 
door wijzigingen in de hoeveelheid pigment per cel, en fysiologische verande-
ringen, waarbij relatief snelle verplaatsing van pigmentkorrels binnen de 
cellen optreedt. Bij laatstgenoemd proces gaat het meestal om een reaktic op 
een stimulus uit het milieu, bijv. een wijziging van kleur of patroon van de 
ondergrond van het dier. 
Bij amfibieën spelen hormonen een belangrijke rol bij het gedrag van de chro-
matoforen. Van de verschillende typen chromatoforen zijn de melanoforen het 
best bestudeerd, vooral omdat zij van grote betekenis zijn bij de aanpassing 
van de huidskleur aan de ondergrond. Het is al ruim 60 jaar bekend dat ook de 
hypofyse nauw betrokken is bij deze zogenaamde ondergrondadaptatie. Gebleken 
is namelijk dat een hormoon geproduceerd door de tussenkwab (pars intermedia) 
van deze klier direkt verantwoordelijk is voor de dispersie van de zwarte 
korrels (melanosomen) in de melanoforen en dit hormoon werd dan ook melanoforen 
stimulerend hormoon, MSH, genoemd. 
Een reeks experimenten, uitgevoerd in de dertiger jaren en waarbij vooral de 
zuidafrikaanse klauwpad Xenopus laevis als proefdier werd gebruikt, bracht aan 
het licht dat prikkeling van het netvlies van de ogen een belangrijke rol speelt 
bij de ondergrondadaptatie. Als een klauwpad op een donkere ondergrond zit, 
worden vooral die delen van het netvlies geprikkeld die direkt licht van boven 
ontvangen. Die prikkeling wordt via de hersenen verwerkt en leidt o.a. tot af-
gifte van MSH door de pars intermedia van de hypofyse. Dit hormoon veroorzaakt 
op zijn beurt spreiding van de pigmentkorrels in de melanoforen van de huid, 
die daardoor donker wordt. Bij overbrenging van het dier op een witte onder-
grond worden ook de bovenste delen van het netvlies geprikkeld, namelijk door 
gereflekteerd licht, en dit heeft tot gevolg dat de MSH-afgifte wordt geremd. 
Na verloop van enige tijd volgt dan verzameling van de melanosomen rond de 
kernen van de melanoforen, waardoor de huid licht getint wordt. 
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In d i t p r o e f s c h r i f t staan de vragen c e n t r a a l hoe MSH in de c e l l e n van de 
pars intermedia van Хеюриг laeûis wordt aangemaakt en op welke manier de a f -
g i f t e ervan wordt ge rege ld . 
Deel I van het p r o e f s c h r i f t b e t r e f t de aanmaak van MSH en daarmee verwante 
pep t i den . De b iosyn the t i sche processen werden bestudeerd aan de hand van pu l se -
chase incubat ies van par tes neuro in te rmed iae , waarb i j de r a d i o a k t i e v e pept iden 
werden gescheiden door middel van hoge druk v l o e i s t o f c h r o m a t o g r a f i e ( " h i g h -
performance l i q u i d chromatography", HPLC) . Het b leek dat de hormoonsynthese 
beg in t met de vorming van een p recurso r , d ie t i j d e n s de chase-per¡ode werd om-
gevormd t o t een aanta l "chase-pept i den" (Hoofdstuk l ) . Met behulp van bioassays 
voor MSH en ad renoco r t i co t roop hormoon (ACTH), ¡mmunoprec ip i ta t ie techn ieken, 
gel e l e k t r o f o r e s e , se l ek t i eve inbouw van rad ioak t i eve aminozuren en "pep t ide 
mapping" werden de meeste chase-pept iden g e k a r a k t e r i s e e r d . D i t le idde t o t een 
i nde l i ng van de pept iden in d r i e groepen: MSH-, ACTH- en e n d o r f i n e - a c h t i ge pep-
t i d e n . Een van de MSH-achtige pept iden kon worden g e ï d e n t i f i c e e r d a l s des-Na-
acety1-a-MSH. Het bleek dat de twee ACTH-achtige peDtiden eigenschappen hebben 
overeenkomend met " c o r t i co t rop in-1 ike in te rmed ia te lobe p e p t i d e " (CLIP) en dat 
de twee e n d o r f i n e - a c h t i ge pept iden v e r s c h i l l e n in hun p r ima i re s t r u k t u u r 
(Hoofdstuk I I ) . Een tweede MSH-achtig pept ide werd geka rak te r i see rd a l s γ,-MSH, 
een g l y c o p e p t i d e met melanotrope a k t i v i t e i t (Hoofdstuk l i l ) . Vanwege de p o t e n t i e 
om e n d o r f i n e ( o p i a a t ) - a c h t i g e , melanotrope en c o r t i c o t r o p e Produkten t e l e v e r e n , 
is voor het prohormoon de naam p r o - o p i o m e l a n o c o r t i n e van t o e p a s s i n g . SDS gel 
e l e k t r o f o r e s e toonde de aanwezigheid aan van twee vormen van het p r o - o p i o m e l a -
n o c o r t i n e (molekuulgewichten 37.300 en 38.200 d a l t o n s ) . Deze twee e i w i t t e n 
bleken ieder één o l i gosacchar ide te b e z i t t e n dat in beide geva l len g e l o k a l i -
seerd is in dat deel van het molekuul dat overeenkomt met het γ,-MSH-gedeelte. 
Met behulp van " t r y p t i c maps" van de nieuw-gevormde p ro-op iomelanocor t ¡nes kon 
worden vas tges te l d dat de twee vormen v e r s c h i l l e n in hun p r ima i re s t r u k t u u r , 
waarb i j één v e r s c h i l be t rekk ing heef t op het gedeel te van de s t r u k t u u r overeen-
komend met endor f i ne (Hoofdstuk IV) . 
De hierboven genoemde r e s u l t a t e n z i j n verkregen aan de hand van in viiro i ncu -
b a t i e s . U i t in vivo exper imenten, waarb i j de rad ioak t i eve aminozuren werden 
toegediend v ia een osmotische min¡pomp, bleek dat de pept iden d ie in vitro ge-
syn the t i see rd worden, deze l fde z i j n a l s d ie welke in het levende d i e r worden 
aangemaakt (Hoofdstuk V ) . 
in deel I I wordt de a f g i f t e van pept iden door de pa is in termedia en de regu-
l a t i e daarvan beschreven. Een mikrosuper fus iesysteem werd on tw ikke ld waarmee de 
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spontane a f g i f t e van Produkten zowel a l s het e f f e k t daarop van een bepaalde 
regulerende s to f werd bepaald aan dezel fde k l i e r (Hoofdstuk V I ) . A l l e r e e r s t 
bleek dat a l l e nieuw-gevormde pept iden werden afgegeven aan het medium. B i j de 
r e g u l a t i e van de p e p t ¡ d e n - a f g ¡ f t e z i j n w a a r s c h i j n l i j k dopamine receptoren en 
α- en ß-adrenerge receptoren be t rokken . B i j i n h i b i t i e , b e w e r k s t e l l i g d v ia do-
pamine of a-adrenerge recep to ren , werd de a f g i f t e van a l l e pept iden geremd en 
in dezel fde mate. B i j s t i m u l a t i e , w a a r s c h i j n l i j k v ia g-adrenerge recep to ren , 
werd de a f g i f t e van a l l e pept iden in dezel fde mate bevorderd . Onder de omstan-
digheden van deze experimenten was de r e g u l a t i e van de pars intermedia voor-
namei i j k van remmende aard (Hoofdstuk V i l ) . B i j een spec ia le analyse b e t r e f f e n -
de de a f g i f t e van a-MSH, gemeten met behulp van een radioimmunoassay, bleek 
een overeenkomstig regu la t iesys teem werkzaam te z i j n (Hoofdstuk V I I I ) . 
De n e u r o t r a n s m i t t e r s a c e t y l c h o l i n e en se ro ton ine , en de pept iden L - p r o l y l - L -
leucy1-g lyc inamide (PLG), vaso toc ine , e n k e f a l i n e en ß-endor f ine bleken nauwe-
l i j k s of geen e f f e k t te hebben op de a f g i f t e van nieuw-gevormde pep t i den . Voor-
lop ige gegevens werden verkregen over de inv loed van γ-aminoboterzuur (GABA), 
+ 2+ 
К - en Ca - ionen (Hoofdstuk V I I ) . C y c l i s c h guanosine monofosfaat ( c y c l i s c h 
GMP) gaf een s p e c i f i e k e remming van de melanotrope pept iden en induceerde bo­
vendien de vorming van twee nog n i e t eerder gevonden pept iden (Appendix b i j 
Hoofdstuk V I I ) . 
In het l a a t s t e hoofdstuk wordt beschreven hoe a-MSH wordt g e s y n t h e t i s e e r d en 
afgegeven. Het bleek dat des-Na-acetyl-a-MSH a l s de d i r e k t e p r e c u r s o r van a-MSH 
f u n g e e r t , w a a r b i j de omvorming, v ia a c e t y l e r i n g , p l a a t s v i n d t v l a k voor of t i j ­
dens de a f g i f t e (Hoofdstuk I X ) . 
Voor een schema dat de samenvatt ing b i e d t van de r e s u l t a t e n over de b i o s y n ­
t h e t i s c h e processen in de pars intermedia wordt verwezen naar de "Concluding 
remarks". 
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CURRICULUM VITAE 
Gerard Martens werd op 28 j u l i IBS'» te Asten (N-Br) geboren. H i j behaalde in 
mei 1972 het eindexamen Atheneum-B aan het Peel land Col lege te Deurne en begon 
in september van dat j aa r met de s tud ie scheikunde aan de Katho l ieke U n i v e r s i -
t e i t te Nijmegen. Het kandidaatsexamen werd in mei 1975 a f g e l e g d . Het doc to-
raalexamen met het hoofdvak biochemie ( P r o f . D r . H.J. Hoenders en P r o f . D r . 
S.L. Bont ing) en de b i j vakken d i e r f y s i o l o g i e (Dr. B.G. Jenks en P r o f . D r . A .P. 
van Overbeeke) en b i o f ys i s che chemie ( P r o f . D r . C.W. H i l be rs ) behaalde h i j in 
f e b r u a r i 1979. T i j dens de doc to raa l fase werd het examen Deskundigheid S t r a l i n g s -
hygiëne voor een C- labora to r ium met goed gevolg a fge legd en werd de o n d e r w i j s -
bevoegdheid in scheikunde verkregen. Van a p r i l 1979 t o t a p r i l I982 was h i j a l s 
wetenschappe l i j k ambtenaar verbonden aan de a f d e l i n g d i e r f y s i o l o g i e van de 
Katho l ieke U n i v e r s i t e i t te Nijmegen in d i ens t van de Nederlandse Organ isa t ie 
voor Zu iver -Wetenschappe l i j k Onderzoek (ZWO). 
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STELLINGEN 
I 
De biologische aktiviteit van peptide hormonen wordt onder andere bepaald 
door het al of niet geacetyleerd zijn van deze produkten. 
II 
Het is geen goed gebruik om ß-endorfine als ß-LPH-(6l-91) aan te duiden. 
Ill 
De meest geschikte dieren voor de bestudering van de regulatie van peptiden-
afgifte door de pars intermedia van Xenopus Zaevis zijn wellicht dieren 
waarvan de dispersiegraad van de melanosomen ligt midden tussen die van vol-
ledig wit- en die van volledig zwart-geadapteerde exemplaren. 
IV 
Het in I98I door McLean en Lowry geïsoleerde peptide uit de hypofyse van 
hondshaaien, wordt door deze onderzoekers ten onrechte als γ-MSH aangeduid. 
McLean, С. en Lowry, P.J. (Ί98Ί) Nature (Land.) 2Э0, 341-343. 
V 
De conclusie van Loh en Gainer dat bij omvorming van niet-geglycosyleerd pro-
opiomelanocortine abnormale eindprodukten ontstaan, valt niet uit de resulta­
ten van hun onderzoek af te leiden. 
Lok, Ï.F. en Gainer, E. (1978) FEBS Letters 96, 269-272. 
VI 
In onderzoekingen waarbij stereotactische technieken worden gebruikt, moet 
rekening worden gehouden met de genetische variabiliteit in de morfologische 
eigenschappen van de proefdieren. 
Wahlsten, D.,Hudspeth, W.J. en Bernhardt, К. (1975) 
J. Comp. Neur. 162, 519-532. 
VI I 
Ligand-receptor bindingsstudies, hoe waardevol ook, hebben het klassi f¡ceren 
van receptoren eerder bemoeilijkt dan vereenvoudigd. 
Birdsall, N.J.M., Burger, A.S.V. en Hulme, E.C. (7978) 
Mol. Pharmacol. 14, 723-736. 
VI! I 
Het opsporen van middelen die in de sport als "doping" worden gebruikt, leidt 
tot de ontwikkeling van nieuwe dopingmiddelen. 
IX 
Het gegeven dat de ongeoefende dammer meestal randopeningen speelt terwijl de 
meer gevorderde speler de voorkeur zal geven aan centrumopeningen, is op zich 
zelf geen illustratie van een doorgaans wel aanwezig krachtsverschil. 
X 
Het huidige betaald voetbal weet noch het publiek noch zich zelf te onderhou-
den. 
ik mei 1982 Gerard J.M. Martens 
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"Biosynthesis and release of peptides related to pro-opiomelanocortin by the 
pars intermedia of the amphibian Xenopus laevis " 


